Seed	Sign	Gene_target	Ensembl	Repeated	N_repeated	Repeated2	N_repeated2	P-value	Ortholist2	Orthologs	TRRUST(+)	Phenotype	GO	GOterm	Keyword	Reactome	Reactome_terms
COQ5	positive	ZFP64	ENSG00000020256	COQ5	1	COQ5	1	0.00262581180464172	WBGene00010264;WBGene00018740				GO:0003676;GO:0005634;GO:0046872;GO:0003677;GO:0005515	nucleic acid binding;nucleus;metal ion binding;DNA binding;protein binding	3D-structure;Alternative splicing;DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger		
COQ5	positive	FKBP3	ENSG00000100442	COQ5	1	COQ5	1	0.00262581180464172	WBGene00001427;WBGene00001431;WBGene00001433	WBGene00001429(0);WBGene00001430(0)			GO:0003723;GO:0005634;GO:0016853;GO:0003755;GO:0005515;GO:0000413;GO:0038023;GO:0005528	peptidyl-prolyl cis-trans isomerase activity;RNA binding;nucleus;isomerase activity;protein binding;protein peptidyl-prolyl isomerization;signaling receptor activity;FK506 binding	3D-structure;Acetylation;Isomerase;Nucleus;Phosphoprotein;Reference proteome;Rotamase		
COQ5	positive	MTFMT	ENSG00000103707	COQ5	1	COQ5	1	0.00262581180464172				Combined oxidative phosphorylation defect type 15;Leigh syndrome with leukodystrophy;COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15;MITOCHONDRIAL COMPLEX I DEFICIENCY NUCLEAR TYPE 27	GO:0006412;GO:0016740;GO:0003824;GO:0005739;GO:0009058;GO:0006413;GO:0016742;GO:0004479;GO:0071951	catalytic activity;biosynthetic process;hydroxymethyl-, formyl- and related transferase activity;methionyl-tRNA formyltransferase activity;conversion of methionyl-tRNA to N-formyl-methionyl-tRNA;translation;transferase activity;mitochondrion;translational initiation	Alternative splicing;Disease mutation;Mitochondrion;Polymorphism;Primary mitochondrial disease;Protein biosynthesis;Reference proteome;Transferase;Transit peptide	R-HSA-392499;R-HSA-72766;R-HSA-5368286;R-HSA-5368287	Metabolism of proteins;Translation;Mitochondrial translation initiation;Mitochondrial translation
COQ5	positive	CPSF3	ENSG00000119203	COQ5	1	COQ5	1	0.00262581180464172	WBGene00013460	WBGene00013460(0)			GO:0003723;GO:0006397;GO:0005634;GO:0046872;GO:0016787;GO:0004519;GO:0090502;GO:0004518;GO:0005515;GO:0004521;GO:0006378;GO:0005847;GO:0005654;GO:0006406;GO:0031124;GO:0000398;GO:0006369;GO:0008409;GO:0006398;GO:0006379	RNA binding;mRNA processing;nucleus;metal ion binding;hydrolase activity;nuclease activity;endonuclease activity;RNA phosphodiester bond hydrolysis, endonucleolytic;protein binding;endoribonuclease activity;mRNA polyadenylation;mRNA cleavage and polyadenylation specificity factor complex;nucleoplasm;mRNA export from nucleus;mRNA 3'-end processing;mRNA splicing, via spliceosome;termination of RNA polymerase II transcription;5'-3' exonuclease activity;mRNA 3'-end processing by stem-loop binding and cleavage;mRNA cleavage	3D-structure;Acetylation;Endonuclease;Hydrolase;Isopeptide bond;Metal-binding;Nuclease;Nucleus;Phosphoprotein;Polymorphism;RNA-binding;Reference proteome;Ribonucleoprotein;Ubl conjugation;Zinc;mRNA processing	R-HSA-73857;R-HSA-74160;R-HSA-8953854;R-HSA-159231;R-HSA-159234;R-HSA-72202;R-HSA-72203;R-HSA-72187;R-HSA-73856;R-HSA-72163;R-HSA-72172;R-HSA-75067;R-HSA-77595	RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;mRNA 3'-end processing;RNA Polymerase II Transcription Termination;mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intronless Pre-mRNA;Processing of Intronless Pre-mRNAs
COQ5	positive	EXOC4	ENSG00000131558	COQ5	1	COQ5	1	0.00262581180464172	WBGene00004753	WBGene00004753(0)			GO:0016020;GO:0015031;GO:0000145;GO:0006887;GO:0042995;GO:0005515;GO:0005886;GO:0006904;GO:0006893;GO:0007268;GO:0045202;GO:0005737;GO:0005829;GO:0006612;GO:0090543;GO:0017160;GO:0047485;GO:0016241;GO:0032584;GO:0090522;GO:0030165;GO:0048341;GO:0005902;GO:0035748	vesicle docking involved in exocytosis;exocyst;vesicle tethering involved in exocytosis;cell;membrane;protein transport;exocytosis;cell projection;protein binding;plasma membrane;Golgi to plasma membrane transport;chemical synaptic transmission;synapse;cytoplasm;cytosol;protein targeting to membrane;Flemming body;Ral GTPase binding;protein N-terminus binding;regulation of macroautophagy;growth cone membrane;PDZ domain binding;paraxial mesoderm formation;microvillus;myelin sheath abaxonal region	Acetylation;Alternative splicing;Cell projection;Coiled coil;Direct protein sequencing;Exocytosis;Phosphoprotein;Polymorphism;Protein transport;Reference proteome;Transport	R-HSA-5653656;R-HSA-1852241;R-HSA-5617833;R-HSA-392499;R-HSA-199991;R-HSA-1445148;R-HSA-5620920;R-HSA-2980736;R-HSA-264876;R-HSA-5620916	Vesicle-mediated transport;Organelle biogenesis and maintenance;Cilium Assembly;Metabolism of proteins;Membrane Trafficking;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Cargo trafficking to the periciliary membrane;Peptide hormone metabolism;Insulin processing;VxPx cargo-targeting to cilium
COQ5	positive	SLC39A11	ENSG00000133195	COQ5	1	COQ5	1	0.00262581180464172	WBGene00019077	WBGene00019077(1)			GO:0005634;GO:0005737;GO:0016020;GO:0016021;GO:0055085;GO:0005794;GO:0006811;GO:0005886;GO:0046873;GO:0030001;GO:0005385;GO:0071577;GO:0006829	membrane;transmembrane transport;metal ion transmembrane transporter activity;metal ion transport;nucleus;cytoplasm;integral component of membrane;Golgi apparatus;ion transport;plasma membrane;zinc ion transmembrane transporter activity;zinc ion transmembrane transport;zinc ion transport	Alternative splicing;Cell membrane;Cytoplasm;Golgi apparatus;Ion transport;Membrane;Nucleus;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix;Transport;Zinc;Zinc transport		
COQ5	positive	PPA2	ENSG00000138777	COQ5	1	COQ5	1	0.00262581180464172	WBGene00008149	WBGene00008149(1)		Sudden arrhythmic cardiac death after infectious or alcohol trigger;SUDDEN CARDIAC FAILURE ALCOHOL-INDUCED;SUDDEN CARDIAC FAILURE INFANTILE	GO:0005737;GO:0046872;GO:0000287;GO:0016787;GO:0005739;GO:0006470;GO:0004427;GO:0006796;GO:0005759;GO:0006418;GO:0051881;GO:0071344;GO:0004722	magnesium ion binding;cytoplasm;inorganic diphosphatase activity;phosphate-containing compound metabolic process;metal ion binding;hydrolase activity;mitochondrion;protein dephosphorylation;mitochondrial matrix;tRNA aminoacylation for protein translation;regulation of mitochondrial membrane potential;diphosphate metabolic process;protein serine/threonine phosphatase activity	Acetylation;Alternative splicing;Direct protein sequencing;Disease mutation;Hydrolase;Magnesium;Metal-binding;Mitochondrion;Phosphoprotein;Polymorphism;Reference proteome;Transit peptide	R-HSA-392499;R-HSA-1430728;R-HSA-72766;R-HSA-379724;R-HSA-379726;R-HSA-71737	Metabolism of proteins;Metabolism;Translation;tRNA Aminoacylation;Mitochondrial tRNA aminoacylation;Pyrophosphate hydrolysis
COQ5	positive	PKP4	ENSG00000144283	COQ5	1	COQ5	1	0.00262581180464172	WBGene00002175				GO:0007155;GO:0098609;GO:0043547;GO:0032467;GO:0005737;GO:0016020;GO:0005886;GO:0030054;GO:0005856;GO:0005515;GO:0048471;GO:0000922;GO:0005819;GO:0030496;GO:0005634;GO:0031424;GO:0051233;GO:0005911;GO:0030155;GO:0072686;GO:0005913;GO:0045296;GO:0007043;GO:0009898;GO:0007267;GO:0070268;GO:0001533;GO:0030057;GO:0044291;GO:0014069	protein binding;cell adhesion;positive regulation of GTPase activity;cell-cell adhesion;positive regulation of cytokinesis;plasma membrane;cell junction;cytoplasm;membrane;cytoskeleton;perinuclear region of cytoplasm;spindle pole;spindle;midbody;nucleus;keratinization;spindle midzone;cell-cell junction;adherens junction;regulation of cell adhesion;mitotic spindle;cadherin binding;cell-cell junction assembly;cytoplasmic side of plasma membrane;cell-cell signaling;cornification;cornified envelope;desmosome;cell-cell contact zone;postsynaptic density	Alternative splicing;Cell adhesion;Cell junction;Cell membrane;Coiled coil;Cytoplasm;Cytoskeleton;Membrane;Methylation;Phosphoprotein;Reference proteome;Repeat	R-HSA-1266738;R-HSA-6805567;R-HSA-6809371	Developmental Biology;Keratinization;Formation of the cornified envelope
COQ5	positive	DFFA	ENSG00000160049	COQ5	1	COQ5	1	0.00262581180464172					GO:0005737;GO:0005829;GO:0005886;GO:0000790;GO:0006915;GO:0005515;GO:0060703;GO:0006309;GO:0005654;GO:0005634;GO:0019904;GO:0044183;GO:0032076;GO:0043065;GO:0061077;GO:0070242;GO:1900118;GO:1902511;GO:0005622;GO:0007165	apoptotic process;apoptotic DNA fragmentation;deoxyribonuclease inhibitor activity;cytoplasm;cytosol;plasma membrane;nuclear chromatin;protein binding;nucleoplasm;regulation of apoptotic process;nucleus;protein-containing complex;protein domain specific binding;protein folding chaperone;negative regulation of deoxyribonuclease activity;positive regulation of apoptotic process;chaperone-mediated protein folding;thymocyte apoptotic process;negative regulation of execution phase of apoptosis;negative regulation of apoptotic DNA fragmentation;signal transduction	3D-structure;Acetylation;Alternative splicing;Apoptosis;Cytoplasm;Direct protein sequencing;Phosphoprotein;Reference proteome	R-HSA-109581;R-HSA-5357801;R-HSA-140342;R-HSA-75153	Apoptosis;Programmed Cell Death;Apoptosis induced DNA fragmentation;Apoptotic execution phase
COQ5	positive	PDSS2	ENSG00000164494	COQ5	1	COQ5	1	0.00262581180464172				Leigh syndrome with nephrotic syndrome;COENZYME Q10 DEFICIENCY PRIMARY 3;COENZYME Q10 DEFICIENCY PRIMARY 3	GO:0016740;GO:0005829;GO:0005739;GO:0008299;GO:0006744;GO:0005759;GO:1990234;GO:0046982;GO:0000010;GO:0050347;GO:0050878	isoprenoid biosynthetic process;transferase activity;cytosol;mitochondrion;ubiquinone biosynthetic process;mitochondrial matrix;protein binding;transferase complex;trans-hexaprenyltranstransferase activity;protein heterodimerization activity;trans-octaprenyltranstransferase activity;regulation of body fluid levels	Alternative splicing;Disease mutation;Isoprene biosynthesis;Mitochondrion;Polymorphism;Primary mitochondrial disease;Reference proteome;Transferase;Ubiquinone biosynthesis	R-HSA-1430728;R-HSA-196854;R-HSA-2142789;R-HSA-8978934	Metabolism;Metabolism of vitamins and cofactors;Ubiquinol biosynthesis;Metabolism of cofactors
COQ5	positive	ECI1	ENSG00000167969	COQ5	1	COQ5	1	0.00262581180464172					GO:0016853;GO:0003824;GO:0005739;GO:0005759;GO:0006629;GO:0006631;GO:0006635;GO:0004165;GO:0004300	catalytic activity;isomerase activity;mitochondrion;mitochondrial matrix;lipid metabolic process;fatty acid metabolic process;dodecenoyl-CoA delta-isomerase activity;fatty acid beta-oxidation;enoyl-CoA hydratase activity;intramolecular oxidoreductase activity, transposing C=C bonds	3D-structure;Acetylation;Alternative splicing;Direct protein sequencing;Fatty acid metabolism;Isomerase;Lipid metabolism;Mitochondrion;Reference proteome;Transit peptide	R-HSA-1430728;R-HSA-556833;R-HSA-8978868;R-HSA-77289;R-HSA-77288	Metabolism;Metabolism of lipids;Fatty acid metabolism;Mitochondrial Fatty Acid Beta-Oxidation;mitochondrial fatty acid beta-oxidation of unsaturated fatty acids
COQ5	positive	NMNAT1	ENSG00000173614	COQ5	1	COQ5	1	0.00262581180464172	WBGene00009176;WBGene00012295			Cone rod dystrophy;Leber congenital amaurosis;Leber congenital amaurosis;LEBER CONGENITAL AMAUROSIS 9	GO:0005654;GO:0003824;GO:0009058;GO:0016604;GO:0005634;GO:0000166;GO:0005524;GO:0016740;GO:0005515;GO:0016779;GO:0000309;GO:0004515;GO:0009435;GO:0009611;GO:0019363;GO:0043410;GO:0043524;GO:1902511;GO:0005737;GO:0042802;GO:0009165;GO:0019674;GO:1990966	catalytic activity;biosynthetic process;nucleoplasm;nuclear body;NAD biosynthetic process;nucleotidyltransferase activity;nucleus;nucleotide binding;ATP binding;transferase activity;protein binding;nicotinamide-nucleotide adenylyltransferase activity;nicotinate-nucleotide adenylyltransferase activity;response to wounding;pyridine nucleotide biosynthetic process;positive regulation of MAPK cascade;negative regulation of neuron apoptotic process;negative regulation of neuron death;negative regulation of apoptotic DNA fragmentation;cytoplasm;identical protein binding;nucleotide biosynthetic process;NAD metabolic process;ATP generation from poly-ADP-D-ribose	3D-structure;ATP-binding;Direct protein sequencing;Disease mutation;Leber congenital amaurosis;Magnesium;NAD;Nucleotide-binding;Nucleotidyltransferase;Nucleus;Phosphoprotein;Pyridine nucleotide biosynthesis;Reference proteome;Transferase;Zinc	R-HSA-1430728;R-HSA-196854;R-HSA-196849;R-HSA-196807	Metabolism;Metabolism of vitamins and cofactors;Metabolism of water-soluble vitamins and cofactors;Nicotinate metabolism
COQ5	positive	TUFM	ENSG00000178952	COQ5	1	COQ5	1	0.00262581180464172	WBGene00007000	WBGene00007000(0)		Combined oxidative phosphorylation defect type 4;COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4;COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4	GO:0003723;GO:0016020;GO:0006412;GO:0000166;GO:0005739;GO:0003924;GO:0005525;GO:0005515;GO:0003746;GO:0006414;GO:0045471;GO:0045202;GO:0070062;GO:0042645;GO:0070125;GO:0005622	GTP binding;GTPase activity;translation elongation factor activity;translational elongation;RNA binding;membrane;translation;nucleotide binding;mitochondrion;protein binding;response to ethanol;synapse;extracellular exosome;viral process;mitochondrial nucleoid;mitochondrial translational elongation	Acetylation;Direct protein sequencing;Disease mutation;Elongation factor;GTP-binding;Host-virus interaction;Mitochondrion;Nucleotide-binding;Phosphoprotein;Primary mitochondrial disease;Protein biosynthesis;Reference proteome;Transit peptide	R-HSA-392499;R-HSA-72766;R-HSA-5368287;R-HSA-5389840	Metabolism of proteins;Translation;Mitochondrial translation;Mitochondrial translation elongation
COQ5	positive	MKS1	ENSG00000011143	COQ5	1	COQ5	1	0.00543718303669905		WBGene00020100(0)		Bardet-Biedl syndrome;Joubert Syndrome;Joubert syndrome with ocular defect;Meckel syndrome;BARDET-BIEDL SYNDROME TYPE 13;Meckel syndrome type 1;BARDET-BIEDL SYNDROME 13;JOUBERT SYNDROME 28;MECKEL SYNDROME TYPE 1	GO:0005737;GO:0005856;GO:0042995;GO:0005515;GO:0005813;GO:0005815;GO:0005929;GO:0036064;GO:0060271;GO:0005829;GO:0030030;GO:0097711;GO:0036038;GO:0001843;GO:0003271;GO:0003279;GO:0007224;GO:0007368;GO:0008589;GO:0010669;GO:0042733;GO:0044458;GO:0048706;GO:0048754;GO:0060122;GO:0060322;GO:0060411;GO:0060828;GO:0061009;GO:1901620;GO:1905515;GO:1990403;GO:2000095;GO:0005814;GO:0016020;GO:0035869	cytoplasm;cytoskeleton;cell projection;protein binding;centrosome;microtubule organizing center;cilium;ciliary basal body;cilium assembly;cytosol;cell projection organization;ciliary basal body-plasma membrane docking;MKS complex;neural tube closure;smoothened signaling pathway involved in regulation of secondary heart field cardioblast proliferation;determination of left/right symmetry;regulation of smoothened signaling pathway;epithelial structure maintenance;embryonic digit morphogenesis;motile cilium assembly;embryonic skeletal system development;branching morphogenesis of an epithelial tube;inner ear receptor cell stereocilium organization;head development;cardiac septum morphogenesis;regulation of canonical Wnt signaling pathway;common bile duct development;regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning;non-motile cilium assembly;embryonic brain development;regulation of Wnt signaling pathway, planar cell polarity pathway;centriole;membrane;ciliary transition zone	Alternative splicing;Bardet-Biedl syndrome;Cell projection;Ciliopathy;Cilium;Cilium biogenesis/degradation;Cytoplasm;Cytoskeleton;Disease mutation;Joubert syndrome;Meckel syndrome;Mental retardation;Obesity;Polymorphism;Reference proteome	R-HSA-1852241;R-HSA-5617833;R-HSA-162582;R-HSA-5358351;R-HSA-5610787;R-HSA-5620912	Organelle biogenesis and maintenance;Cilium Assembly;Signal Transduction;Signaling by Hedgehog;Hedgehog 'off' state;Anchoring of the basal body to the plasma membrane
COQ5	positive	NUCKS1	ENSG00000069275	COQ5	1	COQ5	1	0.00543718303669905					GO:0005737;GO:0005634;GO:0003723;GO:0005730;GO:0006357;GO:0000790;GO:0008134;GO:0000785;GO:0036297;GO:0043923;GO:0003682;GO:0071481;GO:0000724;GO:0003690;GO:0001228;GO:0003697;GO:0001678;GO:0006275;GO:0006325;GO:0019046;GO:0031297;GO:0035822;GO:0042593;GO:0044829;GO:0045944;GO:0046626;GO:0046628;GO:0060382;GO:1990968;GO:1990969	cytoplasm;nucleus;cell;RNA binding;nucleoplasm;nucleolus;regulation of transcription by RNA polymerase II;nuclear chromatin;transcription factor binding;chromatin;interstrand cross-link repair;positive regulation by host of viral transcription;chromatin binding;cellular response to X-ray;double-strand break repair via homologous recombination;double-stranded DNA binding;DNA-binding transcription activator activity, RNA polymerase II-specific;single-stranded DNA binding;cellular glucose homeostasis;regulation of DNA replication;chromatin organization;release from viral latency;replication fork processing;gene conversion;glucose homeostasis;positive regulation by host of viral genome replication;positive regulation of transcription by RNA polymerase II;regulation of insulin receptor signaling pathway;positive regulation of insulin receptor signaling pathway;regulation of DNA strand elongation;modulation by host of RNA binding by virus;modulation by host of viral RNA-binding transcription factor activity	Alternative splicing;Nucleus;Phosphoprotein;Polymorphism;Reference proteome		
COQ5	positive	L2HGDH	ENSG00000087299	COQ5	1	COQ5	1	0.00543718303669905	WBGene00021564	WBGene00021564(1)		L-2-HYDROXYGLUTARIC ACIDURIA;L-2-HYDROXYGLUTARIC ACIDURIA;L-2-HYDROXYGLUTARIC ACIDURIA	GO:0055114;GO:0016491;GO:0005739;GO:0005743;GO:0016021;GO:0006103;GO:0044267;GO:0003973;GO:0047545;GO:0031305	oxidation-reduction process;oxidoreductase activity;mitochondrion;mitochondrial inner membrane;integral component of membrane;2-oxoglutarate metabolic process;cellular protein metabolic process;(S)-2-hydroxy-acid oxidase activity;2-hydroxyglutarate dehydrogenase activity;integral component of mitochondrial inner membrane	Acetylation;Alternative splicing;Disease mutation;FAD;Flavoprotein;Mitochondrion;Oxidoreductase;Polymorphism;Reference proteome;Transit peptide	R-HSA-1430728;R-HSA-1428517;R-HSA-71406;R-HSA-880009	Metabolism;The citric acid (TCA) cycle and respiratory electron transport;Pyruvate metabolism and Citric Acid (TCA) cycle;Interconversion of 2-oxoglutarate and 2-hydroxyglutarate
COQ5	positive	AAAS	ENSG00000094914	COQ5	1	COQ5	1	0.00543718303669905				Triple A syndrome;Achalasia-Addisonianism-Alacrima syndrome;Achalasia-Addisonianism-Alacrima syndrome	GO:0005515;GO:0051028;GO:0005634;GO:0005737;GO:0016020;GO:0015031;GO:0005813;GO:0005829;GO:0005654;GO:0031965;GO:0005856;GO:0005643;GO:0000922;GO:0003674;GO:0001578;GO:0075733;GO:0043657;GO:0006110;GO:0006406;GO:0006409;GO:0016032;GO:0016925;GO:0019083;GO:0060964;GO:1900034;GO:0005635;GO:0072686;GO:0090307;GO:0046822;GO:0006913;GO:0007612;GO:0009566	protein binding;mRNA transport;nucleus;cytoplasm;membrane;protein transport;nucleoplasm;cytosol;cytoskeleton;nuclear membrane;centrosome;nuclear pore;spindle pole;molecular_function;microtubule bundle formation;intracellular transport of virus;host cell;regulation of glycolytic process;mRNA export from nucleus;tRNA export from nucleus;viral process;protein sumoylation;viral transcription;regulation of gene silencing by miRNA;regulation of cellular response to heat;nuclear envelope;mitotic spindle;mitotic spindle assembly;regulation of nucleocytoplasmic transport;nucleocytoplasmic transport;learning;fertilization	Acetylation;Alternative splicing;Cytoplasm;Cytoskeleton;Disease mutation;Nuclear pore complex;Nucleus;Phosphoprotein;Protein transport;Reference proteome;Repeat;Translocation;Transport;WD repeat;mRNA transport	R-HSA-168256;R-HSA-392499;R-HSA-597592;R-HSA-74160;R-HSA-1430728;R-HSA-1640170;R-HSA-72306;R-HSA-8953854;R-HSA-1643685;R-HSA-162587;R-HSA-162599;R-HSA-162906;R-HSA-5663205;R-HSA-1280215;R-HSA-162909;R-HSA-2262752;R-HSA-5619115;R-HSA-68886;R-HSA-69278;R-HSA-8953897;R-HSA-70171;R-HSA-70326;R-HSA-71387;R-HSA-1169408;R-HSA-1169410;R-HSA-159227;R-HSA-159230;R-HSA-159231;R-HSA-159234;R-HSA-159236;R-HSA-165054;R-HSA-168253;R-HSA-168254;R-HSA-168255;R-HSA-168271;R-HSA-168273;R-HSA-168274;R-HSA-168276;R-HSA-168325;R-HSA-168333;R-HSA-170822;R-HSA-176033;R-HSA-177243;R-HSA-180746;R-HSA-180910;R-HSA-191859;R-HSA-194441;R-HSA-211000;R-HSA-2980766;R-HSA-2990846;R-HSA-3108214;R-HSA-3108232;R-HSA-3232142;R-HSA-3301854;R-HSA-3371453;R-HSA-3371556;R-HSA-4085377;R-HSA-4551638;R-HSA-4570464;R-HSA-4615885;R-HSA-5578749;R-HSA-5619102;R-HSA-5619107;R-HSA-6784531;R-HSA-68875;R-HSA-72202;R-HSA-72203;R-HSA-913531	Immune System;Metabolism of proteins;Post-translational protein modification;Gene expression (Transcription);Metabolism;Cell Cycle;tRNA processing;Metabolism of RNA;Disease;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Infectious disease;Cytokine Signaling in Immune system;Host Interactions of HIV factors;Cellular responses to stress;Disorders of transmembrane transporters;M Phase;Cell Cycle, Mitotic;Cellular responses to external stimuli;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;Rev-mediated nuclear export of HIV RNA;Host Interactions with Influenza Factors;Influenza Infection;Influenza Life Cycle;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;NS1 Mediated Effects on Host Pathways;Viral Messenger RNA Synthesis;NEP/NS2 Interacts with the Cellular Export Machinery;Regulation of Glucokinase by Glucokinase Regulatory Protein;Interactions of Vpr with host cellular proteins;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Vpr-mediated nuclear import of PICs;snRNP Assembly;Metabolism of non-coding RNA;Gene Silencing by RNA;Nuclear Envelope Breakdown;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of ubiquitinylation proteins;Nuclear Pore Complex (NPC) Disassembly;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;SUMOylation of SUMOylation proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA replication proteins;Transcriptional regulation by small RNAs;SLC transporter disorders;Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC);tRNA processing in the nucleus;Mitotic Prophase;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;Interferon Signaling
COQ5	positive	CBX5	ENSG00000094916	COQ5	1	COQ5	1	0.00543718303669905	WBGene00001995;WBGene00001996	WBGene00007615(0);WBGene00001995(0)			GO:0005634;GO:0005694;GO:0005515;GO:0006974;GO:0042802;GO:0000775;GO:0000122;GO:0005654;GO:0032991;GO:0000784;GO:0016032;GO:0043021;GO:1990904;GO:0005635;GO:0045892;GO:0070317;GO:0044877;GO:0035064;GO:0005730;GO:0030674;GO:0007596;GO:0017053;GO:0016605;GO:0005721;GO:0090734;GO:0000118;GO:0070491;GO:0031618;GO:0003682;GO:0042803;GO:0042826;GO:0000776;GO:0000792;GO:0005720;GO:0010369;GO:0035097	nucleus;nucleoplasm;chromosome;protein binding;cellular response to DNA damage stimulus;identical protein binding;chromosome, centromeric region;negative regulation of transcription by RNA polymerase II;protein-containing complex;nuclear chromosome, telomeric region;viral process;ribonucleoprotein complex binding;ribonucleoprotein complex;nuclear envelope;negative regulation of transcription, DNA-templated;negative regulation of G0 to G1 transition;protein-containing complex binding;methylated histone binding;nucleolus;protein binding, bridging;blood coagulation;transcriptional repressor complex;PML body;pericentric heterochromatin;site of DNA damage;histone deacetylase complex;repressing transcription factor binding;nuclear pericentric heterochromatin;chromatin binding;histone deacetylase binding;kinetochore;heterochromatin;nuclear heterochromatin;chromocenter;histone methyltransferase complex	3D-structure;Acetylation;Centromere;Chromosome;Direct protein sequencing;Host-virus interaction;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation	R-HSA-109582;R-HSA-392499;R-HSA-597592;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-983231;R-HSA-2990846;R-HSA-3108232;R-HSA-4551638;R-HSA-8953750	Hemostasis;Metabolism of proteins;Post-translational protein modification;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Factors involved in megakaryocyte development and platelet production;SUMOylation;SUMO E3 ligases SUMOylate target proteins;SUMOylation of chromatin organization proteins;Transcriptional Regulation by E2F6
COQ5	positive	PCK2	ENSG00000100889	COQ5	1	COQ5	1	0.00543718303669905	WBGene00011232;WBGene00021043;WBGene00019151	WBGene00019151(0);WBGene00021043(0);WBGene00011232(0)		Phosphoenolpyruvate carboxykinase deficiency;PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY MITOCHONDRIAL	GO:0005739;GO:0005525;GO:0006094;GO:0004611;GO:0004613;GO:0017076;GO:0046872;GO:0000166;GO:0016301;GO:0016310;GO:0016829;GO:0005515;GO:0016831;GO:0005829;GO:0005759;GO:0042594;GO:0070365;GO:0030145;GO:0071333;GO:0033993;GO:0006090;GO:0032869;GO:0019543;GO:0046327;GO:0071549	GTP binding;gluconeogenesis;phosphoenolpyruvate carboxykinase activity;purine nucleotide binding;phosphoenolpyruvate carboxykinase (GTP) activity;mitochondrion;cell;metal ion binding;nucleotide binding;kinase activity;phosphorylation;lyase activity;protein binding;carboxy-lyase activity;cytosol;mitochondrial matrix;response to starvation;response to lipid;hepatocyte differentiation;manganese ion binding;cellular response to glucose stimulus;pyruvate metabolic process;cellular response to insulin stimulus;propionate catabolic process;glycerol biosynthetic process from pyruvate;cellular response to dexamethasone stimulus	Acetylation;Alternative splicing;Decarboxylase;GTP-binding;Gluconeogenesis;Lyase;Manganese;Metal-binding;Mitochondrion;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Transit peptide	R-HSA-1430728;R-HSA-70326;R-HSA-71387;R-HSA-70263	Metabolism;Glucose metabolism;Metabolism of carbohydrates;Gluconeogenesis
COQ5	positive	CSTF1	ENSG00000101138	COQ5	1	COQ5	1	0.00543718303669905	WBGene00000773	WBGene00000773(1)			GO:0005515;GO:0003723;GO:0006397;GO:0005634;GO:0005654;GO:0031124;GO:0000398;GO:0006369;GO:0005848	protein binding;RNA binding;mRNA processing;nucleus;nucleoplasm;mRNA 3'-end processing;mRNA splicing, via spliceosome;termination of RNA polymerase II transcription;mRNA cleavage stimulating factor complex	3D-structure;Direct protein sequencing;Nucleus;Reference proteome;Repeat;WD repeat;mRNA processing	R-HSA-73857;R-HSA-74160;R-HSA-8953854;R-HSA-72203;R-HSA-72187;R-HSA-73856;R-HSA-72163;R-HSA-72172;R-HSA-75067;R-HSA-77595	RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA;Processing of Capped Intron-Containing Pre-mRNA;mRNA 3'-end processing;RNA Polymerase II Transcription Termination;mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intronless Pre-mRNA;Processing of Intronless Pre-mRNAs
COQ5	positive	DNAJA3	ENSG00000103423	COQ5	1	COQ5	1	0.00543718303669905	WBGene00001028;WBGene00001036	WBGene00001028(1)			GO:0005737;GO:0016020;GO:0043231;GO:0046872;GO:0005524;GO:0005739;GO:0005759;GO:0005829;GO:0006457;GO:0005886;GO:0050790;GO:0005515;GO:0006915;GO:0030054;GO:0045202;GO:0045211;GO:0051082;GO:0031072;GO:0009408;GO:0000122;GO:0008285;GO:0042645;GO:0005884;GO:0071340;GO:0031594;GO:0019897;GO:0007005;GO:0030544;GO:0030695;GO:0006264;GO:0006924;GO:0007264;GO:0007528;GO:0007569;GO:0033077;GO:0042102;GO:0043069;GO:0005634	ATP binding;protein folding;heat shock protein binding;unfolded protein binding;response to heat;cytoplasm;membrane;intracellular membrane-bounded organelle;metal ion binding;mitochondrion;mitochondrial matrix;cytosol;plasma membrane;regulation of catalytic activity;protein binding;apoptotic process;cell junction;synapse;postsynaptic membrane;negative regulation of transcription by RNA polymerase II;negative regulation of cell population proliferation;regulation of apoptotic process;mitochondrial nucleoid;actin filament;skeletal muscle acetylcholine-gated channel clustering;neuromuscular junction;extrinsic component of plasma membrane;mitochondrion organization;Hsp70 protein binding;GTPase regulator activity;mitochondrial DNA replication;activation-induced cell death of T cells;small GTPase mediated signal transduction;neuromuscular junction development;cell aging;T cell differentiation in thymus;positive regulation of T cell proliferation;negative regulation of programmed cell death;nucleus	3D-structure;Acetylation;Alternative splicing;Apoptosis;Cell junction;Cell membrane;Chaperone;Cytoplasm;Membrane;Metal-binding;Methylation;Mitochondrion;Phosphoprotein;Polymorphism;Postsynaptic cell membrane;Reference proteome;Repeat;Synapse;Transit peptide;Zinc;Zinc-finger		
COQ5	positive	KNOP1	ENSG00000103550	COQ5	1	COQ5	1	0.00543718303669905					GO:0003723;GO:0005634;GO:0005730	RNA binding;nucleus;nucleolus	Isopeptide bond;Methylation;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation		
COQ5	positive	KDELR1	ENSG00000105438	COQ5	1	COQ5	1	0.00543718303669905	WBGene00001331;WBGene00016195	WBGene00016195(1);WBGene00001331(1)			GO:0016020;GO:0016021;GO:0015031;GO:0005783;GO:0005789;GO:0005794;GO:0046923;GO:0006621;GO:0000139;GO:0031410;GO:0016192;GO:0006888;GO:0005801;GO:0030663;GO:0006890;GO:0030133;GO:0033116;GO:0005793;GO:0005046;GO:0002369;GO:0030217;GO:0070231	integral component of membrane;ER retention sequence binding;protein retention in ER lumen;membrane;protein transport;endoplasmic reticulum;endoplasmic reticulum membrane;Golgi apparatus;cytoplasmic vesicle;Golgi membrane;retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;vesicle-mediated transport;COPI-coated vesicle membrane;endoplasmic reticulum to Golgi vesicle-mediated transport;cis-Golgi network;transport vesicle;endoplasmic reticulum-Golgi intermediate compartment membrane;endoplasmic reticulum-Golgi intermediate compartment;KDEL sequence binding;T cell cytokine production;T cell differentiation;T cell apoptotic process	Alternative splicing;Cytoplasmic vesicle;ER-Golgi transport;Endoplasmic reticulum;Golgi apparatus;Membrane;Phosphoprotein;Protein transport;Receptor;Reference proteome;Transmembrane;Transmembrane helix;Transport	R-HSA-5653656;R-HSA-392499;R-HSA-597592;R-HSA-199991;R-HSA-6811434;R-HSA-6811442;R-HSA-8856688;R-HSA-446203;R-HSA-199977;R-HSA-6807878;R-HSA-948021	Vesicle-mediated transport;Metabolism of proteins;Post-translational protein modification;Membrane Trafficking;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Asparagine N-linked glycosylation;ER to Golgi Anterograde Transport;COPI-mediated anterograde transport;Transport to the Golgi and subsequent modification
COQ5	positive	HIBADH	ENSG00000106049	COQ5	1	COQ5	1	0.00543718303669905	WBGene00007122				GO:0016491;GO:0050661;GO:0055114;GO:0005739;GO:0051287;GO:0008442;GO:0006574;GO:0009083;GO:0005759	oxidation-reduction process;oxidoreductase activity;NADP binding;NAD binding;3-hydroxyisobutyrate dehydrogenase activity;mitochondrion;valine catabolic process;branched-chain amino acid catabolic process;mitochondrial matrix;oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor	3D-structure;Acetylation;Branched-chain amino acid catabolism;Direct protein sequencing;Mitochondrion;NAD;Oxidoreductase;Reference proteome;Transit peptide	R-HSA-1430728;R-HSA-71291;R-HSA-70895	Metabolism;Metabolism of amino acids and derivatives;Branched-chain amino acid catabolism
COQ5	positive	MRPS27	ENSG00000113048	COQ5	1	COQ5	1	0.00543718303669905	WBGene00010766	WBGene00010766(0)			GO:0003723;GO:0005737;GO:0005739;GO:0005840;GO:0005515;GO:0019843;GO:0000049;GO:0006417;GO:0008283;GO:0070131;GO:0005743;GO:0070125;GO:0070126;GO:0005763;GO:0097177	protein binding;RNA binding;cytoplasm;nucleoplasm;nucleolus;plasma membrane;mitochondrion;ribosome;tRNA binding;regulation of translation;rRNA binding;positive regulation of mitochondrial translation;mitochondrial inner membrane;mitochondrial translational elongation;mitochondrial translational termination;mitochondrial small ribosomal subunit;cell population proliferation;mitochondrial ribosome binding	3D-structure;Alternative splicing;Coiled coil;Cytoplasm;Mitochondrion;Polymorphism;RNA-binding;Reference proteome;Repeat;Ribonucleoprotein;Ribosomal protein;Transit peptide;Translation regulation;rRNA-binding;tRNA-binding	R-HSA-392499;R-HSA-72766;R-HSA-5368286;R-HSA-5368287;R-HSA-5389840;R-HSA-5419276	Metabolism of proteins;Translation;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination
COQ5	positive	MPV17	ENSG00000115204	COQ5	1	COQ5	1	0.00543718303669905	WBGene00011826	WBGene00011826(1)		Navajo neurohepatopathy;MITOCHONDRIAL DNA DEPLETION SYNDROME 6;CHARCOT-MARIE-TOOTH DISEASE AXONAL TYPE 2EE;MITOCHONDRIAL DNA DEPLETION SYNDROME 6 (HEPATOCEREBRAL TYPE)	GO:0016020;GO:0016021;GO:0005743;GO:0005739;GO:0005777;GO:0005737;GO:0005829;GO:0003674;GO:0006625;GO:0042592;GO:0005778;GO:2000377;GO:0000002;GO:0032836;GO:0048839;GO:0034614;GO:0015267;GO:1901858;GO:0005515	integral component of membrane;membrane;mitochondrial inner membrane;mitochondrion;transmembrane transport;peroxisome;cytoplasm;cytosol;protein targeting to peroxisome;homeostatic process;peroxisomal membrane;regulation of reactive oxygen species metabolic process;mitochondrial genome maintenance;glomerular basement membrane development;inner ear development;cellular response to reactive oxygen species;channel activity;regulation of mitochondrial DNA metabolic process;protein binding	Charcot-Marie-Tooth disease;Disease mutation;Membrane;Mitochondrion;Mitochondrion inner membrane;Neurodegeneration;Neuropathy;Primary mitochondrial disease;Reference proteome;Transmembrane;Transmembrane helix	R-HSA-9033241;R-HSA-9609507	Peroxisomal protein import;Protein localization
COQ5	positive	MECR	ENSG00000116353	COQ5	1	COQ5	1	0.00543718303669905	WBGene00012375;WBGene00012970	WBGene00012375(1)		MEPAN syndrome;Childhood-Onset Dystonia and Optic Atrophy;DYSTONIA CHILDHOOD-ONSET WITH OPTIC ATROPHY AND BASAL GANGLIAABNORMALITIES	GO:0005634;GO:0005737;GO:0016491;GO:0055114;GO:0005739;GO:0006629;GO:0006631;GO:0006633;GO:0005759;GO:0006635;GO:0019166	oxidation-reduction process;oxidoreductase activity;nucleus;cytoplasm;mitochondrion;lipid metabolic process;fatty acid metabolic process;fatty acid biosynthetic process;mitochondrial matrix;fatty acid beta-oxidation;trans-2-enoyl-CoA reductase (NADPH) activity	3D-structure;Acetylation;Alternative splicing;Cytoplasm;Disease mutation;Dystonia;Fatty acid biosynthesis;Fatty acid metabolism;Lipid biosynthesis;Lipid metabolism;Mitochondrion;NADP;Nucleus;Oxidoreductase;Polymorphism;Reference proteome;Transit peptide	R-HSA-1430728;R-HSA-556833;R-HSA-8978868;R-HSA-77289;R-HSA-77286;R-HSA-77346	Metabolism;Metabolism of lipids;Fatty acid metabolism;Mitochondrial Fatty Acid Beta-Oxidation;mitochondrial fatty acid beta-oxidation of saturated fatty acids;Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA
COQ5	positive	TCTN3	ENSG00000119977	COQ5	1	COQ5	1	0.00543718303669905	WBGene00017120	WBGene00017120(0)		Orofaciodigital syndrome type 4;Orofaciodigital syndrome type 6;Mohr-Majewski Syndrome;JOUBERT SYNDROME 18;OROFACIODIGITAL SYNDROME IV	GO:0005634;GO:0016020;GO:0016021;GO:0006915;GO:0007224;GO:0060271;GO:0030030;GO:0043065;GO:0097711;GO:0060170	nucleus;membrane;integral component of membrane;apoptotic process;smoothened signaling pathway;cilium assembly;cell projection organization;positive regulation of apoptotic process;ciliary basal body-plasma membrane docking;ciliary membrane	Alternative splicing;Apoptosis;Ciliopathy;Cilium biogenesis/degradation;Disease mutation;Glycoprotein;Joubert syndrome;Membrane;Reference proteome;Signal;Transmembrane;Transmembrane helix	R-HSA-1852241;R-HSA-5617833;R-HSA-5620912	Organelle biogenesis and maintenance;Cilium Assembly;Anchoring of the basal body to the plasma membrane
COQ5	positive	MRM2	ENSG00000122687	COQ5	1	COQ5	1	0.00543718303669905	WBGene00009735;WBGene00011281;WBGene00019168	WBGene00009735(1)			GO:0016740;GO:0008168;GO:0001510;GO:0032259;GO:0005739;GO:0005730;GO:0006364;GO:0005759;GO:0000451;GO:0008650;GO:0031167	methyltransferase activity;methylation;RNA methylation;transferase activity;mitochondrion;nucleolus;rRNA processing;mitochondrial matrix;RNA methyltransferase activity;rRNA 2'-O-methylation;rRNA (uridine-2'-O-)-methyltransferase activity;rRNA methylation	3D-structure;Methyltransferase;Mitochondrion;Reference proteome;S-adenosyl-L-methionine;Transferase;Transit peptide;rRNA processing	R-HSA-8953854;R-HSA-72312;R-HSA-8868766;R-HSA-6793080	Metabolism of RNA;rRNA processing;rRNA processing in the mitochondrion;rRNA modification in the mitochondrion
COQ5	positive	ARMC7	ENSG00000125449	COQ5	1	COQ5	1	0.00543718303669905					GO:0005515	protein binding	Alternative splicing;Phosphoprotein;Reference proteome;Repeat		
COQ5	positive	NT5C	ENSG00000125458	COQ5	1	COQ5	1	0.00543718303669905					GO:0016311;GO:0008253;GO:0009264;GO:0005634;GO:0005737;GO:0046872;GO:0000166;GO:0005829;GO:0016787;GO:0009117;GO:0070062;GO:0006195;GO:0046135;GO:0008252;GO:0019103;GO:0009223;GO:0016791	5'-nucleotidase activity;deoxyribonucleotide catabolic process;dephosphorylation;nucleus;cytoplasm;metal ion binding;nucleotide binding;cytosol;hydrolase activity;nucleotide metabolic process;identical protein binding;extracellular exosome;purine nucleotide catabolic process;pyrimidine nucleoside catabolic process;nucleotidase activity;pyrimidine nucleotide binding;pyrimidine deoxyribonucleotide catabolic process;phosphatase activity	3D-structure;Alternative splicing;Cytoplasm;Direct protein sequencing;Hydrolase;Magnesium;Metal-binding;Nucleotide metabolism;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-1430728;R-HSA-15869;R-HSA-74259;R-HSA-8956319;R-HSA-73621	Metabolism;Metabolism of nucleotides;Purine catabolism;Nucleobase catabolism;Pyrimidine catabolism
COQ5	positive	CHCHD5	ENSG00000125611	COQ5	1	COQ5	1	0.00543718303669905					GO:0005739;GO:0005758	mitochondrion;mitochondrial intermembrane space	3D-structure;Acetylation;Alternative splicing;Disulfide bond;Mitochondrion;Reference proteome	R-HSA-9609507;R-HSA-1268020	Protein localization;Mitochondrial protein import
COQ5	positive	COX7C	ENSG00000127184	COQ5	1	COQ5	1	0.00543718303669905		WBGene00009161(1)			GO:0016020;GO:0016021;GO:0005743;GO:0005739;GO:1902600;GO:0004129;GO:0006123;GO:0006091;GO:0022900	cytochrome-c oxidase activity;membrane;integral component of membrane;mitochondrial inner membrane;mitochondrion;proton transmembrane transport;protein binding;mitochondrial electron transport, cytochrome c to oxygen;mitochondrial respiratory chain complex IV;generation of precursor metabolites and energy;oxidative phosphorylation;electron transport chain	3D-structure;Acetylation;Direct protein sequencing;Membrane;Mitochondrion;Mitochondrion inner membrane;Reference proteome;Transit peptide;Transmembrane;Transmembrane helix	R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-1430728;R-HSA-1428517;R-HSA-163200;R-HSA-611105;R-HSA-5628897	Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism;The citric acid (TCA) cycle and respiratory electron transport;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;TP53 Regulates Metabolic Genes
COQ5	positive	SRD5A3	ENSG00000128039	COQ5	1	COQ5	1	0.00543718303669905	WBGene00007102	WBGene00007102(0)		SRD5A3-CDG;Congenital Disorders of Glycosylation;CONGENITAL DISORDER OF GLYCOSYLATION TYPE Iq;KAHRIZI SYNDROME	GO:0016020;GO:0016021;GO:0016491;GO:0055114;GO:0005783;GO:0005789;GO:0016627;GO:0006629;GO:0006488;GO:0006486;GO:0003865;GO:0006702;GO:0047751;GO:0006489;GO:0019348;GO:0016628;GO:0102389;GO:0016095;GO:0019408	oxidoreductase activity, acting on the CH-CH group of donors;lipid metabolic process;dolichol-linked oligosaccharide biosynthetic process;3-oxo-5-alpha-steroid 4-dehydrogenase activity;membrane;integral component of membrane;oxidoreductase activity;oxidation-reduction process;endoplasmic reticulum;endoplasmic reticulum membrane;protein glycosylation;androgen biosynthetic process;cholestenone 5-alpha-reductase activity;dolichyl diphosphate biosynthetic process;dolichol metabolic process;oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor;polyprenol reductase activity;polyprenol catabolic process;dolichol biosynthetic process	Cataract;Congenital disorder of glycosylation;Endoplasmic reticulum;Membrane;Mental retardation;NADP;Oxidoreductase;Reference proteome;Transmembrane;Transmembrane helix	R-HSA-392499;R-HSA-597592;R-HSA-1430728;R-HSA-556833;R-HSA-446193;R-HSA-446203;R-HSA-446219;R-HSA-1643685;R-HSA-3781865;R-HSA-196071;R-HSA-8957322;R-HSA-5609975;R-HSA-193048;R-HSA-446199;R-HSA-4755579	Metabolism of proteins;Post-translational protein modification;Metabolism;Metabolism of lipids;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;Disease;Diseases of glycosylation;Metabolism of steroid hormones;Metabolism of steroids;Diseases associated with glycosylation precursor biosynthesis;Androgen biosynthesis;Synthesis of Dolichyl-phosphate;Defective SRD5A3 causes SRD5A3-CDG (CDG-1q) and KHRZ
COQ5	positive	ATP5MC2	ENSG00000135390	COQ5	1	COQ5	1	0.00543718303669905	WBGene00022336				GO:0016020;GO:0016021;GO:0005739;GO:1902600;GO:0006811;GO:0015078;GO:0008289;GO:0015986;GO:0031966;GO:0005515;GO:0045263;GO:0033177;GO:0005741;GO:0046933;GO:0006754;GO:0042407;GO:0042776;GO:0000276	ATP synthesis coupled proton transport;proton transmembrane transporter activity;proton transmembrane transport;proton-transporting ATP synthase complex, coupling factor F(o);proton-transporting two-sector ATPase complex, proton-transporting domain;membrane;integral component of membrane;mitochondrion;ion transport;lipid binding;protein binding;mitochondrial membrane;mitochondrial outer membrane;ATP biosynthetic process;cristae formation;mitochondrial ATP synthesis coupled proton transport;mitochondrial proton-transporting ATP synthase complex, coupling factor F(o);proton-transporting ATP synthase activity, rotational mechanism	Alternative splicing;CF(0);Hydrogen ion transport;Ion transport;Lipid-binding;Membrane;Methylation;Mitochondrion;Polymorphism;Reference proteome;Transit peptide;Transmembrane;Transmembrane helix;Transport	R-HSA-1852241;R-HSA-1430728;R-HSA-1428517;R-HSA-163200;R-HSA-1592230;R-HSA-8949613;R-HSA-163210	Organelle biogenesis and maintenance;Metabolism;The citric acid (TCA) cycle and respiratory electron transport;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Mitochondrial biogenesis;Cristae formation;Formation of ATP by chemiosmotic coupling
COQ5	positive	MRPS9	ENSG00000135972	COQ5	1	COQ5	1	0.00543718303669905	WBGene00017319	WBGene00017319(1)			GO:0003723;GO:0005730;GO:0005739;GO:0003735;GO:0006412;GO:0005840;GO:0005515;GO:0005763;GO:0005743;GO:0070125;GO:0070126;GO:0042769	structural constituent of ribosome;translation;ribosome;RNA binding;nucleolus;mitochondrion;protein binding;mitochondrial small ribosomal subunit;mitochondrial inner membrane;mitochondrial translational elongation;mitochondrial translational termination;DNA damage response, detection of DNA damage;small ribosomal subunit	3D-structure;Acetylation;Mitochondrion;Polymorphism;Reference proteome;Ribonucleoprotein;Ribosomal protein;Transit peptide	R-HSA-392499;R-HSA-72766;R-HSA-5368286;R-HSA-5368287;R-HSA-5389840;R-HSA-5419276	Metabolism of proteins;Translation;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination
COQ5	positive	ATIC	ENSG00000138363	COQ5	1	COQ5	1	0.00543718303669905	WBGene00016957	WBGene00016957(0)		AICA-ribosiduria;AICA-RIBOSURIA;AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	GO:0016020;GO:0016740;GO:0005829;GO:0016787;GO:0003824;GO:0005886;GO:0042803;GO:0008152;GO:0006164;GO:0006189;GO:0045296;GO:0070062;GO:0003937;GO:0004643;GO:0006139;GO:0009168;GO:0003360;GO:0009116;GO:0009259;GO:0010035;GO:0021549;GO:0021987;GO:0031100;GO:0046452;GO:0046654;GO:0098761	catalytic activity;purine nucleotide biosynthetic process;IMP cyclohydrolase activity;phosphoribosylaminoimidazolecarboxamide formyltransferase activity;membrane;transferase activity;cytosol;plasma membrane;hydrolase activity;protein homodimerization activity;metabolic process;'de novo' IMP biosynthetic process;cadherin binding;extracellular exosome;nucleobase-containing compound metabolic process;purine ribonucleoside monophosphate biosynthetic process;brainstem development;nucleoside metabolic process;ribonucleotide metabolic process;response to inorganic substance;cerebellum development;cerebral cortex development;animal organ regeneration;dihydrofolate metabolic process;tetrahydrofolate biosynthetic process;cellular response to interleukin-7	3D-structure;Acetylation;Alternative splicing;Direct protein sequencing;Disease mutation;Epilepsy;Hydrolase;Multifunctional enzyme;Polymorphism;Purine biosynthesis;Reference proteome;Transferase	R-HSA-1430728;R-HSA-15869;R-HSA-73817;R-HSA-8956320	Metabolism;Metabolism of nucleotides;Purine ribonucleoside monophosphate biosynthesis;Nucleobase biosynthesis
COQ5	positive	GSTCD	ENSG00000138780	COQ5	1	COQ5	1	0.00543718303669905					GO:0003674;GO:0008150;GO:0005737;GO:0005634;GO:0005654;GO:0005515;GO:0070062	molecular_function;biological_process;cytoplasm;protein binding;extracellular exosome	Alternative splicing;Cytoplasm;Phosphoprotein;Reference proteome		
COQ5	positive	ZCRB1	ENSG00000139168	COQ5	1	COQ5	1	0.00543718303669905					GO:0003676;GO:0003723;GO:0006397;GO:0008380;GO:0005634;GO:0008270;GO:0046872;GO:0005681;GO:0005654;GO:0000398;GO:0005689	zinc ion binding;nucleic acid binding;RNA binding;mRNA processing;RNA splicing;nucleus;metal ion binding;spliceosomal complex;nucleoplasm;mRNA splicing, via spliceosome;U12-type spliceosomal complex	3D-structure;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;RNA-binding;Reference proteome;Spliceosome;Zinc;Zinc-finger;mRNA processing;mRNA splicing	R-HSA-8953854;R-HSA-72203;R-HSA-72172;R-HSA-72165	Metabolism of RNA;Processing of Capped Intron-Containing Pre-mRNA;mRNA Splicing;mRNA Splicing - Minor Pathway
COQ5	positive	NDUFB10	ENSG00000140990	COQ5	1	COQ5	1	0.00543718303669905	WBGene00010326	WBGene00010326(0)		Isolated complex I deficiency	GO:0016020;GO:0055114;GO:0005743;GO:0005739;GO:0005515;GO:0070469;GO:0032981;GO:0008137;GO:0005747;GO:0006120	membrane;oxidation-reduction process;mitochondrial inner membrane;mitochondrion;protein binding;respirasome;mitochondrial respiratory chain complex I assembly;NADH dehydrogenase (ubiquinone) activity;mitochondrial respiratory chain complex I;mitochondrial electron transport, NADH to ubiquinone	3D-structure;Alternative splicing;Electron transport;Membrane;Mitochondrion;Mitochondrion inner membrane;Phosphoprotein;Reference proteome;Respiratory chain;Transport	R-HSA-1430728;R-HSA-1428517;R-HSA-163200;R-HSA-611105;R-HSA-6799198	Metabolism;The citric acid (TCA) cycle and respiratory electron transport;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
COQ5	positive	SETDB1	ENSG00000143379	COQ5	1	COQ5	1	0.00543718303669905	WBGene00019883;WBGene00021515	WBGene00019883(0);WBGene00019584(0);WBGene00011729(0);WBGene00018023(0);WBGene00008527(0);WBGene00019690(0);WBGene00020919(0);WBGene00016603(0);WBGene00021282(0);WBGene00022431(0);WBGene00008062(0);WBGene00008206(0);WBGene00020006(0)			GO:0005634;GO:0043231;GO:0008270;GO:0016740;GO:0005829;GO:0005654;GO:0008168;GO:0032259;GO:0003677;GO:0005886;GO:0018024;GO:0034968;GO:0005515;GO:0005737;GO:0046872;GO:0006325;GO:0005694;GO:0007265;GO:0003682;GO:0046974;GO:1990841;GO:0090309;GO:0045869;GO:0051567;GO:0033273;GO:0045471	DNA binding;zinc ion binding;nucleus;protein binding;histone-lysine N-methyltransferase activity;histone lysine methylation;cytoplasm;intracellular membrane-bounded organelle;metal ion binding;transferase activity;nucleoplasm;methyltransferase activity;methylation;chromatin organization;chromosome;Ras protein signal transduction;chromatin binding;negative regulation of gene expression;histone methyltransferase activity (H3-K9 specific);promoter-specific chromatin binding;positive regulation of methylation-dependent chromatin silencing;negative regulation of single stranded viral RNA replication via double stranded DNA intermediate;response to vitamin;response to ethanol;histone H3-K9 methylation;heterochromatin organization	3D-structure;Alternative splicing;Chromatin regulator;Chromosome;Coiled coil;Cytoplasm;Isopeptide bond;Metal-binding;Methylation;Methyltransferase;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Repressor;S-adenosyl-L-methionine;Transcription;Transcription regulation;Transferase;Ubl conjugation;Zinc	R-HSA-3247509;R-HSA-4839726;R-HSA-3214841	Chromatin modifying enzymes;Chromatin organization;PKMTs methylate histone lysines
COQ5	positive	PLPBP	ENSG00000147471	COQ5	1	COQ5	1	0.00543718303669905	WBGene00017286;WBGene00017285	WBGene00017285(0);WBGene00017286(1)		Pyridoxine-dependent epilepsy;Vitamin-B6-Dependent Epilepsy;EPILEPSY EARLY-ONSET VITAMIN B6-DEPENDENT	GO:0005737;GO:0030170;GO:0008150;GO:0005622	pyridoxal phosphate binding;cytoplasm;cytosol;biological_process;intracellular	Disease mutation;Epilepsy;Phosphoprotein;Polymorphism;Pyridoxal phosphate;Reference proteome		
COQ5	positive	ERLIN2	ENSG00000147475	COQ5	1	COQ5	1	0.00543718303669905	WBGene00016592	WBGene00016592(1)		Autosomal recessive spastic paraplegia type 18;Juvenile primary lateral sclerosis;Recessive intellectual disability-motor dysfunction-multiple joint contractures syndrome;Autosomal Recessive Mental Retardation;SPASTIC PARAPLEGIA 18 AUTOSOMAL RECESSIVE	GO:0005783;GO:0031625;GO:0030433;GO:0016020;GO:0016021;GO:0005829;GO:0005789;GO:0005886;GO:0006629;GO:0008202;GO:0005515;GO:0045121;GO:0008203;GO:0055085;GO:0032991;GO:0032933;GO:0015485;GO:0045541;GO:0045717	endoplasmic reticulum;ubiquitin protein ligase binding;membrane;integral component of membrane;cytosol;plasma membrane;endoplasmic reticulum membrane;lipid metabolic process;steroid metabolic process;protein binding;membrane raft;cholesterol metabolic process;transmembrane transport;protein-containing complex;ubiquitin-dependent ERAD pathway;SREBP signaling pathway;cholesterol binding;negative regulation of cholesterol biosynthetic process;negative regulation of fatty acid biosynthetic process	Acetylation;Alternative splicing;Cholesterol metabolism;Direct protein sequencing;Endoplasmic reticulum;Glycoprotein;Hereditary spastic paraplegia;Lipid metabolism;Membrane;Neurodegeneration;Polymorphism;Reference proteome;Signal-anchor;Steroid metabolism;Sterol metabolism;Transmembrane;Transmembrane helix	R-HSA-382551;R-HSA-1643685;R-HSA-382556;R-HSA-5619084;R-HSA-5619115;R-HSA-5663202;R-HSA-5678895;R-HSA-1226099;R-HSA-1839124;R-HSA-5655302;R-HSA-8853336	Transport of small molecules;Disease;ABC-family proteins mediated transport;ABC transporter disorders;Disorders of transmembrane transporters;Diseases of signal transduction;Defective CFTR causes cystic fibrosis;Signaling by FGFR in disease;FGFR1 mutant receptor activation;Signaling by FGFR1 in disease;Signaling by plasma membrane FGFR1 fusions
COQ5	positive	AUH	ENSG00000148090	COQ5	1	COQ5	1	0.00543718303669905	WBGene00001154	WBGene00007130(0);WBGene00001154(0)		3-methylglutaconic aciduria type 1;3-methylglutaconic aciduria type 1;3-@METHYLGLUTACONIC ACIDURIA TYPE I	GO:0003723;GO:0003824;GO:0016829;GO:0005739;GO:0009083;GO:0005759;GO:0003730;GO:0006635;GO:0006552;GO:0004300;GO:0004490;GO:0050011	catalytic activity;RNA binding;lyase activity;mitochondrion;branched-chain amino acid catabolic process;mitochondrial matrix;mRNA 3'-UTR binding;fatty acid beta-oxidation;leucine catabolic process;enoyl-CoA hydratase activity;methylglutaconyl-CoA hydratase activity;itaconyl-CoA hydratase activity	3D-structure;Acetylation;Alternative splicing;Branched-chain amino acid catabolism;Direct protein sequencing;Disease mutation;Lyase;Mitochondrion;RNA-binding;Reference proteome;Transit peptide	R-HSA-1430728;R-HSA-71291;R-HSA-70895	Metabolism;Metabolism of amino acids and derivatives;Branched-chain amino acid catabolism
COQ5	positive	INIP	ENSG00000148153	COQ5	1	COQ5	1	0.00543718303669905					GO:0005634;GO:0005654;GO:0006281;GO:0005515;GO:0006974;GO:0010212;GO:0070876	nucleus;DNA repair;cellular response to DNA damage stimulus;SOSS complex;nucleoplasm;protein binding;response to ionizing radiation	3D-structure;Acetylation;Alternative splicing;DNA damage;DNA repair;Nucleus;Phosphoprotein;Reference proteome		
COQ5	positive	DCP1B	ENSG00000151065	COQ5	1	COQ5	1	0.00543718303669905	WBGene00021929	WBGene00021929(0)			GO:0005634;GO:0005737;GO:0016020;GO:0043231;GO:0005829;GO:0016787;GO:0008047;GO:0005515;GO:0000290;GO:0043085;GO:0000932;GO:0043928;GO:0000184;GO:0031087	enzyme activator activity;deadenylation-dependent decapping of nuclear-transcribed mRNA;positive regulation of catalytic activity;nucleus;cytoplasm;membrane;intracellular membrane-bounded organelle;cytosol;hydrolase activity;protein binding;P-body;mRNA binding;exonucleolytic catabolism of deadenylated mRNA;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;enzyme regulator activity;deadenylation-independent decapping of nuclear-transcribed mRNA	Acetylation;Alternative splicing;Cytoplasm;Hydrolase;Nonsense-mediated mRNA decay;Nucleus;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-8953854;R-HSA-429914;R-HSA-430039	Metabolism of RNA;Deadenylation-dependent mRNA decay;mRNA decay by 5' to 3' exoribonuclease
COQ5	positive	GALK2	ENSG00000156958	COQ5	1	COQ5	1	0.00543718303669905	WBGene00006461	WBGene00006461(0)			GO:0005737;GO:0000166;GO:0005524;GO:0016301;GO:0016740;GO:0016310;GO:0016773;GO:0005829;GO:0006012;GO:0004335;GO:0005534;GO:0046835;GO:0033499;GO:0005975;GO:0033858	ATP binding;cytoplasm;phosphotransferase activity, alcohol group as acceptor;galactokinase activity;galactose metabolic process;carbohydrate phosphorylation;kinase activity;galactose binding;nucleotide binding;transferase activity;phosphorylation;cytosol;galactose catabolic process via UDP-galactose;carbohydrate metabolic process;carbohydrate kinase activity;N-acetylgalactosamine kinase activity	3D-structure;ATP-binding;Alternative splicing;Kinase;Nucleotide-binding;Polymorphism;Reference proteome;Transferase		
COQ5	positive	RPUSD3	ENSG00000156990	COQ5	1	COQ5	1	0.00543718303669905	WBGene00013967	WBGene00013967(0)			GO:0003723;GO:0009982;GO:0001522;GO:0009451;GO:0006397;GO:0016853;GO:0005739;GO:0005759;GO:0005515;GO:0070131	RNA binding;pseudouridine synthase activity;pseudouridine synthesis;RNA modification;mRNA processing;isomerase activity;mitochondrion;mitochondrial matrix;protein binding;positive regulation of mitochondrial translation	Alternative splicing;Isomerase;Mitochondrion;Phosphoprotein;Polymorphism;Reference proteome;Transit peptide;mRNA processing		
COQ5	positive	DPY30	ENSG00000162961	COQ5	1	COQ5	1	0.00543718303669905	WBGene00001088				GO:0005634;GO:0005794;GO:0005654;GO:0006325;GO:0042803;GO:0005515;GO:0048188;GO:0042802;GO:0044666;GO:0005802;GO:0016197;GO:0051568;GO:0035097;GO:0045652	Set1C/COMPASS complex;MLL3/4 complex;nucleus;Golgi apparatus;nucleoplasm;chromatin organization;protein homodimerization activity;protein binding;identical protein binding;trans-Golgi network;endosomal transport;histone H3-K4 methylation;histone methyltransferase complex;regulation of megakaryocyte differentiation	3D-structure;Acetylation;Chromatin regulator;Golgi apparatus;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation	R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-8878171;R-HSA-3247509;R-HSA-4839726;R-HSA-3214841;R-HSA-8936459	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;Chromatin modifying enzymes;Chromatin organization;PKMTs methylate histone lysines;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function
COQ5	positive	NAXE	ENSG00000163382	COQ5	1	COQ5	1	0.00543718303669905	WBGene00012476	WBGene00012476(0)		Lethal Neurometabolic Disorder of Early Childhood;ENCEPHALOPATHY PROGRESSIVE EARLY-ONSET WITH BRAIN EDEMA AND/ORLEUKOENCEPHALOPATHY 1	GO:0043231;GO:0005829;GO:0005654;GO:0005615;GO:0046872;GO:0000166;GO:0016853;GO:0005739;GO:0005576;GO:0046496;GO:0005515;GO:0070062;GO:0005759;GO:0052856;GO:0052857;GO:0034356;GO:0042802;GO:0005929;GO:0044297	intracellular membrane-bounded organelle;nucleoplasm;cytosol;extracellular space;metal ion binding;nucleotide binding;isomerase activity;mitochondrion;extracellular region;nicotinamide nucleotide metabolic process;protein binding;extracellular exosome;mitochondrial matrix;NADHX epimerase activity;NADPHX epimerase activity;NAD biosynthesis via nicotinamide riboside salvage pathway;identical protein binding;cilium;cell body	Alternative splicing;Disease mutation;Isomerase;Metal-binding;Mitochondrion;NAD;NADP;Neurodegeneration;Nucleotide-binding;Phosphoprotein;Polymorphism;Potassium;Reference proteome;Secreted;Transit peptide	R-HSA-1430728;R-HSA-196854;R-HSA-196849;R-HSA-196807;R-HSA-197264	Metabolism;Metabolism of vitamins and cofactors;Metabolism of water-soluble vitamins and cofactors;Nicotinate metabolism;Nicotinamide salvaging
COQ5	positive	CHCHD4	ENSG00000163528	COQ5	1	COQ5	1	0.00543718303669905	WBGene00022773;WBGene00008690;WBGene00022772;WBGene00018366	WBGene00022772(0);WBGene00022773(0);WBGene00018366(0);WBGene00008690(0)			GO:0005623;GO:0015031;GO:0016491;GO:0055114;GO:0005739;GO:0015035;GO:0045041;GO:0005515;GO:0005758;GO:0051084;GO:0018171;GO:0022417	protein disulfide oxidoreductase activity;protein import into mitochondrial intermembrane space;protein transport;oxidoreductase activity;oxidation-reduction process;mitochondrion;protein binding;mitochondrial intermembrane space;'de novo' posttranslational protein folding;mitochondrial respiratory chain complex assembly;peptidyl-cysteine oxidation;protein maturation by protein folding	3D-structure;Alternative splicing;Disulfide bond;Mitochondrion;Oxidoreductase;Protein transport;Redox-active center;Reference proteome;Translocation;Transport	R-HSA-9609507;R-HSA-1268020	Protein localization;Mitochondrial protein import
COQ5	positive	YEATS2	ENSG00000163872	COQ5	1	COQ5	1	0.00543718303669905	WBGene00013692				GO:0005634;GO:0006355;GO:0000981;GO:0005515;GO:0042393;GO:0000122;GO:0045892;GO:0043966;GO:0005671;GO:0017025;GO:0140030;GO:0072686	regulation of transcription, DNA-templated;nucleus;protein binding;histone binding;negative regulation of transcription by RNA polymerase II;negative regulation of transcription, DNA-templated;histone H3 acetylation;Ada2/Gcn5/Ada3 transcription activator complex;modification-dependent protein binding;TBP-class protein binding;mitotic spindle	3D-structure;Coiled coil;Isopeptide bond;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation	R-HSA-3247509;R-HSA-4839726;R-HSA-3214847	Chromatin modifying enzymes;Chromatin organization;HATs acetylate histones
COQ5	positive	PIGX	ENSG00000163964	COQ5	1	COQ5	1	0.00543718303669905					GO:0005789;GO:0006506;GO:0016020;GO:0016021;GO:0005783;GO:0016254	endoplasmic reticulum membrane;GPI anchor biosynthetic process;membrane;integral component of membrane	Alternative splicing;Endoplasmic reticulum;GPI-anchor biosynthesis;Glycoprotein;Membrane;Polymorphism;Reference proteome;Signal;Transmembrane;Transmembrane helix	R-HSA-392499;R-HSA-597592;R-HSA-163125;R-HSA-162710	Metabolism of proteins;Post-translational protein modification;Post-translational modification: synthesis of GPI-anchored proteins;Synthesis of glycosylphosphatidylinositol (GPI)
COQ5	positive	TRUB2	ENSG00000167112	COQ5	1	COQ5	1	0.00543718303669905	WBGene00021544	WBGene00021544(0)			GO:0003723;GO:0006396;GO:0006397;GO:0016853;GO:0005829;GO:0005739;GO:0005759;GO:0009982;GO:0001522;GO:0009451;GO:0070131	RNA binding;RNA processing;pseudouridine synthase activity;pseudouridine synthesis;RNA modification;mRNA processing;isomerase activity;mitochondrion;mitochondrial matrix;positive regulation of mitochondrial translation	Alternative splicing;Isomerase;Mitochondrion;Polymorphism;Reference proteome;Transit peptide;mRNA processing		
COQ5	positive	NDUFB1	ENSG00000183648	COQ5	1	COQ5	1	0.00543718303669905					GO:0016607;GO:0016020;GO:0016021;GO:0055114;GO:0005739;GO:0005743;GO:0070469;GO:0003954;GO:0032981;GO:0008137;GO:0005747;GO:0006120	mitochondrion;NADH dehydrogenase activity;nuclear speck;membrane;integral component of membrane;oxidation-reduction process;mitochondrial inner membrane;respirasome;mitochondrial respiratory chain complex I assembly;NADH dehydrogenase (ubiquinone) activity;mitochondrial respiratory chain complex I;mitochondrial electron transport, NADH to ubiquinone	3D-structure;Alternative splicing;Electron transport;Membrane;Mitochondrion;Mitochondrion inner membrane;Reference proteome;Respiratory chain;Transmembrane;Transmembrane helix;Transport	R-HSA-1430728;R-HSA-1428517;R-HSA-163200;R-HSA-611105;R-HSA-6799198	Metabolism;The citric acid (TCA) cycle and respiratory electron transport;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
COQ5	positive	TMLHE	ENSG00000185973	COQ5	1	COQ5	1	0.00543718303669905	WBGene00001523	WBGene00001523(1)		AUTISM SUSCEPTIBILITY TO X-LINKED 6	GO:0046872;GO:0016491;GO:0055114;GO:0005739;GO:0005759;GO:0005506;GO:0051213;GO:0045329;GO:0016702;GO:0050353	oxidation-reduction process;oxidoreductase activity;iron ion binding;carnitine biosynthetic process;trimethyllysine dioxygenase activity;metal ion binding;mitochondrion;mitochondrial matrix;dioxygenase activity;oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen	Acetylation;Alternative promoter usage;Alternative splicing;Autism;Autism spectrum disorder;Carnitine biosynthesis;Dioxygenase;Disease mutation;Iron;Metal-binding;Mitochondrion;Oxidoreductase;Reference proteome;Transit peptide	R-HSA-1430728;R-HSA-71291;R-HSA-71262	Metabolism;Metabolism of amino acids and derivatives;Carnitine synthesis
COQ5	positive	IFT140	ENSG00000187535	COQ5	1	COQ5	1	0.00543718303669905	WBGene00000490	WBGene00000490(0)		Jeune syndrome;Leber congenital amaurosis;Retinitis pigmentosa;Saldino-Mainzer syndrome;Mainzer-Saldino Syndrome;RETINITIS PIGMENTOSA 80;SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY	GO:0005737;GO:0005856;GO:0042995;GO:0005813;GO:0005815;GO:0005515;GO:0005929;GO:0036064;GO:0035735;GO:0060271;GO:0061512;GO:0097542;GO:0003674;GO:0030030;GO:1902017;GO:0005930;GO:0060041;GO:0042073;GO:0072001;GO:0048705;GO:0035721;GO:0030991;GO:0007368;GO:0007507;GO:0008589;GO:0021532;GO:0031076;GO:0035108;GO:0035845;GO:0042733;GO:0048701;GO:1905515;GO:1990403;GO:0001750;GO:0032391;GO:0097730	cytoplasm;cytoskeleton;cell projection;centrosome;microtubule organizing center;protein binding;cilium;ciliary basal body;intraciliary transport involved in cilium assembly;cilium assembly;protein localization to cilium;ciliary tip;molecular_function;cell projection organization;regulation of cilium assembly;axoneme;intraciliary transport;intraciliary retrograde transport;intraciliary transport particle A;determination of left/right symmetry;heart development;regulation of smoothened signaling pathway;neural tube patterning;embryonic camera-type eye development;limb morphogenesis;photoreceptor cell outer segment organization;embryonic digit morphogenesis;embryonic cranial skeleton morphogenesis;non-motile cilium assembly;embryonic brain development;photoreceptor outer segment;centriole;photoreceptor connecting cilium;non-motile cilium	Alternative splicing;Cell projection;Ciliopathy;Cilium;Cilium biogenesis/degradation;Cytoplasm;Cytoskeleton;Disease mutation;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Retinitis pigmentosa;TPR repeat;WD repeat	R-HSA-1852241;R-HSA-5617833;R-HSA-5620924;R-HSA-162582;R-HSA-5358351;R-HSA-5610787	Organelle biogenesis and maintenance;Cilium Assembly;Intraflagellar transport;Signal Transduction;Signaling by Hedgehog;Hedgehog 'off' state
COQ5	positive	DHRS4L2	ENSG00000187630	COQ5	1	COQ5	1	0.00543718303669905	WBGene00000976;WBGene00010063	WBGene00000993(0);WBGene00219274(0);WBGene00000975(0);WBGene00011424(0);WBGene00021647(0);WBGene00021646(0);WBGene00000981(0);WBGene00000970(0);WBGene00008986(0);WBGene00008985(0);WBGene00022809(0)			GO:0016491;GO:0055114;GO:0005576	oxidoreductase activity;oxidation-reduction process;extracellular region	Alternative splicing;Glycoprotein;NADP;Oxidoreductase;Polymorphism;Reference proteome;Secreted;Signal		
COQ5	positive	TMA16	ENSG00000198498	COQ5	1	COQ5	1	0.00543718303669905					GO:0005634;GO:0005730;GO:0005515	nucleoplasm;nucleolus;nucleus;protein binding	ADP-ribosylation;Polymorphism;Reference proteome		
COQ5	positive	HNRNPUL2	ENSG00000214753	COQ5	1	COQ5	1	0.00543718303669905	WBGene00012769				GO:0003723;GO:0005634;GO:0016020;GO:0005654;GO:0008150;GO:0005515	protein binding;RNA binding;nucleus;membrane;nucleoplasm;biological_process	Direct protein sequencing;Methylation;Nucleus;Phosphoprotein;Reference proteome		
COQ5	negative	EHD1	ENSG00000110047	COQ5	1	COQ5	1	0.00017182207497024	WBGene00004373	WBGene00004373(1)			GO:0042632;GO:0005623;GO:0016020;GO:0006886;GO:0015031;GO:0046872;GO:0000166;GO:0005524;GO:0005509;GO:0005525;GO:0005886;GO:0032456;GO:0042995;GO:0005515;GO:0042802;GO:0005768;GO:0005929;GO:0060271;GO:0061512;GO:0045296;GO:0006897;GO:0070062;GO:0030030;GO:0031901;GO:0010008;GO:0051260;GO:0055038;GO:0060170;GO:1901741;GO:0031175;GO:0007596;GO:0017137;GO:0005811;GO:0020018;GO:0034383;GO:0010886;GO:1990090;GO:2001137;GO:0031095;GO:0010976;GO:0016197;GO:0005769;GO:0030139;GO:0048471	protein binding;GTP binding;calcium ion binding;endocytic recycling;cholesterol homeostasis;membrane;intracellular protein transport;protein transport;metal ion binding;nucleotide binding;ATP binding;endosome;plasma membrane;cell projection;identical protein binding;endocytosis;cilium;cilium assembly;protein localization to cilium;cadherin binding;extracellular exosome;cell projection organization;early endosome membrane;endosome membrane;protein homooligomerization;recycling endosome membrane;ciliary membrane;positive regulation of myoblast fusion;neuron projection development;blood coagulation;Rab GTPase binding;lipid droplet;ciliary pocket membrane;low-density lipoprotein particle clearance;positive regulation of cholesterol storage;cellular response to nerve growth factor stimulus;positive regulation of endocytic recycling;platelet dense tubular network membrane;positive regulation of neuron projection development;endosomal transport;early endosome;endocytic vesicle;perinuclear region of cytoplasm	3D-structure;ATP-binding;Acetylation;Calcium;Cell membrane;Cell projection;Cilium;Cilium biogenesis/degradation;Coiled coil;Direct protein sequencing;Endosome;Membrane;Metal-binding;Nucleotide-binding;Phosphoprotein;Protein transport;Reference proteome;Transport	R-HSA-109582;R-HSA-983231	Hemostasis;Factors involved in megakaryocyte development and platelet production
COQ5	negative	TPRG1L	ENSG00000158109	COQ5	1	COQ5	1	0.00017182207497024					GO:0016020;GO:0030054;GO:0031410;GO:0045202;GO:0005737;GO:0070062;GO:0003674;GO:0008150;GO:0008021;GO:0030672;GO:0051966;GO:0042802;GO:0044305	membrane;cell projection;cell junction;cytoplasmic vesicle;synapse;cytoplasm;extracellular exosome;molecular_function;biological_process;synaptic vesicle;synaptic vesicle membrane;presynaptic active zone;regulation of synaptic transmission, glutamatergic;identical protein binding;calyx of Held	Alternative splicing;Cell junction;Cell projection;Cytoplasmic vesicle;Membrane;Phosphoprotein;Reference proteome;Synapse		
COQ5	negative	RAB8B	ENSG00000166128	COQ5	1	COQ5	1	0.00017182207497024	WBGene00004272;WBGene00004273	WBGene00004272(1)			GO:0016020;GO:0015031;GO:0043231;GO:0000166;GO:0005654;GO:0003924;GO:0005525;GO:0005886;GO:0016604;GO:0031410;GO:0005778;GO:0006886;GO:0005515;GO:0070062;GO:0030670;GO:0032482;GO:0009306;GO:0005768;GO:0008021;GO:0005102;GO:0019003;GO:0072659;GO:0017157;GO:0030140;GO:0045335;GO:0006904;GO:0019882;GO:0055038;GO:0034332;GO:0032869;GO:0045046;GO:0048210;GO:0030911;GO:0031346;GO:0051461;GO:0048471;GO:0051286;GO:0098793	GTP binding;GTPase activity;membrane;protein transport;intracellular membrane-bounded organelle;nucleotide binding;nucleoplasm;plasma membrane;nuclear body;cytoplasmic vesicle;peroxisomal membrane;protein binding;intracellular protein transport;extracellular exosome;phagocytic vesicle membrane;Rab protein signal transduction;endomembrane system;protein secretion;endosome;synaptic vesicle;signaling receptor binding;GDP binding;protein localization to plasma membrane;regulation of exocytosis;trans-Golgi network transport vesicle;phagocytic vesicle;vesicle docking involved in exocytosis;antigen processing and presentation;recycling endosome membrane;cellular response to insulin stimulus;protein import into peroxisome membrane;Golgi vesicle fusion to target membrane;TPR domain binding;positive regulation of cell projection organization;positive regulation of corticotropin secretion;cell-substrate junction organization;perinuclear region of cytoplasm;cell tip;presynapse	Cell membrane;Cytoplasmic vesicle;GTP-binding;Lipoprotein;Membrane;Methylation;Nucleotide-binding;Phosphoprotein;Prenylation;Protein transport;Reference proteome;Transport	R-HSA-5653656;R-HSA-392499;R-HSA-597592;R-HSA-199991;R-HSA-8876198;R-HSA-9007101;R-HSA-8873719;R-HSA-8854214	Vesicle-mediated transport;Metabolism of proteins;Post-translational protein modification;Membrane Trafficking;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking;RAB geranylgeranylation;TBC/RABGAPs
COQ5	negative	OGFR	ENSG00000060491	COQ5	1	COQ5	1	0.000462599651611884					GO:0005634;GO:0005737;GO:0016020;GO:0005515;GO:0038023;GO:0004985;GO:0038003;GO:0005575;GO:0040008;GO:0001558	membrane;signaling receptor activity;opioid receptor activity;nucleus;cytoplasm;protein binding;opioid receptor signaling pathway;cellular_component;regulation of growth;regulation of cell growth	Acetylation;Alternative splicing;Cytoplasm;Growth regulation;Nucleus;Phosphoprotein;Polymorphism;Receptor;Reference proteome;Repeat		
COQ5	negative	BIRC2	ENSG00000110330	COQ5	1	COQ5	1	0.000462599651611884		WBGene00000250(0)			GO:0005634;GO:0005737;GO:0046872;GO:0016740;GO:0043066;GO:0008270;GO:0042981;GO:1903508;GO:0005515;GO:0004842;GO:0006915;GO:0003713;GO:0042802;GO:0061630;GO:0005829;GO:0016579;GO:0033209;GO:0043123;GO:0042127;GO:0051726;GO:0047485;GO:0002756;GO:0007249;GO:0035666;GO:0007166;GO:0043161;GO:0009898;GO:0035631;GO:0051087;GO:0010803;GO:0043027;GO:0043154;GO:0060544;GO:0045595;GO:0000209;GO:0050727;GO:1902527;GO:0045088;GO:2000116;GO:0043130;GO:0031398;GO:0070424;GO:1990001;GO:0098770;GO:0034121;GO:0038061;GO:0039535;GO:0060546;GO:1902523;GO:1902524;GO:0001666;GO:0001890;GO:0010243;GO:0014070;GO:0045471;GO:0051291;GO:0051591;GO:0070266;GO:0071356;GO:1901222;GO:1902443;GO:1902916;GO:2000377;GO:0001741;GO:0032991;GO:0045121	regulation of apoptotic process;nucleus;cytoplasm;metal ion binding;transferase activity;negative regulation of apoptotic process;zinc ion binding;positive regulation of nucleic acid-templated transcription;protein binding;ubiquitin-protein transferase activity;apoptotic process;regulation of innate immune response;transcription coactivator activity;identical protein binding;ubiquitin protein ligase activity;cytosol;protein deubiquitination;tumor necrosis factor-mediated signaling pathway;regulation of cell cycle;positive regulation of I-kappaB kinase/NF-kappaB signaling;regulation of cell population proliferation;protein N-terminus binding;MyD88-independent toll-like receptor signaling pathway;I-kappaB kinase/NF-kappaB signaling;TRIF-dependent toll-like receptor signaling pathway;cell surface receptor signaling pathway;proteasome-mediated ubiquitin-dependent protein catabolic process;cytoplasmic side of plasma membrane;CD40 receptor complex;positive regulation of protein K63-linked ubiquitination;chaperone binding;regulation of tumor necrosis factor-mediated signaling pathway;regulation of inflammatory response;cysteine-type endopeptidase inhibitor activity involved in apoptotic process;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;regulation of necroptotic process;regulation of cell differentiation;protein polyubiquitination;positive regulation of protein monoubiquitination;regulation of cysteine-type endopeptidase activity;ubiquitin binding;positive regulation of protein ubiquitination;regulation of nucleotide-binding oligomerization domain containing signaling pathway;inhibition of cysteine-type endopeptidase activity involved in apoptotic process;FBXO family protein binding;regulation of toll-like receptor signaling pathway;NIK/NF-kappaB signaling;regulation of RIG-I signaling pathway;negative regulation of necroptotic process;positive regulation of protein K48-linked ubiquitination;protein-containing complex binding;response to hypoxia;placenta development;response to organonitrogen compound;response to organic cyclic compound;response to ethanol;response to cAMP;necroptotic process;cellular response to tumor necrosis factor;regulation of NIK/NF-kappaB signaling;negative regulation of ripoptosome assembly involved in necroptotic process;positive regulation of protein polyubiquitination;regulation of reactive oxygen species metabolic process;XY body;protein-containing complex;membrane raft	3D-structure;Activator;Alternative splicing;Apoptosis;Cytoplasm;Metal-binding;Nucleus;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;Transferase;Ubl conjugation;Ubl conjugation pathway;Zinc;Zinc-finger	R-HSA-168249;R-HSA-168256;R-HSA-392499;R-HSA-597592;R-HSA-109581;R-HSA-162582;R-HSA-5357801;R-HSA-73887;R-HSA-1280215;R-HSA-5668541;R-HSA-5688426;R-HSA-5689880;R-HSA-166016;R-HSA-166166;R-HSA-168898;R-HSA-937041;R-HSA-937061;R-HSA-5213460;R-HSA-5218859;R-HSA-5675482;R-HSA-75153;R-HSA-168164;R-HSA-5676594;R-HSA-168643;R-HSA-168638;R-HSA-168927;R-HSA-5357905;R-HSA-5357956;R-HSA-75893;R-HSA-111465	Innate Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Apoptosis;Signal Transduction;Programmed Cell Death;Death Receptor Signalling;Cytokine Signaling in Immune system;TNFR2 non-canonical NF-kB pathway;Deubiquitination;Ub-specific processing proteases;Toll Like Receptor 4 (TLR4) Cascade;MyD88-independent TLR4 cascade ;Toll-like Receptor Cascades;IKK complex recruitment mediated by RIP1;TRIF(TICAM1)-mediated TLR4 signaling ;RIPK1-mediated regulated necrosis;Regulated Necrosis;Regulation of necroptotic cell death;Apoptotic execution phase;Toll Like Receptor 3 (TLR3) Cascade;TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;NOD1/2 Signaling Pathway;TICAM1, RIP1-mediated IKK complex recruitment;Regulation of TNFR1 signaling;TNFR1-induced NFkappaB signaling pathway;TNF signaling;Apoptotic cleavage of cellular proteins
COQ5	negative	VPS37B	ENSG00000139722	COQ5	1	COQ5	1	0.000462599651611884	WBGene00016990;WBGene00016991				GO:0005737;GO:0016020;GO:0015031;GO:0005886;GO:0005515;GO:0000813;GO:0032509;GO:0030496;GO:0005768;GO:0031902;GO:0043231;GO:0070062;GO:0048306;GO:0006612;GO:0006623;GO:0016197;GO:0016236;GO:0019058;GO:0036258;GO:0039702;GO:0043162;GO:0075733;GO:0010008;GO:0043657;GO:1902188;GO:1903774	endosome transport via multivesicular body sorting pathway;ESCRT I complex;cytoplasm;membrane;protein transport;endosome;plasma membrane;protein binding;midbody;late endosome membrane;intracellular membrane-bounded organelle;extracellular exosome;calcium-dependent protein binding;protein targeting to membrane;protein targeting to vacuole;endosomal transport;macroautophagy;viral life cycle;multivesicular body assembly;viral budding via host ESCRT complex;ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway;intracellular transport of virus;endosome membrane;host cell;positive regulation of viral release from host cell;positive regulation of viral budding via host ESCRT complex	Endosome;Membrane;Methylation;Protein transport;Reference proteome;Transport	R-HSA-5653656;R-HSA-199991;R-HSA-1643685;R-HSA-162587;R-HSA-162588;R-HSA-162599;R-HSA-162906;R-HSA-174490;R-HSA-174495;R-HSA-175474;R-HSA-5663205;R-HSA-917729;R-HSA-9612973;R-HSA-9615710	Vesicle-mediated transport;Membrane Trafficking;Disease;HIV Life Cycle;Budding and maturation of HIV virion;Late Phase of HIV Life Cycle;HIV Infection;Membrane binding and targetting of GAG proteins;Synthesis And Processing Of GAG, GAGPOL Polyproteins;Assembly Of The HIV Virion;Infectious disease;Endosomal Sorting Complex Required For Transport (ESCRT);Autophagy;Late endosomal microautophagy
COQ5	negative	RASA3	ENSG00000185989	COQ5	1	COQ5	1	0.000462599651611884	WBGene00001515	WBGene00001516(0);WBGene00001515(0)			GO:0016020;GO:0046872;GO:0035556;GO:0007165;GO:0005886;GO:0005096;GO:0043547;GO:0043087;GO:0051209;GO:0046580;GO:0005829;GO:0000165;GO:0031235;GO:0015278	signal transduction;GTPase activator activity;intracellular signal transduction;regulation of GTPase activity;negative regulation of Ras protein signal transduction;cell;membrane;metal ion binding;plasma membrane;positive regulation of GTPase activity;release of sequestered calcium ion into cytosol;cytosol;MAPK cascade;intrinsic component of the cytoplasmic side of the plasma membrane;calcium-release channel activity	Acetylation;Alternative splicing;Cell membrane;GTPase activation;Membrane;Metal-binding;Phosphoprotein;Reference proteome;Repeat;Zinc;Zinc-finger	R-HSA-168256;R-HSA-162582;R-HSA-1643685;R-HSA-1280215;R-HSA-449147;R-HSA-449836;R-HSA-5658442;R-HSA-5663202;R-HSA-5673001;R-HSA-5683057;R-HSA-5684996;R-HSA-9607240;R-HSA-6802957;R-HSA-6802949	Immune System;Signal Transduction;Disease;Cytokine Signaling in Immune system;Signaling by Interleukins;Other interleukin signaling;Regulation of RAS by GAPs;Diseases of signal transduction;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;FLT3 Signaling;Oncogenic MAPK signaling;Signaling by RAS mutants
COQ5	negative	ZC3H11A	ENSG00000058673	COQ5	1	COQ5	1	0.00116451401121576					GO:0003723;GO:0051028;GO:0046872;GO:0005515;GO:0003729;GO:0005654;GO:0006406;GO:0006405;GO:0031124;GO:0000346;GO:0016973	metal ion binding;RNA binding;mRNA transport;protein binding;mRNA binding;nucleoplasm;mRNA export from nucleus;RNA export from nucleus;mRNA 3'-end processing;transcription export complex;poly(A)+ mRNA export from nucleus	Coiled coil;Isopeptide bond;Metal-binding;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Transport;Ubl conjugation;Zinc;Zinc-finger;mRNA transport	R-HSA-73857;R-HSA-74160;R-HSA-8953854;R-HSA-159236;R-HSA-72202;R-HSA-72203;R-HSA-72187;R-HSA-73856	RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA;Transport of Mature mRNA derived from an Intron-Containing Transcript;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;mRNA 3'-end processing;RNA Polymerase II Transcription Termination
COQ5	negative	PTOV1	ENSG00000104960	COQ5	1	COQ5	1	0.00116451401121576					GO:0005634;GO:0005737;GO:0016020;GO:0005886;GO:0048471;GO:0044798;GO:0045944	nucleoplasm;nucleus;cytoplasm;membrane;plasma membrane;perinuclear region of cytoplasm;nuclear transcription factor complex;positive regulation of transcription by RNA polymerase II	Activator;Alternative splicing;Cell membrane;Cytoplasm;Membrane;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation		
COQ5	negative	EIF4G2	ENSG00000110321	COQ5	1	COQ5	1	0.00116451401121576	WBGene00002066				GO:0003723;GO:0003743;GO:0006413;GO:0005829;GO:0007507;GO:0045727;GO:0045773;GO:0060999;GO:0030424;GO:0005515;GO:0016020;GO:0006412;GO:0003729;GO:0045296;GO:0006417;GO:0016281;GO:0010507;GO:0005913;GO:0008135;GO:0007050;GO:0006446;GO:0008219;GO:0030307;GO:0034645	protein binding;RNA binding;translation initiation factor activity;translational initiation;cytosol;heart development;positive regulation of translation;positive regulation of axon extension;positive regulation of dendritic spine development;axon	3D-structure;Acetylation;Alternative splicing;Direct protein sequencing;Initiation factor;Isopeptide bond;Methylation;Phosphoprotein;Polymorphism;Protein biosynthesis;Reference proteome;Repressor;Translation regulation;Ubl conjugation	R-HSA-168256;R-HSA-1280215;R-HSA-1169408;R-HSA-1169410;R-HSA-913531	Immune System;Cytokine Signaling in Immune system;ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Interferon Signaling
COQ5	negative	TBC1D15	ENSG00000121749	COQ5	1	COQ5	1	0.00116451401121576	WBGene00013016;WBGene00008444				GO:0005737;GO:0005515;GO:0005096;GO:0017137;GO:0006886;GO:0090630;GO:0043087;GO:0005576	cytoplasm;protein binding;GTPase activator activity;Rab GTPase binding;intracellular protein transport;activation of GTPase activity;regulation of GTPase activity;extracellular region	Acetylation;Alternative splicing;Cytoplasm;GTPase activation;Phosphoprotein;Reference proteome	R-HSA-5653656;R-HSA-199991;R-HSA-9007101;R-HSA-8854214	Vesicle-mediated transport;Membrane Trafficking;Rab regulation of trafficking;TBC/RABGAPs
COQ5	negative	RNF11	ENSG00000123091	COQ5	1	COQ5	1	0.00116451401121576	WBGene00007226	WBGene00007226(1)			GO:0005634;GO:0005737;GO:0046872;GO:0005515;GO:0006511;GO:0005768;GO:0005769;GO:0070062;GO:0055037;GO:0003677;GO:0004842;GO:0051865;GO:0000151;GO:0008270	nucleus;cytoplasm;metal ion binding;endosome;protein binding;ubiquitin-dependent protein catabolic process;early endosome;extracellular exosome;recycling endosome;DNA binding;protein autoubiquitination;ubiquitin ligase complex;zinc ion binding;ubiquitin protein ligase activity	Cytoplasm;Direct protein sequencing;Endosome;Lipoprotein;Metal-binding;Myristate;Nucleus;Palmitate;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation;Ubl conjugation pathway;Zinc;Zinc-finger		
COQ5	negative	TBC1D20	ENSG00000125875	COQ5	1	COQ5	1	0.00116451401121576	WBGene00013196	WBGene00013196(1)		Micro syndrome;Warburg micro syndrome 4;Warburg micro syndrome 4	GO:0016020;GO:0016021;GO:0005789;GO:0005515;GO:0005783;GO:0005096;GO:0017137;GO:0006888;GO:0043547;GO:0030173;GO:0016032;GO:0031965;GO:0048208;GO:0033116;GO:0007030;GO:0090110;GO:0046726;GO:0044829;GO:0019068;GO:1902953;GO:0001675;GO:0002088;GO:0007283;GO:0008584;GO:0034389;GO:0043010;GO:0070309;GO:0072520	membrane;integral component of membrane;endoplasmic reticulum membrane;protein binding;endoplasmic reticulum;GTPase activator activity;Rab GTPase binding;endoplasmic reticulum to Golgi vesicle-mediated transport;positive regulation of GTPase activity;integral component of Golgi membrane;viral process;nuclear membrane;COPII vesicle coating;endoplasmic reticulum-Golgi intermediate compartment membrane;Golgi organization;COPII-coated vesicle cargo loading;positive regulation by virus of viral protein levels in host cell;positive regulation by host of viral genome replication;virion assembly;positive regulation of ER to Golgi vesicle-mediated transport;acrosome assembly;lens development in camera-type eye;spermatogenesis;male gonad development;lipid droplet organization;camera-type eye development;lens fiber cell morphogenesis;seminiferous tubule development	3D-structure;Alternative splicing;GTPase activation;Host-virus interaction;Membrane;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix	R-HSA-5653656;R-HSA-392499;R-HSA-597592;R-HSA-199991;R-HSA-9007101;R-HSA-446203;R-HSA-199977;R-HSA-948021;R-HSA-204005;R-HSA-8854214	Vesicle-mediated transport;Metabolism of proteins;Post-translational protein modification;Membrane Trafficking;Rab regulation of trafficking;Asparagine N-linked glycosylation;ER to Golgi Anterograde Transport;Transport to the Golgi and subsequent modification;COPII-mediated vesicle transport;TBC/RABGAPs
COQ5	negative	CPEB2	ENSG00000137449	COQ5	1	COQ5	1	0.00116451401121576	WBGene00000770;WBGene00000771;WBGene00001481	WBGene00000770(0);WBGene00000771(0)			GO:0003676;GO:0003723;GO:0005634;GO:0005737;GO:0003730;GO:0045182;GO:0006417;GO:0043022;GO:0043005;GO:0045202;GO:0000900;GO:0008135;GO:2000766;GO:1990124;GO:0043023;GO:0034599;GO:0032869;GO:0043024;GO:0071243;GO:0071456;GO:0035925;GO:0005095;GO:0006412;GO:0034260;GO:1900248	nucleic acid binding;translation regulator activity;mRNA 3'-UTR binding;regulation of translation;RNA binding;nucleus;cytoplasm;neuron projection;synapse;ribosome binding;translation repressor activity, mRNA regulatory element binding;translation factor activity, RNA binding;negative regulation of cytoplasmic translation;messenger ribonucleoprotein complex;ribosomal large subunit binding;cellular response to oxidative stress;cellular response to insulin stimulus;ribosomal small subunit binding;cellular response to arsenic-containing substance;cellular response to hypoxia;mRNA 3'-UTR AU-rich region binding;GTPase inhibitor activity;translation;negative regulation of GTPase activity;negative regulation of cytoplasmic translational elongation	Alternative splicing;Cytoplasm;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Translation regulation		
COQ5	negative	MARCH6	ENSG00000145495	COQ5	1	COQ5	1	0.00116451401121576	WBGene00018847	WBGene00018847(1)			GO:0016020;GO:0016021;GO:0008270;GO:0046872;GO:0016740;GO:0005783;GO:0005789;GO:0016567;GO:0005515;GO:0004842;GO:0044322;GO:0061630;GO:0070936;GO:0030176;GO:0019899;GO:1904380;GO:0043161;GO:0030433;GO:1990381;GO:0036503;GO:0031624;GO:0010498;GO:0000835	zinc ion binding;membrane;integral component of membrane;metal ion binding;transferase activity;endoplasmic reticulum;endoplasmic reticulum membrane;protein ubiquitination;protein binding;ubiquitin-protein transferase activity;endoplasmic reticulum quality control compartment;ubiquitin protein ligase activity;protein K48-linked ubiquitination;integral component of endoplasmic reticulum membrane;enzyme binding;endoplasmic reticulum mannose trimming;proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent ERAD pathway;ubiquitin-specific protease binding;ERAD pathway;ubiquitin conjugating enzyme binding;proteasomal protein catabolic process;ER ubiquitin ligase complex	Acetylation;Alternative splicing;Endoplasmic reticulum;Membrane;Metal-binding;Polymorphism;Reference proteome;Transferase;Transmembrane;Transmembrane helix;Ubl conjugation;Ubl conjugation pathway;Zinc;Zinc-finger	R-HSA-392499;R-HSA-597592;R-HSA-446203;R-HSA-532668;R-HSA-901032;R-HSA-901042	Metabolism of proteins;Post-translational protein modification;Asparagine N-linked glycosylation;N-glycan trimming in the ER and Calnexin/Calreticulin cycle;ER Quality Control Compartment (ERQC);Calnexin/calreticulin cycle
COQ5	negative	WDR26	ENSG00000162923	COQ5	1	COQ5	1	0.00116451401121576	WBGene00021482			Intellectual disability-seizures-abnormal gait-facial dysmorphism syndrome;Intellectual Disability Seizures Abnormal Gait and Distinctive Facial Features;SKRABAN-DEARDORFF SYNDROME	GO:0005515;GO:0005829;GO:0005654;GO:0005634;GO:0005737;GO:0005739;GO:0000151	protein binding;nucleoplasm;cytosol;nucleus;cytoplasm;mitochondrion;ubiquitin ligase complex	Alternative splicing;Cytoplasm;Disease mutation;Mental retardation;Mitochondrion;Nucleus;Phosphoprotein;Reference proteome;Repeat;WD repeat		
COQ5	negative	CREBRF	ENSG00000164463	COQ5	1	COQ5	1	0.00116451401121576					GO:0005634;GO:0006355;GO:0003700;GO:0005515;GO:0006986;GO:0000981;GO:0005654;GO:0001228;GO:0045944;GO:0000977;GO:0030968;GO:0042711;GO:1900170;GO:1902213;GO:0016604	response to unfolded protein;nucleus;nucleoplasm;regulation of transcription, DNA-templated;DNA-binding transcription factor activity;protein binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;positive regulation of transcription by RNA polymerase II;RNA polymerase II regulatory region sequence-specific DNA binding;endoplasmic reticulum unfolded protein response;maternal behavior;negative regulation of glucocorticoid mediated signaling pathway;positive regulation of prolactin signaling pathway;nuclear body	Alternative splicing;Nucleus;Polymorphism;Reference proteome;Repressor;Stress response;Transcription;Transcription regulation;Transport;Unfolded protein response	R-HSA-392499;R-HSA-381119;R-HSA-8874211	Metabolism of proteins;Unfolded Protein Response (UPR);CREB3 factors activate genes
COQ5	negative	DYNLT3	ENSG00000165169	COQ5	1	COQ5	1	0.00116451401121576	WBGene00008764;WBGene00011469				GO:0005634;GO:0005737;GO:0003774;GO:0051301;GO:0005694;GO:0005856;GO:0005515;GO:0007049;GO:0005874;GO:0042802;GO:0000775;GO:0000776;GO:0000777;GO:0005868;GO:0030286;GO:0007346;GO:0045931;GO:0061673	nucleus;cytoplasm;motor activity;cytoskeleton;cell division;chromosome;protein binding;cell cycle;microtubule;cytoplasmic dynein complex;dynein complex;identical protein binding;chromosome, centromeric region;kinetochore;condensed chromosome kinetochore;regulation of mitotic cell cycle;positive regulation of mitotic cell cycle;mitotic spindle astral microtubule	Cell cycle;Cell division;Centromere;Chromosome;Cytoplasm;Cytoskeleton;Dynein;Kinetochore;Microtubule;Mitosis;Motor protein;Nitration;Nucleus;Reference proteome;Transport		
COQ5	negative	TMEM88	ENSG00000167874	COQ5	1	COQ5	1	0.00116451401121576					GO:0016020;GO:0016021;GO:0005886;GO:0007275;GO:0016055;GO:0090090;GO:0030165;GO:0050821;GO:0005515;GO:0005829;GO:0072659	negative regulation of canonical Wnt signaling pathway;membrane;integral component of membrane;plasma membrane;multicellular organism development;Wnt signaling pathway;PDZ domain binding;protein stabilization;protein binding;cytosol;protein localization to plasma membrane	Cell membrane;Developmental protein;Membrane;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix;Wnt signaling pathway		
COQ5	negative	ADORA2B	ENSG00000170425	COQ5	1	COQ5	1	0.00116451401121576	WBGene00011878				GO:0016020;GO:0016021;GO:0004930;GO:0007186;GO:0005886;GO:0005515;GO:0007165;GO:0001609;GO:0001973;GO:0044267;GO:0005887;GO:0007588;GO:0006968;GO:0000187;GO:0007190;GO:0002882;GO:0007189;GO:0007254;GO:0010575;GO:0010753;GO:0031284;GO:0031668;GO:0032722;GO:0032755;GO:0043306;GO:0060087;GO:2000300;GO:0045202;GO:0098685;GO:0098978	G protein-coupled receptor signaling pathway;integral component of membrane;G protein-coupled receptor activity;G protein-coupled adenosine receptor activity;adenosine receptor signaling pathway;membrane;plasma membrane;protein binding;signal transduction;cellular protein metabolic process;integral component of plasma membrane;excretion;cellular defense response;activation of MAPK activity;activation of adenylate cyclase activity;positive regulation of chronic inflammatory response to non-antigenic stimulus;adenylate cyclase-activating G protein-coupled receptor signaling pathway;JNK cascade;positive regulation of vascular endothelial growth factor production;positive regulation of cGMP-mediated signaling;positive regulation of guanylate cyclase activity;cellular response to extracellular stimulus;positive regulation of chemokine production;positive regulation of interleukin-6 production;positive regulation of mast cell degranulation;relaxation of vascular smooth muscle;regulation of synaptic vesicle exocytosis;synapse;Schaffer collateral - CA1 synapse;glutamatergic synapse	Cell membrane;Disulfide bond;G-protein coupled receptor;Glycoprotein;Lipoprotein;Membrane;Palmitate;Receptor;Reference proteome;Transducer;Transmembrane;Transmembrane helix	R-HSA-392499;R-HSA-162582;R-HSA-372790;R-HSA-388396;R-HSA-418555;R-HSA-500792;R-HSA-373076;R-HSA-418038;R-HSA-5683826;R-HSA-417973	Metabolism of proteins;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (s) signalling events;GPCR ligand binding;Class A/1 (Rhodopsin-like receptors);Nucleotide-like (purinergic) receptors;Surfactant metabolism;Adenosine P1 receptors
COQ5	negative	FASTKD5	ENSG00000215251	COQ5	1	COQ5	1	0.00116451401121576					GO:0003723;GO:0006397;GO:0004672;GO:0006468;GO:0005739;GO:0005515;GO:0019843;GO:0042645;GO:0035770;GO:0000963	protein kinase activity;RNA binding;mRNA processing;protein phosphorylation;mitochondrion;protein binding;rRNA binding;mitochondrial nucleoid;ribonucleoprotein granule;mitochondrial RNA processing	Acetylation;Mitochondrion;Mitochondrion nucleoid;Phosphoprotein;Polymorphism;RNA-binding;Reference proteome;Transit peptide;mRNA processing;rRNA-binding		
COQ5	negative	IDS	ENSG00000010404	COQ5	1	COQ5	1	0.00274241805041497				Mucopolysaccharidosis type 2 attenuated form;Mucopolysaccharidosis type 2 severe form;MUCOPOLYSACCHARIDOSIS TYPE 2;MUCOPOLYSACCHARIDOSIS TYPE II	GO:0046872;GO:0016787;GO:0003824;GO:0008484;GO:0005764;GO:0004423;GO:0043202;GO:0006027;GO:0030207	catalytic activity;sulfuric ester hydrolase activity;iduronate-2-sulfatase activity;metal ion binding;hydrolase activity;calcium ion binding;lysosome;lysosomal lumen;glycosaminoglycan catabolic process;chondroitin sulfate catabolic process	3D-structure;Alternative splicing;Calcium;Direct protein sequencing;Disease mutation;Disulfide bond;Glycoprotein;Hydrolase;Lysosome;Metal-binding;Mucopolysaccharidosis;Reference proteome;Signal;Zymogen	R-HSA-1430728;R-HSA-1643685;R-HSA-71387;R-HSA-1630316;R-HSA-1638091;R-HSA-1793185;R-HSA-2024096;R-HSA-2024101;R-HSA-5668914;R-HSA-5663084;R-HSA-2206281;R-HSA-2206296	Metabolism;Disease;Metabolism of carbohydrates;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;Chondroitin sulfate/dermatan sulfate metabolism;HS-GAG degradation;CS/DS degradation;Diseases of metabolism;Diseases of carbohydrate metabolism;Mucopolysaccharidoses;MPS II - Hunter syndrome
COQ5	negative	BID	ENSG00000015475	COQ5	1	COQ5	1	0.00274241805041497					GO:0005737;GO:0016020;GO:0005829;GO:0042981;GO:0005739;GO:0005515;GO:0006915;GO:0005741;GO:0043065;GO:0031966;GO:0006919;GO:0031334;GO:0090200;GO:0008625;GO:0008637;GO:2001244;GO:0032461;GO:0043066;GO:1900740;GO:2001238;GO:0042770;GO:0001836;GO:0051402;GO:0005123;GO:0031625;GO:0046982;GO:0006626;GO:0010918;GO:0032459;GO:0042127;GO:0042775;GO:0065003;GO:0090150;GO:0097191;GO:0097284;GO:0097345;GO:1901030;GO:1902108;GO:1902230;GO:2000045;GO:2000271;GO:2001235;GO:0032592	cytoplasm;regulation of apoptotic process;positive regulation of apoptotic process;membrane;cytosol;mitochondrion;protein binding;apoptotic process;mitochondrial outer membrane;mitochondrial membrane;activation of cysteine-type endopeptidase activity involved in apoptotic process;positive regulation of protein-containing complex assembly;positive regulation of release of cytochrome c from mitochondria;extrinsic apoptotic signaling pathway via death domain receptors;apoptotic mitochondrial changes;positive regulation of intrinsic apoptotic signaling pathway;negative regulation of apoptotic process;positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway;positive regulation of extrinsic apoptotic signaling pathway;signal transduction in response to DNA damage;release of cytochrome c from mitochondria;neuron apoptotic process;death receptor binding;ubiquitin protein ligase binding;protein targeting to mitochondrion;positive regulation of mitochondrial membrane potential;regulation of cell population proliferation;mitochondrial ATP synthesis coupled electron transport;protein-containing complex assembly;establishment of protein localization to membrane;extrinsic apoptotic signaling pathway;hepatocyte apoptotic process;mitochondrial outer membrane permeabilization;positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway;regulation of mitochondrial membrane permeability involved in apoptotic process;negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage;regulation of G1/S transition of mitotic cell cycle;positive regulation of fibroblast apoptotic process;positive regulation of apoptotic signaling pathway;integral component of mitochondrial membrane	3D-structure;Acetylation;Alternative splicing;Apoptosis;Cytoplasm;Membrane;Mitochondrion;Mitochondrion outer membrane;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation	R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-109581;R-HSA-5357801;R-HSA-5633008;R-HSA-109606;R-HSA-114452;R-HSA-6803204;R-HSA-111453;R-HSA-75108;R-HSA-111447;R-HSA-111452;R-HSA-114294	Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Apoptosis;Programmed Cell Death;TP53 Regulates Transcription of Cell Death Genes;Intrinsic Pathway for Apoptosis;Activation of BH3-only proteins;TP53 Regulates Transcription of Genes Involved in Cytochrome C Release;BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members;Activation, myristolyation of BID and translocation to mitochondria;Activation of BAD and translocation to mitochondria ;Activation and oligomerization of BAK protein;Activation, translocation and oligomerization of BAX
COQ5	negative	CHPF2	ENSG00000033100	COQ5	1	COQ5	1	0.00274241805041497	WBGene00003253	WBGene00003253(1)			GO:0016740;GO:0005794;GO:0008376;GO:0032580;GO:0016020;GO:0016021;GO:0000139;GO:0030206;GO:0050510	acetylgalactosaminyltransferase activity;Golgi cisterna membrane;transferase activity;Golgi apparatus;membrane;integral component of membrane;Golgi membrane;chondroitin sulfate biosynthetic process;N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity	Alternative splicing;Glycoprotein;Golgi apparatus;Membrane;Reference proteome;Signal-anchor;Transferase;Transmembrane;Transmembrane helix	R-HSA-1430728;R-HSA-71387;R-HSA-1630316;R-HSA-1793185;R-HSA-2022870	Metabolism;Metabolism of carbohydrates;Glycosaminoglycan metabolism;Chondroitin sulfate/dermatan sulfate metabolism;Chondroitin sulfate biosynthesis
COQ5	negative	ATP11B	ENSG00000058063	COQ5	1	COQ5	1	0.00274241805041497	WBGene00013034;WBGene00019166				GO:0016020;GO:0016021;GO:0046872;GO:0000166;GO:0005524;GO:0000287;GO:0005783;GO:0005794;GO:0006811;GO:0006869;GO:0015914;GO:0140326;GO:0005886;GO:0005768;GO:0005769;GO:0005515;GO:0005637;GO:0034220;GO:0005802;GO:0055037;GO:0055038;GO:0043312;GO:0035577;GO:0045332;GO:0015075;GO:0015917	integral component of membrane;ATP binding;magnesium ion binding;nucleotide binding;phospholipid transport;ATPase-coupled intramembrane lipid transporter activity;membrane;metal ion binding;endoplasmic reticulum;endosome;Golgi apparatus;ion transport;lipid transport;plasma membrane;protein binding;early endosome;nuclear inner membrane;ion transmembrane transport;trans-Golgi network;recycling endosome;recycling endosome membrane;neutrophil degranulation;azurophil granule membrane;phospholipid translocation;ion transmembrane transporter activity;aminophospholipid transport	ATP-binding;Endoplasmic reticulum;Endosome;Golgi apparatus;Lipid transport;Magnesium;Membrane;Metal-binding;Nucleotide-binding;Phosphoprotein;Reference proteome;Translocase;Transmembrane;Transmembrane helix;Transport	R-HSA-168249;R-HSA-168256;R-HSA-382551;R-HSA-983712;R-HSA-6798695;R-HSA-936837	Innate Immune System;Immune System;Transport of small molecules;Ion channel transport;Neutrophil degranulation;Ion transport by P-type ATPases
COQ5	negative	CYB5R4	ENSG00000065615	COQ5	1	COQ5	1	0.00274241805041497	WBGene00013123	WBGene00013123(1)			GO:0046872;GO:0016491;GO:0055114;GO:0005783;GO:0048471;GO:0020037;GO:0005789;GO:0006801;GO:0016174;GO:0042593;GO:0015701;GO:0046677;GO:0004128;GO:0006091;GO:0030073;GO:0048468;GO:0016653;GO:0003032	oxidation-reduction process;oxidoreductase activity;heme binding;metal ion binding;endoplasmic reticulum;perinuclear region of cytoplasm;endoplasmic reticulum membrane;superoxide metabolic process;NAD(P)H oxidase activity;glucose homeostasis;bicarbonate transport;response to antibiotic;cytochrome-b5 reductase activity, acting on NAD(P)H;generation of precursor metabolites and energy;insulin secretion;cell development;oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor;detection of oxygen	3D-structure;Acetylation;Endoplasmic reticulum;FAD;Flavoprotein;Heme;Iron;Metal-binding;NAD;Oxidoreductase;Polymorphism;Reference proteome	R-HSA-382551;R-HSA-1237044;R-HSA-1480926	Transport of small molecules;Erythrocytes take up carbon dioxide and release oxygen;O2/CO2 exchange in erythrocytes
COQ5	negative	PRKCQ	ENSG00000065675	COQ5	1	COQ5	1	0.00274241805041497	WBGene00006599				GO:0005737;GO:0016020;GO:0046872;GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0035556;GO:0005886;GO:0005515;GO:0016235;GO:0004697;GO:0005815;GO:0006954;GO:0002376;GO:0038095;GO:0050852;GO:0005829;GO:0050870;GO:0018105;GO:0001558;GO:0032753;GO:0051092;GO:0006355;GO:0030168;GO:0007411;GO:0060326;GO:0006509;GO:0045652;GO:0032212;GO:0051973;GO:1904355;GO:0046627;GO:0090330;GO:0070233;GO:0032740;GO:0042102;GO:0045086;GO:2000318;GO:2000570;GO:0001772	ATP binding;protein phosphorylation;intracellular signal transduction;protein serine/threonine kinase activity;protein kinase activity;protein kinase C activity;cytoplasm;membrane;metal ion binding;nucleotide binding;kinase activity;transferase activity;phosphorylation;plasma membrane;protein binding;aggresome;calcium-dependent protein kinase C activity;centriolar satellite;inflammatory response;immune system process;Fc-epsilon receptor signaling pathway;T cell receptor signaling pathway;cytosol;positive regulation of T cell activation;regulation of transcription, DNA-templated;peptidyl-serine phosphorylation;regulation of cell growth;positive regulation of interleukin-4 production;positive regulation of NF-kappaB transcription factor activity;platelet activation;axon guidance;cell chemotaxis;membrane protein ectodomain proteolysis;regulation of megakaryocyte differentiation;positive regulation of telomere maintenance via telomerase;positive regulation of telomerase activity;positive regulation of telomere capping;negative regulation of insulin receptor signaling pathway;regulation of platelet aggregation;negative regulation of T cell apoptotic process;positive regulation of interleukin-17 production;positive regulation of T cell proliferation;positive regulation of interleukin-2 biosynthetic process;positive regulation of T-helper 17 type immune response;positive regulation of T-helper 2 cell activation;immunological synapse	3D-structure;ATP-binding;Alternative splicing;Cell membrane;Cytoplasm;Immunity;Inflammatory response;Kinase;Magnesium;Membrane;Metal-binding;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Serine/threonine-protein kinase;Transferase;Zinc;Zinc-finger	R-HSA-109582;R-HSA-1280218;R-HSA-168249;R-HSA-168256;R-HSA-2454202;R-HSA-2871837;R-HSA-202403;R-HSA-202424;R-HSA-1266738;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-422475;R-HSA-109581;R-HSA-162582;R-HSA-5357801;R-HSA-372790;R-HSA-388396;R-HSA-8878171;R-HSA-416476;R-HSA-418594;R-HSA-418597;R-HSA-76002;R-HSA-75153;R-HSA-373752;R-HSA-2187338;R-HSA-8936459;R-HSA-2514856;R-HSA-2514859;R-HSA-111465;R-HSA-114508	Hemostasis;Adaptive Immune System;Innate Immune System;Immune System;Fc epsilon receptor (FCERI) signaling;FCERI mediated NF-kB activation;TCR signaling;Downstream TCR signaling;Developmental Biology;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Axon guidance;Apoptosis;Signal Transduction;Programmed Cell Death;Signaling by GPCR;GPCR downstream signalling;Transcriptional regulation by RUNX1;G alpha (q) signalling events;G alpha (i) signalling events;G alpha (z) signalling events;Platelet activation, signaling and aggregation;Apoptotic execution phase;Netrin-1 signaling;Visual phototransduction;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;The phototransduction cascade;Inactivation, recovery and regulation of the phototransduction cascade;Apoptotic cleavage of cellular proteins;Effects of PIP2 hydrolysis
COQ5	negative	TRAM1	ENSG00000067167	COQ5	1	COQ5	1	0.00274241805041497	WBGene00007696	WBGene00007696(1)			GO:0005623;GO:0016020;GO:0016021;GO:0006616;GO:0015031;GO:0005783;GO:0005789;GO:0005515;GO:0016032;GO:0030176;GO:0038023;GO:0005791;GO:0006613	integral component of membrane;SRP-dependent cotranslational protein targeting to membrane, translocation;membrane;protein transport;endoplasmic reticulum;endoplasmic reticulum membrane;protein binding;viral process;integral component of endoplasmic reticulum membrane;signaling receptor activity;rough endoplasmic reticulum;cotranslational protein targeting to membrane	Alternative splicing;Endoplasmic reticulum;Glycoprotein;Host-virus interaction;Membrane;Phosphoprotein;Protein transport;Reference proteome;Translocation;Transmembrane;Transmembrane helix;Transport	R-HSA-392499;R-HSA-72766;R-HSA-1799339	Metabolism of proteins;Translation;SRP-dependent cotranslational protein targeting to membrane
COQ5	negative	DGKD	ENSG00000077044	COQ5	1	COQ5	1	0.00274241805041497	WBGene00006483	WBGene00019428(0);WBGene00006483(0)			GO:0005634;GO:0005737;GO:0016020;GO:0015031;GO:0046872;GO:0000166;GO:0005524;GO:0016301;GO:0016740;GO:0016310;GO:0005829;GO:0035556;GO:0007165;GO:0003951;GO:0046982;GO:0005886;GO:0005515;GO:0042803;GO:0007275;GO:0004143;GO:0007205;GO:0006897;GO:0051260;GO:0030168;GO:0007173;GO:0010033;GO:0046339;GO:0046486;GO:0046834;GO:0019992;GO:0019932	protein binding;signal transduction;intracellular signal transduction;protein homodimerization activity;diacylglycerol kinase activity;protein kinase C-activating G protein-coupled receptor signaling pathway;kinase activity;NAD+ kinase activity;protein heterodimerization activity;nucleus;cytoplasm;membrane;protein transport;metal ion binding;nucleotide binding;ATP binding;transferase activity;phosphorylation;cytosol;plasma membrane;multicellular organism development;identical protein binding;endocytosis;platelet activation;epidermal growth factor receptor signaling pathway;kinase binding;response to organic substance;diacylglycerol metabolic process;glycerolipid metabolic process;lipid phosphorylation;diacylglycerol binding;second-messenger-mediated signaling	3D-structure;ATP-binding;Alternative splicing;Cytoplasm;Endocytosis;Kinase;Membrane;Metal-binding;Nucleotide-binding;Phosphoprotein;Protein transport;Reference proteome;Repeat;Transferase;Transport;Zinc;Zinc-finger	R-HSA-109582;R-HSA-162582;R-HSA-372790;R-HSA-388396;R-HSA-416476;R-HSA-76002;R-HSA-114508	Hemostasis;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (q) signalling events;Platelet activation, signaling and aggregation;Effects of PIP2 hydrolysis
COQ5	negative	GTPBP1	ENSG00000100226	COQ5	1	COQ5	1	0.00274241805041497	WBGene00000480;WBGene00011449	WBGene00000480(1)			GO:0003723;GO:0005737;GO:0016020;GO:0000166;GO:0003924;GO:0005525;GO:0005829;GO:0006955;GO:0007165;GO:0003746;GO:0006414;GO:0046039;GO:0061014;GO:0000177	GTP binding;GTPase activity;RNA binding;cytoplasm;membrane;nucleotide binding;cytosol;immune response;signal transduction;translation elongation factor activity;translational elongation;GTP metabolic process;positive regulation of mRNA catabolic process;cytoplasmic exosome (RNase complex)	Cytoplasm;GTP-binding;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome		
COQ5	negative	NXT2	ENSG00000101888	COQ5	1	COQ5	1	0.00274241805041497	WBGene00003836	WBGene00003836(0)			GO:0051028;GO:0005634;GO:0005737;GO:0015031;GO:0005829;GO:0005654;GO:0005515;GO:0048471;GO:0006606;GO:0044613;GO:0006913	mRNA transport;nucleus;cytoplasm;protein transport;nucleoplasm;cytosol;protein binding;perinuclear region of cytoplasm;protein import into nucleus;nuclear pore central transport channel;nucleocytoplasmic transport	Alternative splicing;Cytoplasm;Nucleus;Protein transport;Reference proteome;Transport;mRNA transport		
COQ5	negative	TSC22D1	ENSG00000102804	COQ5	1	COQ5	1	0.00274241805041497	WBGene00011824;WBGene00016269;WBGene00019273	WBGene00011824(0);WBGene00012994(0)	CNP		GO:0005634;GO:0005737;GO:0006355;GO:0003700;GO:0005515;GO:0006357;GO:0000981;GO:0006366	regulation of transcription, DNA-templated;DNA-binding transcription factor activity;nucleus;cytoplasm;protein binding;regulation of transcription by RNA polymerase II;DNA-binding transcription factor activity, RNA polymerase II-specific;transcription by RNA polymerase II	Alternative splicing;Cytoplasm;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repressor;Transcription;Transcription regulation		
COQ5	negative	CACTIN	ENSG00000105298	COQ5	1	COQ5	1	0.00274241805041497	WBGene00012230	WBGene00012230(0)			GO:0003723;GO:0006397;GO:0008380;GO:0005634;GO:0016607;GO:0005829;GO:0005654;GO:0005681;GO:0007275;GO:0000398;GO:0071013;GO:0002376;GO:0045087;GO:0005515;GO:0071222;GO:0032088;GO:0071347;GO:0071356;GO:0032720;GO:0001933;GO:0032688;GO:0031665;GO:0034122;GO:0060339;GO:0032717	protein binding;RNA binding;mRNA processing;RNA splicing;nucleus;cytoplasm;nuclear speck;nucleoplasm;cytosol;spliceosomal complex;multicellular organism development;mRNA splicing, via spliceosome;catalytic step 2 spliceosome;immune system process;innate immune response;cellular response to lipopolysaccharide;negative regulation of NF-kappaB transcription factor activity;cellular response to interleukin-1;cellular response to tumor necrosis factor;negative regulation of tumor necrosis factor production;negative regulation of protein phosphorylation;negative regulation of I-kappaB kinase/NF-kappaB signaling;negative regulation of interferon-beta production;negative regulation of lipopolysaccharide-mediated signaling pathway;negative regulation of toll-like receptor signaling pathway;negative regulation of type I interferon-mediated signaling pathway;negative regulation of interleukin-8 production	3D-structure;Alternative splicing;Coiled coil;Cytoplasm;Developmental protein;Immunity;Innate immunity;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Spliceosome;Ubl conjugation;mRNA processing;mRNA splicing		
COQ5	negative	SLAIN2	ENSG00000109171	COQ5	1	COQ5	1	0.00274241805041497					GO:0005737;GO:0005813;GO:0005829;GO:0005856;GO:0005515;GO:0031113;GO:0031122;GO:0015630;GO:0007020;GO:0031116;GO:0035371	cytoplasm;cytosol;cytoskeleton;centrosome;protein binding;regulation of microtubule polymerization;cytoplasmic microtubule organization;microtubule cytoskeleton;microtubule nucleation;positive regulation of microtubule polymerization;microtubule plus-end	3D-structure;Acetylation;Coiled coil;Cytoplasm;Cytoskeleton;Methylation;Phosphoprotein;Reference proteome		
COQ5	negative	CHIC2	ENSG00000109220	COQ5	1	COQ5	1	0.00274241805041497	WBGene00044319	WBGene00044319(1)		LEUKEMIA ACUTE MYELOID	GO:0016020;GO:0043231;GO:0005886;GO:0005515;GO:0031410;GO:0003674;GO:0008150;GO:0005798;GO:0005794	membrane;intracellular membrane-bounded organelle;plasma membrane;protein binding;cytoplasmic vesicle;molecular_function;biological_process;Golgi-associated vesicle;Golgi apparatus	Cell membrane;Chromosomal rearrangement;Coiled coil;Cytoplasmic vesicle;Lipoprotein;Membrane;Palmitate;Reference proteome		
COQ5	negative	SH2B3	ENSG00000111252	COQ5	1	COQ5	1	0.00274241805041497				Essential thrombocythemia;Growth retardation-mild developmental delay-chronic hepatitis syndrome;ERYTHROCYTOSIS FAMILIAL 1;MYELOFIBROSIS MYELOFIBROSIS WITH MYELOID METAPLASIA INCLUDED;THROMBOCYTHEMIA 1	GO:0008285;GO:0051898;GO:0046426;GO:0060761;GO:0042532;GO:0007165;GO:0035591;GO:0009967;GO:0005515;GO:0035556;GO:0005886;GO:0005829;GO:0030097;GO:0007596;GO:0001780;GO:0090331;GO:0005070;GO:0035162;GO:0035855;GO:0038163;GO:1990782;GO:0007169;GO:0005068;GO:1990869;GO:0005173;GO:0030154;GO:0035702;GO:0036016;GO:0043407;GO:0048821;GO:0070100;GO:1900235	signal transduction;hemopoiesis;signaling adaptor activity;negative regulation of tyrosine phosphorylation of STAT protein;negative regulation of cell population proliferation;negative regulation of protein kinase B signaling;negative regulation of receptor signaling pathway via JAK-STAT;negative regulation of response to cytokine stimulus;positive regulation of signal transduction;protein binding;plasma membrane;intracellular signal transduction;cytosol;blood coagulation;neutrophil homeostasis;negative regulation of platelet aggregation;SH3/SH2 adaptor activity;embryonic hemopoiesis;megakaryocyte development;thrombopoietin-mediated signaling pathway;protein tyrosine kinase binding;transmembrane receptor protein tyrosine kinase signaling pathway;transmembrane receptor protein tyrosine kinase adaptor activity;cellular response to chemokine;stem cell factor receptor binding;cell differentiation;monocyte homeostasis;cellular response to interleukin-3;negative regulation of MAP kinase activity;erythrocyte development;negative regulation of chemokine-mediated signaling pathway;negative regulation of Kit signaling pathway	Diabetes mellitus;Phosphoprotein;Polymorphism;Reference proteome;SH2 domain	R-HSA-109582;R-HSA-162582;R-HSA-983231;R-HSA-9006934;R-HSA-1433557;R-HSA-1433559	Hemostasis;Signal Transduction;Factors involved in megakaryocyte development and platelet production;Signaling by Receptor Tyrosine Kinases;Signaling by SCF-KIT;Regulation of KIT signaling
COQ5	negative	QKI	ENSG00000112531	COQ5	1	COQ5	1	0.00274241805041497	WBGene00006423;WBGene00001595			Angiocentric glioma;Intellectual disability	GO:0003676;GO:0003723;GO:0006397;GO:0008380;GO:0051028;GO:0005634;GO:0005737;GO:0005515;GO:0007275;GO:0030154;GO:0003729;GO:0006417;GO:0017124;GO:0001570;GO:0007286;GO:0008366;GO:0010628;GO:0042552;GO:0042692;GO:0042759;GO:0045202	nucleic acid binding;RNA binding;mRNA processing;RNA splicing;mRNA transport;nucleus;cytoplasm;protein binding;multicellular organism development;cell differentiation;mRNA binding;regulation of translation;SH3 domain binding;vasculogenesis;spermatid development;axon ensheathment;positive regulation of gene expression;myelination;muscle cell differentiation;long-chain fatty acid biosynthetic process;synapse	3D-structure;Alternative splicing;Cytoplasm;Developmental protein;Differentiation;Methylation;Nucleus;Phosphoprotein;Polymorphism;RNA-binding;Reference proteome;SH3-binding;Translation regulation;Transport;mRNA processing;mRNA splicing;mRNA transport	R-HSA-1643685;R-HSA-5663202;R-HSA-6802952;R-HSA-6802957	Disease;Diseases of signal transduction;Signaling by BRAF and RAF fusions;Oncogenic MAPK signaling
COQ5	negative	FBRSL1	ENSG00000112787	COQ5	1	COQ5	1	0.00274241805041497					GO:0003723	RNA binding	Isopeptide bond;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation		
COQ5	negative	SKP1	ENSG00000113558	COQ5	1	COQ5	1	0.00274241805041497	WBGene00004807;WBGene00004808;WBGene00004809;WBGene00004810;WBGene00004811;WBGene00004812;WBGene00004813;WBGene00004814;WBGene00004815;WBGene00004816;WBGene00004818;WBGene00004819;WBGene00004820;WBGene00004821;WBGene00004822;WBGene00004823;WBGene00004825;WBGene00004826;WBGene00004827;WBGene00018935	WBGene00004809(1);WBGene00004816(1);WBGene00004818(1);WBGene00018935(1);WBGene00004812(1);WBGene00004810(1);WBGene00004820(1);WBGene00004808(1);WBGene00004819(1);WBGene00004813(1);WBGene00004821(1);WBGene00004815(1);WBGene00004823(1);WBGene00004822(1);WBGene00004807(1);WBGene00004814(1);WBGene00004811(1);WBGene00004826(1)			GO:0016567;GO:0005515;GO:0004842;GO:0006511;GO:0038095;GO:0005634;GO:0005737;GO:0050852;GO:0061630;GO:0005654;GO:0005829;GO:0000209;GO:0002223;GO:0010972;GO:0031146;GO:0038061;GO:0043687;GO:0070498;GO:1901990;GO:0016032;GO:0000086;GO:0031519;GO:0019904;GO:0016055;GO:0051403;GO:0008013;GO:0097602;GO:0035518;GO:0006879;GO:0019005;GO:0010265;GO:0031467;GO:0051457;GO:0005813	ubiquitin-dependent protein catabolic process;cell;protein ubiquitination;protein binding;Fc-epsilon receptor signaling pathway;nucleus;cytoplasm;T cell receptor signaling pathway;ubiquitin protein ligase activity;nucleoplasm;cytosol;protein polyubiquitination;stimulatory C-type lectin receptor signaling pathway;negative regulation of G2/M transition of mitotic cell cycle;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;NIK/NF-kappaB signaling;post-translational protein modification;interleukin-1-mediated signaling pathway;regulation of mitotic cell cycle phase transition;viral process;G2/M transition of mitotic cell cycle;PcG protein complex;protein domain specific binding;Wnt signaling pathway;stress-activated MAPK cascade;beta-catenin binding;cullin family protein binding;histone H2A monoubiquitination;cellular iron ion homeostasis;SCF ubiquitin ligase complex;SCF complex assembly;Cul7-RING ubiquitin ligase complex;maintenance of protein location in nucleus;centrosome	3D-structure;Alternative splicing;Direct protein sequencing;Host-virus interaction;Isopeptide bond;Phosphoprotein;Reference proteome;Ubl conjugation;Ubl conjugation pathway	R-HSA-1280218;R-HSA-168249;R-HSA-168256;R-HSA-2454202;R-HSA-2871837;R-HSA-983705;R-HSA-202403;R-HSA-202424;R-HSA-392499;R-HSA-597592;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-983168;R-HSA-983169;R-HSA-382551;R-HSA-162582;R-HSA-1640170;R-HSA-1643685;R-HSA-162906;R-HSA-5663205;R-HSA-1168372;R-HSA-1169091;R-HSA-1280215;R-HSA-162909;R-HSA-174113;R-HSA-174143;R-HSA-176408;R-HSA-180534;R-HSA-195253;R-HSA-195721;R-HSA-446652;R-HSA-449147;R-HSA-453274;R-HSA-453276;R-HSA-5358351;R-HSA-5607761;R-HSA-5607764;R-HSA-5610780;R-HSA-5610783;R-HSA-5610785;R-HSA-5610787;R-HSA-5621481;R-HSA-5663202;R-HSA-5668541;R-HSA-5676590;R-HSA-68949;R-HSA-69052;R-HSA-69239;R-HSA-69242;R-HSA-69275;R-HSA-69278;R-HSA-69306;R-HSA-8854050;R-HSA-8878166;R-HSA-8939902;R-HSA-8951664;R-HSA-9020702;R-HSA-2565942;R-HSA-157118;R-HSA-1980143;R-HSA-2644602;R-HSA-2644603;R-HSA-2644606;R-HSA-2894858;R-HSA-2894862;R-HSA-166016;R-HSA-166058;R-HSA-166166;R-HSA-168138;R-HSA-168179;R-HSA-168181;R-HSA-168188;R-HSA-168898;R-HSA-181438;R-HSA-937061;R-HSA-975138;R-HSA-975155;R-HSA-187577;R-HSA-453279;R-HSA-69202;R-HSA-69206;R-HSA-69656;R-HSA-9013694;R-HSA-9604323;R-HSA-400253;R-HSA-69231;R-HSA-69236;R-HSA-168142;R-HSA-168164;R-HSA-168176;R-HSA-448424;R-HSA-450294;R-HSA-975871;R-HSA-5684264;R-HSA-917937;R-HSA-2122947;R-HSA-1170546;R-HSA-2644605;R-HSA-2644607	Adaptive Immune System;Innate Immune System;Immune System;Fc epsilon receptor (FCERI) signaling;FCERI mediated NF-kB activation;Signaling by the B Cell Receptor (BCR);TCR signaling;Downstream TCR signaling;Metabolism of proteins;Post-translational protein modification;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Transport of small molecules;Signal Transduction;Cell Cycle;Disease;HIV Infection;Infectious disease;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cytokine Signaling in Immune system;Host Interactions of HIV factors;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;Regulation of APC/C activators between G1/S and early anaphase;Vpu mediated degradation of CD4;Degradation of beta-catenin by the destruction complex;Signaling by WNT;Interleukin-1 family signaling;Signaling by Interleukins;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Signaling by Hedgehog;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;C-type lectin receptors (CLRs);Diseases of signal transduction;TNFR2 non-canonical NF-kB pathway;NIK-->noncanonical NF-kB signaling;Orc1 removal from chromatin;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX2;Regulation of RUNX2 expression and activity;Neddylation;Interleukin-1 signaling;Regulation of PLK1 Activity at G2/M Transition;Signaling by NOTCH;Signaling by NOTCH1;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;SCF(Skp2)-mediated degradation of p27/p21;Mitotic G1 phase and G1/S transition;Cyclin E associated events during G1/S transition ;G1/S Transition;Cyclin A:Cdk2-associated events at S phase entry;Signaling by NOTCH4;Negative regulation of NOTCH4 signaling;Circadian Clock;Cyclin D associated events in G1;G1 Phase;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Interleukin-17 signaling;MAP kinase activation;MyD88 cascade initiated on plasma membrane;MAP3K8 (TPL2)-dependent MAPK1/3 activation;Iron uptake and transport;NOTCH1 Intracellular Domain Regulates Transcription;Prolactin receptor signaling;FBXW7 Mutants and NOTCH1 in Cancer;Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling
COQ5	negative	RO60	ENSG00000116747	COQ5	1	COQ5	1	0.00274241805041497	WBGene00004405	WBGene00004405(1)			GO:0003723;GO:0005737;GO:0046872;GO:0005829;GO:0005654;GO:0030030;GO:1990904;GO:0010468;GO:0006383;GO:0035457;GO:0030620;GO:0002520;GO:0007224;GO:0009411;GO:0060271;GO:0005634	RNA binding;cytoplasm;metal ion binding;nucleoplasm;cytosol;cell projection organization;ribonucleoprotein complex;regulation of gene expression;transcription by RNA polymerase III;cellular response to interferon-alpha;U2 snRNA binding;immune system development;smoothened signaling pathway;response to UV;cilium assembly;nucleus	Acetylation;Alternative splicing;Cilium biogenesis/degradation;Cytoplasm;Direct protein sequencing;Metal-binding;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ribonucleoprotein		
COQ5	negative	YPEL5	ENSG00000119801	COQ5	1	COQ5	1	0.00274241805041497	WBGene00015250;WBGene00015251;WBGene00009503	WBGene00015250(0);WBGene00015251(1)			GO:0005634;GO:0005737;GO:0046872;GO:0005856;GO:0000922;GO:0005813;GO:0005815;GO:0030496;GO:0005576;GO:0005515;GO:0000151;GO:0008283;GO:0043312;GO:1904813;GO:1904724;GO:0097431	nucleus;cytoplasm;metal ion binding;cytoskeleton;spindle pole;centrosome;microtubule organizing center;midbody;extracellular region;protein binding;ubiquitin ligase complex;neutrophil degranulation;ficolin-1-rich granule lumen;tertiary granule lumen;mitotic spindle pole;cell population proliferation	Cytoplasm;Cytoskeleton;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Zinc	R-HSA-168249;R-HSA-168256;R-HSA-6798695	Innate Immune System;Immune System;Neutrophil degranulation
COQ5	negative	GNA13	ENSG00000120063	COQ5	1	COQ5	1	0.00274241805041497	WBGene00001674	WBGene00001664(0);WBGene00001675(0);WBGene00001665(0);WBGene00001678(0);WBGene00001666(0);WBGene00001745(0);WBGene00001670(0);WBGene00001671(0);WBGene00001674(0);WBGene00001673(0);WBGene00001668(0);WBGene00001676(0);WBGene00001667(0)			GO:0005634;GO:0005737;GO:0016020;GO:0046872;GO:0000166;GO:0007186;GO:0005829;GO:0007165;GO:0003924;GO:0005525;GO:0005886;GO:0001664;GO:0005515;GO:0005834;GO:0042470;GO:0019001;GO:0031683;GO:0031752;GO:0001525;GO:0001569;GO:0001701;GO:0007188;GO:0007189;GO:0007204;GO:0007266;GO:0008360;GO:0030154;GO:0030168;GO:0030334;GO:0031584;GO:0035556;GO:0031526;GO:0005925;GO:0070062;GO:0051056;GO:0043065	G protein-coupled receptor signaling pathway;signal transduction;GTPase activity;G-protein beta/gamma-subunit complex binding;G protein-coupled receptor binding;Rho protein signal transduction;guanyl nucleotide binding;cell;nucleus;cytoplasm;membrane;metal ion binding;nucleotide binding;cytosol;focal adhesion;GTP binding;plasma membrane;protein binding;heterotrimeric G-protein complex;melanosome;D5 dopamine receptor binding;angiogenesis;branching involved in blood vessel morphogenesis;in utero embryonic development;adenylate cyclase-modulating G protein-coupled receptor signaling pathway;adenylate cyclase-activating G protein-coupled receptor signaling pathway;positive regulation of cytosolic calcium ion concentration;regulation of cell shape;cell differentiation;platelet activation;regulation of cell migration;activation of phospholipase D activity;intracellular signal transduction;brush border membrane;extracellular exosome;regulation of small GTPase mediated signal transduction;positive regulation of apoptotic process	Alternative splicing;Cell membrane;Cytoplasm;GTP-binding;Lipoprotein;Magnesium;Membrane;Metal-binding;Nucleotide-binding;Nucleus;Palmitate;Phosphoprotein;Polymorphism;Reference proteome;Transducer	R-HSA-109582;R-HSA-162582;R-HSA-194315;R-HSA-194840;R-HSA-193648;R-HSA-193704;R-HSA-204998;R-HSA-372790;R-HSA-388396;R-HSA-416482;R-HSA-73887;R-HSA-392518;R-HSA-76002;R-HSA-456926;R-HSA-428930	Hemostasis;Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Cell death signalling via NRAGE, NRIF and NADE;Signaling by GPCR;GPCR downstream signalling;G alpha (12/13) signalling events;Death Receptor Signalling;Signal amplification;Platelet activation, signaling and aggregation;Thrombin signalling through proteinase activated receptors (PARs);Thromboxane signalling through TP receptor
COQ5	negative	ZNFX1	ENSG00000124201	COQ5	1	COQ5	1	0.00274241805041497	WBGene00014208	WBGene00014965(0);WBGene00016566(0);WBGene00016565(0)			GO:0005634;GO:0003723;GO:0008270;GO:0046872;GO:0006355;GO:0003700;GO:0006357;GO:0000981;GO:0000790;GO:0030702;GO:0000775;GO:0031048;GO:0031380	zinc ion binding;regulation of transcription, DNA-templated;nucleus;DNA-binding transcription factor activity;RNA binding;metal ion binding;regulation of transcription by RNA polymerase II;DNA-binding transcription factor activity, RNA polymerase II-specific;nuclear chromatin;chromatin silencing at centromere;chromosome, centromeric region;chromatin silencing by small RNA;nuclear RNA-directed RNA polymerase complex	Alternative splicing;Coiled coil;Metal-binding;Polymorphism;Reference proteome;Repeat;Zinc;Zinc-finger		
COQ5	negative	USP9X	ENSG00000124486	COQ5	1	COQ5	1	0.00274241805041497	WBGene00011980			X-linked female restricted facial dysmorphism-short stature-choanal atresia-intellectual disability;X-linked non-syndromic intellectual disability;Mental retardation X-linked 99;Mental retardation X-linked 99;MENTAL RETARDATION X-LINKED 99 SYNDROMIC FEMALE-RESTRICTED	GO:0005737;GO:0016020;GO:0016579;GO:0016787;GO:0051301;GO:0005829;GO:0042995;GO:0005515;GO:0008233;GO:0008234;GO:0006508;GO:0007049;GO:0048511;GO:0006511;GO:0036459;GO:0007059;GO:0016567;GO:0030426;GO:0050821;GO:0044267;GO:0004197;GO:0004843;GO:0030509;GO:1990380;GO:0006625;GO:0071108;GO:0007179;GO:0070410;GO:0042752;GO:0001764;GO:0007292;GO:0000122;GO:0048675;GO:1901537;GO:0071947;GO:0101005	ubiquitin-dependent protein catabolic process;thiol-dependent ubiquitinyl hydrolase activity;protein deubiquitination;cytoplasm;membrane;hydrolase activity;cell division;cytosol;cell projection;protein binding;peptidase activity;cysteine-type peptidase activity;proteolysis;cell cycle;rhythmic process;chromosome segregation;protein ubiquitination;growth cone;protein stabilization;cellular protein metabolic process;cell migration;cysteine-type endopeptidase activity;thiol-dependent ubiquitin-specific protease activity;BMP signaling pathway;Lys48-specific deubiquitinase activity;protein targeting to peroxisome;protein K48-linked deubiquitination;transforming growth factor beta receptor signaling pathway;co-SMAD binding;regulation of circadian rhythm;neuron migration;female gamete generation;negative regulation of transcription by RNA polymerase II;positive regulation of DNA demethylation;axon extension;protein deubiquitination involved in ubiquitin-dependent protein catabolic process;ubiquitinyl hydrolase activity	3D-structure;Alternative splicing;Biological rhythms;Cell cycle;Cell division;Cell projection;Chromosome partition;Cytoplasm;Disease mutation;Hydrolase;Mental retardation;Mitosis;Phosphoprotein;Protease;Reference proteome;Thiol protease;Ubl conjugation pathway	R-HSA-392499;R-HSA-597592;R-HSA-8852135;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-8866652;R-HSA-162582;R-HSA-977225;R-HSA-5688426;R-HSA-5689880;R-HSA-9033241;R-HSA-9609507;R-HSA-9006936;R-HSA-170834;R-HSA-2173793;R-HSA-2173795	Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Synthesis of active ubiquitin: roles of E1 and E2 enzymes;Signal Transduction;Amyloid fiber formation;Deubiquitination;Ub-specific processing proteases;Peroxisomal protein import;Protein localization;Signaling by TGF-beta family members;Signaling by TGF-beta Receptor Complex;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;Downregulation of SMAD2/3:SMAD4 transcriptional activity
COQ5	negative	IRAK2	ENSG00000134070	COQ5	1	COQ5	1	0.00274241805041497	WBGene00004029	WBGene00004029(0);WBGene00007258(0);WBGene00021214(0);WBGene00012159(0)			GO:0032088;GO:0000166;GO:0004672;GO:0005524;GO:0006468;GO:0007165;GO:0005515;GO:0007249;GO:0006954;GO:0002755;GO:0005886;GO:0005634;GO:0005737;GO:0004674;GO:0035556;GO:0005829;GO:0010008;GO:0070498;GO:0019221;GO:0051092;GO:0042803;GO:0046982;GO:0002224;GO:0007254;GO:0000187;GO:0001959;GO:0031663;GO:0034162;GO:0043433;GO:0070423;GO:0070555	ATP binding;protein binding;signal transduction;inflammatory response;protein phosphorylation;protein kinase activity;MyD88-dependent toll-like receptor signaling pathway;I-kappaB kinase/NF-kappaB signaling;regulation of cytokine-mediated signaling pathway;interleukin-1-mediated signaling pathway;negative regulation of NF-kappaB transcription factor activity;nucleotide binding;plasma membrane;nucleus;cytoplasm;protein serine/threonine kinase activity;intracellular signal transduction;cytosol;endosome membrane;cytokine-mediated signaling pathway;positive regulation of NF-kappaB transcription factor activity;protein homodimerization activity;protein heterodimerization activity;toll-like receptor signaling pathway;JNK cascade;activation of MAPK activity;lipopolysaccharide-mediated signaling pathway;toll-like receptor 9 signaling pathway;negative regulation of DNA-binding transcription factor activity;nucleotide-binding oligomerization domain containing signaling pathway;response to interleukin-1	3D-structure;ATP-binding;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-168249;R-HSA-168256;R-HSA-1280215;R-HSA-446652;R-HSA-449147;R-HSA-9020702;R-HSA-166016;R-HSA-166058;R-HSA-166166;R-HSA-168138;R-HSA-168179;R-HSA-168181;R-HSA-168188;R-HSA-168898;R-HSA-181438;R-HSA-937061;R-HSA-937072;R-HSA-975138;R-HSA-975155;R-HSA-975163;R-HSA-168142;R-HSA-168164;R-HSA-168176;R-HSA-448424;R-HSA-450294;R-HSA-450321;R-HSA-975871;R-HSA-168643;R-HSA-168638;R-HSA-445989;R-HSA-450302;R-HSA-937042	Innate Immune System;Immune System;Cytokine Signaling in Immune system;Interleukin-1 family signaling;Signaling by Interleukins;Interleukin-1 signaling;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6-mediated induction of TAK1 complex within TLR4 complex;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Interleukin-17 signaling;MAP kinase activation;JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1;MyD88 cascade initiated on plasma membrane;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;NOD1/2 Signaling Pathway;TAK1 activates NFkB by phosphorylation and activation of IKKs complex;activated TAK1 mediates p38 MAPK activation;IRAK2 mediated activation of TAK1 complex
COQ5	negative	SPOCD1	ENSG00000134668	COQ5	1	COQ5	1	0.00274241805041497					GO:0006351;GO:0010923	transcription, DNA-templated;negative regulation of phosphatase activity	Alternative splicing;Polymorphism;Reference proteome		
COQ5	negative	C7orf25	ENSG00000136197	COQ5	1	COQ5	1	0.00274241805041497	WBGene00018015	WBGene00018015(0)			GO:0005515	protein binding	Alternative splicing;Polymorphism;Reference proteome		
COQ5	negative	MIGA2	ENSG00000148343	COQ5	1	COQ5	1	0.00274241805041497	WBGene00010465	WBGene00010465(0)			GO:0016020;GO:0016021;GO:0005739;GO:0042803;GO:0005741;GO:0008053;GO:0005887;GO:0005515;GO:0046982;GO:0060348	membrane;integral component of membrane;mitochondrion;protein homodimerization activity;mitochondrial outer membrane;mitochondrial fusion;protein binding;integral component of plasma membrane;protein heterodimerization activity;bone development	Alternative splicing;Membrane;Mitochondrion;Mitochondrion outer membrane;Phosphoprotein;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix	R-HSA-1430728;R-HSA-556833;R-HSA-1483257;R-HSA-1483206;R-HSA-1483166	Metabolism;Metabolism of lipids;Phospholipid metabolism;Glycerophospholipid biosynthesis;Synthesis of PA
COQ5	negative	FERMT3	ENSG00000149781	COQ5	1	COQ5	1	0.00274241805041497	WBGene00006836	WBGene00006836(1)		LEUKOCYTE ADHESION DEFICIENCY TYPE III;LEUKOCYTE ADHESION DEFICIENCY TYPE III	GO:0007229;GO:0016020;GO:0007155;GO:0042995;GO:0030054;GO:0005576;GO:0070062;GO:0002102;GO:0030335;GO:0070527;GO:0002576;GO:0005178;GO:0031093;GO:0033622;GO:0034446;GO:0033632;GO:0007159	integrin-mediated signaling pathway;membrane;cell adhesion;cell projection;cell junction;extracellular region;extracellular exosome;podosome;positive regulation of cell migration;platelet aggregation;platelet degranulation;integrin binding;platelet alpha granule lumen;integrin activation;substrate adhesion-dependent cell spreading;regulation of cell-cell adhesion mediated by integrin;leukocyte cell-cell adhesion	3D-structure;Alternative splicing;Cell adhesion;Cell junction;Cell projection;Direct protein sequencing;Disease mutation;Phosphoprotein;Reference proteome	R-HSA-109582;R-HSA-76002;R-HSA-76005;R-HSA-114608	Hemostasis;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Platelet degranulation 
COQ5	negative	PDK1	ENSG00000152256	COQ5	1	COQ5	1	0.00274241805041497	WBGene00022719				GO:0000166;GO:0004672;GO:0005524;GO:0016301;GO:0016740;GO:0016310;GO:0006468;GO:0005739;GO:0005759;GO:0005634;GO:0005730;GO:0005515;GO:0005975;GO:0006006;GO:0008283;GO:0008631;GO:0010510;GO:0010906;GO:0004740;GO:0097411;GO:0005967	protein kinase activity;nucleotide binding;ATP binding;kinase activity;transferase activity;phosphorylation;protein phosphorylation;mitochondrion;mitochondrial matrix;nucleoplasm;nucleolus;protein binding;carbohydrate metabolic process;protein serine/threonine kinase activity;glucose metabolic process;glucose homeostasis;negative regulation of pyruvate dehydrogenase activity;intrinsic apoptotic signaling pathway in response to oxidative stress;cell population proliferation;regulation of acetyl-CoA biosynthetic process from pyruvate;regulation of glucose metabolic process;pyruvate dehydrogenase (acetyl-transferring) kinase activity;hypoxia-inducible factor-1alpha signaling pathway;mitochondrial pyruvate dehydrogenase complex	3D-structure;ATP-binding;Alternative splicing;Carbohydrate metabolism;Glucose metabolism;Kinase;Mitochondrion;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Transferase;Transit peptide	R-HSA-1430728;R-HSA-162582;R-HSA-9006931;R-HSA-1428517;R-HSA-204174;R-HSA-5362517;R-HSA-70268;R-HSA-71406	Metabolism;Signal Transduction;Signaling by Nuclear Receptors;The citric acid (TCA) cycle and respiratory electron transport;Regulation of pyruvate dehydrogenase (PDH) complex;Signaling by Retinoic Acid;Pyruvate metabolism;Pyruvate metabolism and Citric Acid (TCA) cycle
COQ5	negative	CNST	ENSG00000162852	COQ5	1	COQ5	1	0.00274241805041497					GO:0016020;GO:0016021;GO:0043231;GO:0005794;GO:0005886;GO:0005515;GO:0005802;GO:0031410;GO:0019902;GO:0010923;GO:0071253;GO:0030133;GO:0042998;GO:0032991	trans-Golgi network;connexin binding;positive regulation of Golgi to plasma membrane protein transport;membrane;integral component of membrane;intracellular membrane-bounded organelle;Golgi apparatus;plasma membrane;protein binding;cytoplasmic vesicle;phosphatase binding;negative regulation of phosphatase activity;transport vesicle;protein-containing complex	Alternative splicing;Cell membrane;Cytoplasmic vesicle;Golgi apparatus;Membrane;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix		
COQ5	negative	ITGA2	ENSG00000164171	COQ5	1	COQ5	1	0.00274241805041497		WBGene00003929(0)		Fetal and neonatal alloimmune thrombocytopenia;BLEEDING DISORDER PLATELET-TYPE 9	GO:0016020;GO:0016021;GO:0046872;GO:0007155;GO:0005515;GO:0009986;GO:0007229;GO:0008305;GO:0046718;GO:0005925;GO:0005886;GO:0016032;GO:0001540;GO:0007596;GO:0030198;GO:0044877;GO:0009887;GO:0007160;GO:0001618;GO:0005518;GO:0031589;GO:0098639;GO:0033627;GO:0048333;GO:0034666;GO:0005178;GO:0038064;GO:0043236;GO:0043395;GO:0046982;GO:0001666;GO:0002687;GO:0006929;GO:0006971;GO:0007565;GO:0008283;GO:0010634;GO:0010694;GO:0014070;GO:0014075;GO:0014850;GO:0014911;GO:0030879;GO:0031346;GO:0032967;GO:0033343;GO:0033591;GO:0038065;GO:0042060;GO:0042493;GO:0043388;GO:0043589;GO:0045184;GO:0045727;GO:0045785;GO:0045987;GO:0048041;GO:0048661;GO:0050729;GO:0050927;GO:0050966;GO:0051971;GO:0060100;GO:0070365;GO:0071107;GO:0071260;GO:0071392;GO:0071407;GO:0005634;GO:0009897;GO:0030424;GO:0042995;GO:0043679;GO:0045178;GO:0048471	cell adhesion;integrin complex;membrane;integral component of membrane;metal ion binding;focal adhesion;protein binding;cell surface;integrin-mediated signaling pathway;viral entry into host cell;plasma membrane;viral process;amyloid-beta binding;blood coagulation;extracellular matrix organization;protein-containing complex binding;animal organ morphogenesis;cell-matrix adhesion;virus receptor activity;collagen binding;cell-substrate adhesion;collagen binding involved in cell-matrix adhesion;cell adhesion mediated by integrin;mesodermal cell differentiation;integrin alpha2-beta1 complex;integrin binding;collagen receptor activity;laminin binding;heparan sulfate proteoglycan binding;response to hypoxia;positive regulation of leukocyte migration;substrate-dependent cell migration;hypotonic response;female pregnancy;cell population proliferation;positive regulation of epithelial cell migration;positive regulation of alkaline phosphatase activity;response to organic cyclic compound;response to amine;response to muscle activity;positive regulation of smooth muscle cell migration;mammary gland development;positive regulation of cell projection organization;positive regulation of collagen biosynthetic process;positive regulation of collagen binding;response to L-ascorbic acid;collagen-activated signaling pathway;wound healing;response to drug;positive regulation of DNA binding;skin morphogenesis;establishment of protein localization;positive regulation of translation;positive regulation of cell adhesion;positive regulation of smooth muscle contraction;focal adhesion assembly;positive regulation of smooth muscle cell proliferation;positive regulation of inflammatory response;positive regulation of positive chemotaxis;detection of mechanical stimulus involved in sensory perception of pain;positive regulation of transmission of nerve impulse;positive regulation of phagocytosis, engulfment;hepatocyte differentiation;response to parathyroid hormone;cellular response to mechanical stimulus;cellular response to estradiol stimulus;cellular response to organic cyclic compound;nucleus;external side of plasma membrane;axon;cell projection;axon terminus;basal part of cell;perinuclear region of cytoplasm	3D-structure;Calcium;Cell adhesion;Direct protein sequencing;Disulfide bond;Glycoprotein;Host cell receptor for virus entry;Host-virus interaction;Integrin;Magnesium;Membrane;Metal-binding;Polymorphism;Receptor;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix	R-HSA-109582;R-HSA-1266738;R-HSA-373760;R-HSA-422475;R-HSA-162582;R-HSA-1474244;R-HSA-216083;R-HSA-3000178;R-HSA-9006934;R-HSA-3000171;R-HSA-447041;R-HSA-3000170;R-HSA-6806834;R-HSA-3000157;R-HSA-8874081;R-HSA-8875878;R-HSA-75892	Hemostasis;Developmental Biology;L1CAM interactions;Axon guidance;Signal Transduction;Extracellular matrix organization;Integrin cell surface interactions;ECM proteoglycans;Signaling by Receptor Tyrosine Kinases;Non-integrin membrane-ECM interactions;CHL1 interactions;Syndecan interactions;Signaling by MET;Laminin interactions;MET activates PTK2 signaling;MET promotes cell motility;Platelet Adhesion to exposed collagen
COQ5	negative	SMPD1	ENSG00000166311	COQ5	1	COQ5	1	0.00274241805041497	WBGene00000212;WBGene00000213;WBGene00000211	WBGene00000213(0);WBGene00000212(0);WBGene00000211(0)		Niemann-Pick disease type A;Niemann-Pick disease type B;Niemann-Pick disease type A;Niemann-Pick disease type B;NIEMANN-PICK DISEASE TYPE A;NIEMANN-PICK DISEASE TYPE BNIEMANN-PICK DISEASE TYPE E INCLUDED	GO:0043407;GO:0046872;GO:0016787;GO:0008270;GO:0005615;GO:0005886;GO:0005515;GO:0008152;GO:0005576;GO:0016798;GO:0005764;GO:0005768;GO:0006687;GO:0070062;GO:0004767;GO:0006685;GO:0007399;GO:0007165;GO:0043202;GO:0046513;GO:0006684;GO:0023021;GO:0035307;GO:0008081;GO:0061750;GO:0006672;GO:0008203;GO:0042220;GO:0042493;GO:0043065;GO:0042599;GO:0016020;GO:0016021	hydrolase activity;sphingomyelin phosphodiesterase activity;sphingomyelin catabolic process;negative regulation of MAP kinase activity;metal ion binding;zinc ion binding;endosome;extracellular space;plasma membrane;protein binding;metabolic process;extracellular region;hydrolase activity, acting on glycosyl bonds;lysosome;glycosphingolipid metabolic process;extracellular exosome;nervous system development;signal transduction;lysosomal lumen;ceramide biosynthetic process;sphingomyelin metabolic process;termination of signal transduction;positive regulation of protein dephosphorylation;phosphoric diester hydrolase activity;acid sphingomyelin phosphodiesterase activity;ceramide metabolic process;cholesterol metabolic process;response to cocaine;response to drug;positive regulation of apoptotic process;lamellar body;membrane;integral component of membrane	3D-structure;Alternative splicing;Direct protein sequencing;Disease mutation;Disulfide bond;Glycoprotein;Glycosidase;Hydrolase;Lysosome;Metal-binding;Neurodegeneration;Niemann-Pick disease;Reference proteome;Secreted;Signal;Zinc	R-HSA-1430728;R-HSA-1660662;R-HSA-428157;R-HSA-556833	Metabolism;Glycosphingolipid metabolism;Sphingolipid metabolism;Metabolism of lipids
COQ5	negative	ILK	ENSG00000166333	COQ5	1	COQ5	1	0.00274241805041497	WBGene00003931	WBGene00003931(1)			GO:0005737;GO:0016020;GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0005829;GO:0005654;GO:0005925;GO:0005886;GO:0030054;GO:0042995;GO:0005515;GO:0045893;GO:0030027;GO:0019901;GO:0001934;GO:0034446;GO:0008283;GO:0007160;GO:0007229;GO:0090263;GO:0001725;GO:0070527;GO:0042327;GO:0030017;GO:1901224;GO:0034329;GO:0009967;GO:0033209;GO:0005178;GO:0017124;GO:0019904;GO:0001558;GO:0001658;GO:0001954;GO:0003151;GO:0006469;GO:0007050;GO:0007569;GO:0008284;GO:0010667;GO:0010761;GO:0014044;GO:0014912;GO:0018105;GO:0021675;GO:0022011;GO:0030030;GO:0030335;GO:0030513;GO:0032288;GO:0032956;GO:0043066;GO:0043406;GO:0043410;GO:0043491;GO:0043524;GO:0045197;GO:0045663;GO:0045669;GO:0045773;GO:0048662;GO:0048812;GO:0050772;GO:0050775;GO:0051291;GO:0051897;GO:0097435;GO:2000178;GO:0005911;GO:0030424;GO:0032991;GO:0043025;GO:0043034;GO:0043195;GO:0043198	ATP binding;protein binding;protein phosphorylation;protein kinase activity;cytoplasm;membrane;nucleotide binding;protein serine/threonine kinase activity;kinase activity;transferase activity;phosphorylation;nucleoplasm;cytosol;focal adhesion;plasma membrane;cell junction;cell projection;positive regulation of transcription, DNA-templated;lamellipodium;protein kinase binding;positive regulation of protein phosphorylation;substrate adhesion-dependent cell spreading;cell-matrix adhesion;integrin-mediated signaling pathway;positive regulation of canonical Wnt signaling pathway;stress fiber;platelet aggregation;positive regulation of phosphorylation;sarcomere;positive regulation of NIK/NF-kappaB signaling;cell junction assembly;positive regulation of signal transduction;tumor necrosis factor-mediated signaling pathway;integrin binding;SH3 domain binding;protein domain specific binding;protein-containing complex binding;regulation of cell growth;branching involved in ureteric bud morphogenesis;positive regulation of cell-matrix adhesion;outflow tract morphogenesis;negative regulation of protein kinase activity;cell cycle arrest;cell aging;positive regulation of cell population proliferation;negative regulation of cardiac muscle cell apoptotic process;fibroblast migration;Schwann cell development;negative regulation of smooth muscle cell migration;peptidyl-serine phosphorylation;nerve development;myelination in peripheral nervous system;cell projection organization;positive regulation of cell migration;positive regulation of BMP signaling pathway;myelin assembly;regulation of actin cytoskeleton organization;negative regulation of apoptotic process;positive regulation of MAP kinase activity;positive regulation of MAPK cascade;protein kinase B signaling;negative regulation of neuron apoptotic process;establishment or maintenance of epithelial cell apical/basal polarity;positive regulation of myoblast differentiation;positive regulation of osteoblast differentiation;positive regulation of axon extension;negative regulation of smooth muscle cell proliferation;neuron projection morphogenesis;positive regulation of axonogenesis;positive regulation of dendrite morphogenesis;positive regulation of protein kinase B signaling;supramolecular fiber organization;negative regulation of neural precursor cell proliferation;cell-cell junction;axon;protein-containing complex;neuronal cell body;costamere;terminal bouton;dendritic shaft	3D-structure;ANK repeat;ATP-binding;Acetylation;Alternative splicing;Cell junction;Cell membrane;Cell projection;Cytoplasm;Kinase;Membrane;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Serine/threonine-protein kinase;Transferase	R-HSA-1500931;R-HSA-446728;R-HSA-446343;R-HSA-446353	Cell-Cell communication;Cell junction organization;Localization of the PINCH-ILK-PARVIN complex to focal adhesions;Cell-extracellular matrix interactions
COQ5	negative	ING5	ENSG00000168395	COQ5	1	COQ5	1	0.00274241805041497	WBGene00013095;WBGene00021545				GO:0005634;GO:0016573;GO:0008285;GO:0003682;GO:2001235;GO:0070776;GO:0046872;GO:0006325;GO:0005515;GO:0006260;GO:0045893;GO:0005654;GO:1901796;GO:0035064;GO:0045926;GO:0006473;GO:0043966;GO:0043065	nucleus;histone acetylation;negative regulation of cell population proliferation;MOZ/MORF histone acetyltransferase complex;chromatin binding;positive regulation of apoptotic signaling pathway;metal ion binding;chromatin organization;protein binding;DNA replication;positive regulation of transcription, DNA-templated;nucleoplasm;histone H4 acetylation;regulation of signal transduction by p53 class mediator;methylated histone binding;histone acetyltransferase complex;negative regulation of growth;protein acetylation;histone H3 acetylation;histone H3-K14 acetylation;positive regulation of apoptotic process	3D-structure;Acetylation;Activator;Alternative splicing;Chromatin regulator;Chromosome;Metal-binding;Methylation;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Zinc;Zinc-finger	R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-5633007;R-HSA-3247509;R-HSA-4839726;R-HSA-3214847;R-HSA-6804758	Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Regulation of TP53 Activity;Chromatin modifying enzymes;Chromatin organization;HATs acetylate histones;Regulation of TP53 Activity through Acetylation
COQ5	negative	PPP2R2D	ENSG00000175470	COQ5	1	COQ5	1	0.00274241805041497	WBGene00006352	WBGene00006352(0)			GO:0005737;GO:0051301;GO:0005515;GO:0007049;GO:0019888;GO:0043666;GO:0000159;GO:0000278;GO:0005829;GO:0004722;GO:0010458;GO:0070262	protein phosphatase regulator activity;protein phosphatase type 2A complex;protein binding;cytoplasm;cell division;cell cycle;regulation of phosphoprotein phosphatase activity;cytosol;exit from mitosis;mitotic cell cycle;peptidyl-serine dephosphorylation	Cell cycle;Cell division;Cytoplasm;Mitosis;Phosphoprotein;Polymorphism;Reference proteome;Repeat;WD repeat	R-HSA-1640170;R-HSA-68886;R-HSA-69278;R-HSA-68875;R-HSA-2465910	Cell Cycle;M Phase;Cell Cycle, Mitotic;Mitotic Prophase;MASTL Facilitates Mitotic Progression
COQ5	negative	LSMEM1	ENSG00000181016	COQ5	1	COQ5	1	0.00274241805041497					GO:0016020;GO:0016021;GO:0005829;GO:0005515	membrane;integral component of membrane;cytosol;protein binding	Alternative splicing;Coiled coil;Membrane;Phosphoprotein;Reference proteome;Transmembrane;Transmembrane helix		
COQ5	negative	TMEM259	ENSG00000182087	COQ5	1	COQ5	1	0.00274241805041497	WBGene00021985	WBGene00021985(1)			GO:0016020;GO:0016021;GO:0005783;GO:0005789;GO:0034976;GO:1901215;GO:1904294	membrane;integral component of membrane;endoplasmic reticulum;endoplasmic reticulum membrane;response to endoplasmic reticulum stress;negative regulation of neuron death;positive regulation of ERAD pathway	Acetylation;Alternative splicing;Endoplasmic reticulum;Glycoprotein;Membrane;Phosphoprotein;Reference proteome;Transmembrane;Transmembrane helix		
COQ5	negative	TSPYL2	ENSG00000184205	COQ5	1	COQ5	1	0.00274241805041497	WBGene00005007	WBGene00005007(0)			GO:0005634;GO:0005737;GO:0006325;GO:0006334;GO:0005515;GO:0007049;GO:0005730;GO:0005654;GO:0030308;GO:0045786;GO:0009966;GO:0036498;GO:0045859;GO:0000182;GO:0008156	nucleus;nucleosome assembly;cytoplasm;chromatin organization;protein binding;cell cycle;nucleolus;nucleoplasm;negative regulation of cell growth;negative regulation of cell cycle;regulation of signal transduction;IRE1-mediated unfolded protein response;regulation of protein kinase activity;rDNA binding;negative regulation of DNA replication	Cell cycle;Chromatin regulator;Cytoplasm;Isopeptide bond;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Transcription;Transcription regulation;Ubl conjugation	R-HSA-392499;R-HSA-381038;R-HSA-381070;R-HSA-381119	Metabolism of proteins;XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR)
COQ5	negative	IRF7	ENSG00000185507	COQ5	1	COQ5	1	0.00274241805041497			ATF4;CD80;CXCL10;IFNA1;IFNA13;IFNA2;IFNB1	IMMUNODEFICIENCY 39	GO:0044212;GO:0045944;GO:0005634;GO:0005737;GO:0005829;GO:0005654;GO:0006355;GO:0003677;GO:0003700;GO:0005515;GO:0006974;GO:0045893;GO:0002376;GO:0045087;GO:0051607;GO:0000981;GO:0000790;GO:0010008;GO:0009615;GO:0016032;GO:0032727;GO:0035666;GO:0006366;GO:0000978;GO:0032728;GO:0060333;GO:0000122;GO:0032481;GO:0060337;GO:0050776;GO:0002819;GO:0034124;GO:0039530;GO:0032608;GO:0019043;GO:0032479;GO:0032607;GO:0034127;GO:0045655;GO:2000110;GO:0000987;GO:0001158;GO:0010468;GO:0016064;GO:0045351;GO:0060340	transcription regulatory region DNA binding;regulation of transcription, DNA-templated;protein binding;DNA-binding transcription factor activity;positive regulation of transcription by RNA polymerase II;nucleus;cytoplasm;nucleoplasm;cytosol;DNA binding;cellular response to DNA damage stimulus;positive regulation of transcription, DNA-templated;immune system process;innate immune response;defense response to virus;DNA-binding transcription factor activity, RNA polymerase II-specific;nuclear chromatin;endosome membrane;response to virus;viral process;positive regulation of interferon-alpha production;TRIF-dependent toll-like receptor signaling pathway;transcription by RNA polymerase II;RNA polymerase II cis-regulatory region sequence-specific DNA binding;positive regulation of interferon-beta production;interferon-gamma-mediated signaling pathway;negative regulation of transcription by RNA polymerase II;positive regulation of type I interferon production;type I interferon signaling pathway;regulation of immune response;regulation of type I interferon production;regulation of adaptive immune response;regulation of MyD88-dependent toll-like receptor signaling pathway;MDA-5 signaling pathway;interferon-beta production;establishment of viral latency;interferon-alpha production;regulation of MyD88-independent toll-like receptor signaling pathway;regulation of monocyte differentiation;negative regulation of macrophage apoptotic process;cis-regulatory region sequence-specific DNA binding;regulation of gene expression;immunoglobulin mediated immune response;type I interferon biosynthetic process;positive regulation of type I interferon-mediated signaling pathway	3D-structure;Acetylation;Activator;Alternative splicing;Antiviral defense;Cytoplasm;DNA-binding;Disease mutation;Host-virus interaction;Immunity;Innate immunity;Isopeptide bond;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Transcription;Transcription regulation;Ubl conjugation	R-HSA-168249;R-HSA-168256;R-HSA-1280215;R-HSA-913531;R-HSA-166016;R-HSA-166166;R-HSA-168138;R-HSA-168181;R-HSA-168898;R-HSA-936964;R-HSA-937061;R-HSA-975155;R-HSA-877300;R-HSA-909733;R-HSA-168164;R-HSA-1834949;R-HSA-168928;R-HSA-9013973;R-HSA-918233;R-HSA-933541;R-HSA-975110;R-HSA-3134963	Innate Immune System;Immune System;Cytokine Signaling in Immune system;Interferon Signaling;Toll Like Receptor 4 (TLR4) Cascade;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll-like Receptor Cascades;Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon;TRIF(TICAM1)-mediated TLR4 signaling ;MyD88 dependent cascade initiated on endosome;Interferon gamma signaling;Interferon alpha/beta signaling;Toll Like Receptor 3 (TLR3) Cascade;Cytosolic sensors of pathogen-associated DNA ;DDX58/IFIH1-mediated induction of interferon-alpha/beta;TICAM1-dependent activation of IRF3/IRF7;TRAF3-dependent IRF activation pathway;TRAF6 mediated IRF7 activation;TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling;DEx/H-box helicases activate type I IFN and inflammatory cytokines production 
COQ5	negative	SEMA4D	ENSG00000187764	COQ5	1	COQ5	1	0.00274241805041497		WBGene00004889(0)			GO:0005615;GO:0030335;GO:0045668;GO:0016020;GO:0016021;GO:0005886;GO:0007275;GO:0030154;GO:0030215;GO:0005887;GO:0007399;GO:0043547;GO:0005515;GO:0000122;GO:0001934;GO:0008360;GO:0005102;GO:0050731;GO:0006955;GO:0007155;GO:0004888;GO:0043066;GO:0007162;GO:0071526;GO:0045499;GO:0001755;GO:0048843;GO:0050919;GO:0014068;GO:0043931;GO:1900220;GO:0048814;GO:0050732;GO:0010693;GO:0031344;GO:0038023;GO:0048672;GO:0070486;GO:1905704;GO:0050772	protein binding;semaphorin receptor binding;extracellular space;positive regulation of cell migration;negative regulation of osteoblast differentiation;membrane;integral component of membrane;plasma membrane;multicellular organism development;cell differentiation;integral component of plasma membrane;nervous system development;positive regulation of GTPase activity;negative regulation of transcription by RNA polymerase II;positive regulation of protein phosphorylation;regulation of cell shape;signaling receptor binding;positive regulation of peptidyl-tyrosine phosphorylation;immune response;cell adhesion;transmembrane signaling receptor activity;negative regulation of apoptotic process;negative regulation of cell adhesion;semaphorin-plexin signaling pathway;chemorepellent activity;neural crest cell migration;negative regulation of axon extension involved in axon guidance;negative chemotaxis;positive regulation of phosphatidylinositol 3-kinase signaling;ossification involved in bone maturation;semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis;regulation of dendrite morphogenesis;negative regulation of peptidyl-tyrosine phosphorylation;negative regulation of alkaline phosphatase activity;regulation of cell projection organization;signaling receptor activity;positive regulation of collateral sprouting;leukocyte aggregation;positive regulation of inhibitory synapse assembly;positive regulation of axonogenesis	3D-structure;Alternative splicing;Cell membrane;Developmental protein;Differentiation;Disulfide bond;Glycoprotein;Immunoglobulin domain;Membrane;Neurogenesis;Phosphoprotein;Polymorphism;Receptor;Reference proteome;Signal;Transmembrane;Transmembrane helix	R-HSA-1266738;R-HSA-422475;R-HSA-373755;R-HSA-400685;R-HSA-416572;R-HSA-416700;R-HSA-416550	Developmental Biology;Axon guidance;Semaphorin interactions;Sema4D in semaphorin signaling;Sema4D induced cell migration and growth-cone collapse;Other semaphorin interactions;Sema4D mediated inhibition of cell attachment and migration
COQ5	negative	STK40	ENSG00000196182	COQ5	1	COQ5	1	0.00274241805041497	WBGene00010700				GO:0005634;GO:0005737;GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0005829;GO:0005654;GO:0005515;GO:0003016;GO:0005977;GO:0010468;GO:0030324;GO:0035264;GO:0043066;GO:0043408;GO:0048286;GO:0060425	ATP binding;protein phosphorylation;protein kinase activity;nucleus;cytoplasm;nucleotide binding;protein serine/threonine kinase activity;kinase activity;transferase activity;phosphorylation;nucleoplasm;cytosol;protein binding;respiratory system process;glycogen metabolic process;regulation of gene expression;lung development;multicellular organism growth;negative regulation of apoptotic process;regulation of MAPK cascade;lung alveolus development;lung morphogenesis	3D-structure;ATP-binding;Alternative splicing;Cytoplasm;Kinase;Nucleotide-binding;Nucleus;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase		
COQ5	negative	SVIL	ENSG00000197321	COQ5	1	COQ5	1	0.00274241805041497	WBGene00015691;WBGene00010593	WBGene00010593(0)			GO:0005634;GO:0005737;GO:0016020;GO:0005829;GO:0003779;GO:0051015;GO:0005886;GO:0015629;GO:0005856;GO:0042995;GO:0005515;GO:0030054;GO:0005925;GO:0030496;GO:0007010;GO:0002102;GO:0032154;GO:0071437;GO:0032467;GO:0043034;GO:0007519;GO:0036449	actin filament binding;actin binding;cytoskeleton organization;nucleus;cytoplasm;membrane;cytosol;plasma membrane;cytoskeleton;focal adhesion;actin cytoskeleton;cell projection;protein binding;cell junction;midbody;podosome;cleavage furrow;invadopodium;positive regulation of cytokinesis;costamere;skeletal muscle tissue development;microtubule minus-end	3D-structure;Actin-binding;Alternative splicing;Calcium;Cell junction;Cell membrane;Cell projection;Cytoplasm;Cytoskeleton;Membrane;Methylation;Phosphoprotein;Polymorphism;Reference proteome;Repeat		
COQ5	negative	MAP3K5	ENSG00000197442	COQ5	1	COQ5	1	0.00274241805041497	WBGene00003822	WBGene00003822(0)			GO:0005737;GO:0046872;GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0005783;GO:0042803;GO:0005515;GO:0006915;GO:0000287;GO:0004709;GO:0002376;GO:0045087;GO:0042802;GO:0005829;GO:0043065;GO:0016032;GO:0000165;GO:0032991;GO:0019904;GO:0019903;GO:0070059;GO:0045893;GO:0008631;GO:0007254;GO:0034976;GO:0097190;GO:1990604;GO:0000186;GO:0007257;GO:1901216;GO:0070301;GO:0043280;GO:0034198;GO:0051403;GO:0019901;GO:0000187;GO:0001934;GO:0002931;GO:0010666;GO:0010941;GO:0038066;GO:0042060;GO:0043507;GO:0045663;GO:0046330;GO:0071356;GO:0072577;GO:0097300;GO:1900745;GO:1902170;GO:1904707;GO:0009897;GO:1902911	ATP binding;protein phosphorylation;protein kinase activity;cytoplasm;metal ion binding;nucleotide binding;protein serine/threonine kinase activity;kinase activity;transferase activity;phosphorylation;endoplasmic reticulum;protein homodimerization activity;protein binding;apoptotic process;MAP kinase kinase kinase activity;magnesium ion binding;immune system process;innate immune response;identical protein binding;cytosol;positive regulation of apoptotic process;viral process;MAPK cascade;protein-containing complex;protein domain specific binding;protein phosphatase binding;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;positive regulation of transcription, DNA-templated;intrinsic apoptotic signaling pathway in response to oxidative stress;JNK cascade;response to endoplasmic reticulum stress;apoptotic signaling pathway;IRE1-TRAF2-ASK1 complex;activation of MAPKK activity;activation of JUN kinase activity;positive regulation of neuron death;cellular response to hydrogen peroxide;positive regulation of cysteine-type endopeptidase activity involved in apoptotic process;cellular response to amino acid starvation;stress-activated MAPK cascade;protein kinase binding;activation of MAPK activity;positive regulation of protein phosphorylation;response to ischemia;positive regulation of cardiac muscle cell apoptotic process;regulation of cell death;p38MAPK cascade;wound healing;positive regulation of JUN kinase activity;positive regulation of myoblast differentiation;positive regulation of JNK cascade;cellular response to tumor necrosis factor;endothelial cell apoptotic process;programmed necrotic cell death;positive regulation of p38MAPK cascade;cellular response to reactive nitrogen species;positive regulation of vascular smooth muscle cell proliferation;external side of plasma membrane;protein kinase complex	3D-structure;ATP-binding;Alternative splicing;Apoptosis;Coiled coil;Cytoplasm;Endoplasmic reticulum;Host-virus interaction;Immunity;Innate immunity;Kinase;Magnesium;Metal-binding;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Stress response;Transferase;Ubl conjugation	R-HSA-2262752;R-HSA-8953897;R-HSA-2559580;R-HSA-2559583	Cellular responses to stress;Cellular responses to external stimuli;Oxidative Stress Induced Senescence;Cellular Senescence
COQ5	negative	PJA2	ENSG00000198961	COQ5	1	COQ5	1	0.00274241805041497	WBGene00021842				GO:0005737;GO:0016020;GO:0046872;GO:0016740;GO:0005783;GO:0005789;GO:0016567;GO:0005794;GO:0035329;GO:0004842;GO:0045111;GO:0005886;GO:0000139;GO:0030054;GO:0006954;GO:0045202;GO:0045211;GO:0045087;GO:0005515;GO:0010738;GO:0061630;GO:0014069;GO:0007616;GO:0046330;GO:0034236;GO:0034237;GO:0034137;GO:0043030;GO:1900745	ubiquitin-protein transferase activity;protein ubiquitination;hippo signaling;regulation of protein kinase A signaling;cytoplasm;membrane;metal ion binding;transferase activity;endoplasmic reticulum;endoplasmic reticulum membrane;Golgi apparatus;intermediate filament cytoskeleton;plasma membrane;cell junction;inflammatory response;Golgi membrane;synapse;innate immune response;protein binding;ubiquitin protein ligase activity;postsynaptic density;long-term memory;positive regulation of JNK cascade;protein kinase A catalytic subunit binding;protein kinase A regulatory subunit binding;positive regulation of toll-like receptor 2 signaling pathway;regulation of macrophage activation;positive regulation of p38MAPK cascade	Acetylation;Alternative splicing;Cell junction;Cell membrane;Cytoplasm;Direct protein sequencing;Endoplasmic reticulum;Golgi apparatus;Membrane;Metal-binding;Phosphoprotein;Polymorphism;Reference proteome;Synapse;Transferase;Ubl conjugation pathway;Zinc;Zinc-finger	R-HSA-1280218;R-HSA-168256;R-HSA-983168;R-HSA-983169	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
COQ5	negative	STK19	ENSG00000204344	COQ5	1	COQ5	1	0.00274241805041497					GO:0005634;GO:0016607;GO:0000166;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0016310;GO:0006468;GO:0046579;GO:0017016	nucleus;nuclear speck;nucleotide binding;protein serine/threonine kinase activity;ATP binding;kinase activity;transferase activity;phosphorylation;protein phosphorylation;positive regulation of Ras protein signal transduction;Ras GTPase binding	ATP-binding;Alternative splicing;Kinase;Manganese;Nucleotide-binding;Nucleus;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase		
COQ5	negative	HLA-E	ENSG00000204592	COQ5	1	COQ5	1	0.00274241805041497					GO:0016020;GO:0016021;GO:0005794;GO:0005886;GO:0005515;GO:0005576;GO:0006955;GO:0000139;GO:0009986;GO:0002376;GO:0045087;GO:0005615;GO:0002250;GO:0009897;GO:0050776;GO:0042605;GO:0019882;GO:0002474;GO:0042612;GO:0070062;GO:0002479;GO:0019731;GO:0050830;GO:0005102;GO:0030670;GO:0002519;GO:0032753;GO:0045953;GO:0060333;GO:0012507;GO:0002717;GO:0060337;GO:0001916;GO:0042288;GO:0071556;GO:0045954;GO:0031901;GO:0032760;GO:0002729;GO:0002480;GO:0042270;GO:0055038;GO:0030881;GO:0002476;GO:0002486;GO:0042608;GO:0036037;GO:2000566;GO:0032736;GO:0046703;GO:0001815;GO:0002477;GO:0002715;GO:0032759;GO:0032819;GO:0051024;GO:2001187;GO:0032398	immune response;antigen processing and presentation;membrane;integral component of membrane;Golgi apparatus;plasma membrane;protein binding;extracellular region;Golgi membrane;cell surface;immune system process;innate immune response;adaptive immune response;extracellular space;external side of plasma membrane;regulation of immune response;defense response to Gram-positive bacterium;peptide antigen binding;extracellular exosome;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;viral process;antibacterial humoral response;antigen processing and presentation of peptide antigen via MHC class I;MHC class I protein complex;signaling receptor binding;phagocytic vesicle membrane;natural killer cell tolerance induction;positive regulation of interleukin-4 production;negative regulation of natural killer cell mediated cytotoxicity;interferon-gamma-mediated signaling pathway;ER to Golgi transport vesicle membrane;positive regulation of natural killer cell mediated immunity;type I interferon signaling pathway;positive regulation of T cell mediated cytotoxicity;MHC class I protein binding;integral component of lumenal side of endoplasmic reticulum membrane;positive regulation of natural killer cell mediated cytotoxicity;early endosome membrane;positive regulation of tumor necrosis factor production;positive regulation of natural killer cell cytokine production;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;protection from natural killer cell mediated cytotoxicity;recycling endosome membrane;beta-2-microglobulin binding;T cell receptor binding;CD8-positive, alpha-beta T cell activation;positive regulation of CD8-positive, alpha-beta T cell proliferation;positive regulation of interleukin-13 production;natural killer cell lectin-like receptor binding;positive regulation of antibody-dependent cellular cytotoxicity;antigen processing and presentation of endogenous peptide antigen via MHC class Ib;antigen processing and presentation of exogenous peptide antigen via MHC class Ib;regulation of natural killer cell mediated immunity;positive regulation of TRAIL production;positive regulation of natural killer cell proliferation;positive regulation of immunoglobulin secretion;positive regulation of CD8-positive, alpha-beta T cell activation;MHC class Ib protein complex	3D-structure;Adaptive immunity;Cell membrane;Disulfide bond;Glycoprotein;Golgi apparatus;Host-virus interaction;Immunity;Innate immunity;MHC I;Membrane;Phosphoprotein;Polymorphism;Reference proteome;Secreted;Signal;Transmembrane;Transmembrane helix	R-HSA-1280218;R-HSA-168249;R-HSA-168256;R-HSA-198933;R-HSA-983169;R-HSA-1236974;R-HSA-1236975;R-HSA-1280215;R-HSA-2172127;R-HSA-913531;R-HSA-2424491;R-HSA-877300;R-HSA-909733;R-HSA-983170;R-HSA-1236977	Adaptive Immune System;Innate Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Class I MHC mediated antigen processing & presentation;ER-Phagosome pathway;Antigen processing-Cross presentation;Cytokine Signaling in Immune system;DAP12 interactions;Interferon Signaling;DAP12 signaling;Interferon gamma signaling;Interferon alpha/beta signaling;Antigen Presentation: Folding, assembly and peptide loading of class I MHC;Endosomal/Vacuolar pathway
COQ5	negative	MLLT11	ENSG00000213190	COQ5	1	COQ5	1	0.00274241805041497					GO:0005634;GO:0005737;GO:0005829;GO:0005654;GO:0005856;GO:0005515;GO:0045893;GO:0005815;GO:0097190;GO:0003674;GO:0043065;GO:0097191;GO:0090200;GO:0097193;GO:0051901	apoptotic signaling pathway;nucleus;cytoplasm;nucleoplasm;cytosol;cytoskeleton;protein binding;positive regulation of transcription, DNA-templated;microtubule organizing center;molecular_function;positive regulation of apoptotic process;extrinsic apoptotic signaling pathway;positive regulation of release of cytochrome c from mitochondria;intrinsic apoptotic signaling pathway;positive regulation of mitochondrial depolarization	Chromosomal rearrangement;Cytoplasm;Cytoskeleton;Nucleus;Phosphoprotein;Proto-oncogene;Reference proteome;Ubl conjugation		
COQ5	negative	HIST1H3A	ENSG00000275714	COQ5	1	COQ5	1	0.00274241805041497	WBGene00001876;WBGene00001880;WBGene00001883;WBGene00001887;WBGene00001891;WBGene00001899;WBGene00001901;WBGene00001906;WBGene00001914;WBGene00001916;WBGene00001919;WBGene00001923;WBGene00001929;WBGene00001933;WBGene00001937	WBGene00001937(1);WBGene00001929(1);WBGene00001923(1);WBGene00001883(1);WBGene00001876(1);WBGene00001906(1);WBGene00001891(1);WBGene00001919(1);WBGene00001914(1);WBGene00001916(1);WBGene00001887(1);WBGene00001880(1);WBGene00001933(1);WBGene00001899(1);WBGene00001901(1)			GO:0005634;GO:0016020;GO:0003677;GO:0046982;GO:0006334;GO:0000786;GO:0005694;GO:0005515;GO:0005576;GO:0005654;GO:0045296;GO:0070062;GO:0044267;GO:0032991;GO:0060964;GO:0038111;GO:0045652;GO:0006335;GO:0007596;GO:0000228;GO:0000183;GO:0045814;GO:0051290;GO:0000788;GO:0006325;GO:0032200;GO:0060968	DNA binding;nucleosome;protein heterodimerization activity;nucleus;membrane;nucleosome assembly;chromosome;protein binding;extracellular region;nucleoplasm;cadherin binding;extracellular exosome;cellular protein metabolic process;protein-containing complex;regulation of gene silencing by miRNA;interleukin-7-mediated signaling pathway;regulation of megakaryocyte differentiation;DNA replication-dependent nucleosome assembly;blood coagulation;nuclear chromosome;chromatin silencing at rDNA;negative regulation of gene expression, epigenetic;nuclear nucleosome;chromatin organization;telomere organization;regulation of gene silencing	3D-structure;ADP-ribosylation;Acetylation;Chromosome;Citrullination;DNA-binding;Direct protein sequencing;Disease mutation;Hydroxylation;Methylation;Nucleosome core;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation	R-HSA-109582;R-HSA-168256;R-HSA-1266738;R-HSA-392499;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-162582;R-HSA-194315;R-HSA-977225;R-HSA-1474165;R-HSA-1500620;R-HSA-1640170;R-HSA-1280215;R-HSA-195721;R-HSA-201681;R-HSA-2262752;R-HSA-449147;R-HSA-68886;R-HSA-69278;R-HSA-8878171;R-HSA-8939236;R-HSA-8953897;R-HSA-195258;R-HSA-983231;R-HSA-211000;R-HSA-5578749;R-HSA-68875;R-HSA-157118;R-HSA-8939211;R-HSA-9006931;R-HSA-201722;R-HSA-2559580;R-HSA-2559583;R-HSA-212165;R-HSA-3214815;R-HSA-3247509;R-HSA-427413;R-HSA-4839726;R-HSA-5250941;R-HSA-1266695;R-HSA-5617472;R-HSA-5619507;R-HSA-9018519;R-HSA-1912422;R-HSA-1912408;R-HSA-2559582;R-HSA-3214858;R-HSA-3214842;R-HSA-3214841;R-HSA-8936459;R-HSA-3214847;R-HSA-5625740;R-HSA-5250913;R-HSA-5250924;R-HSA-73772;R-HSA-73854;R-HSA-73864;R-HSA-912446;R-HSA-427359;R-HSA-212300;R-HSA-5625886;R-HSA-2299718;R-HSA-427389;R-HSA-5334118;R-HSA-73728;R-HSA-9616222	Hemostasis;Immune System;Developmental Biology;Metabolism of proteins;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Signal Transduction;Signaling by Rho GTPases;Amyloid fiber formation;Reproduction;Meiosis;Cell Cycle;Cytokine Signaling in Immune system;Signaling by WNT;TCF dependent signaling in response to WNT;Cellular responses to stress;Signaling by Interleukins;M Phase;Cell Cycle, Mitotic;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Cellular responses to external stimuli;RHO GTPase Effectors;Factors involved in megakaryocyte development and platelet production;Gene Silencing by RNA;Transcriptional regulation by small RNAs;Mitotic Prophase;Signaling by NOTCH;ESR-mediated signaling;Signaling by Nuclear Receptors;Formation of the beta-catenin:TCF transactivating complex;Oxidative Stress Induced Senescence;Cellular Senescence;Epigenetic regulation of gene expression;HDACs deacetylate histones;Chromatin modifying enzymes;NoRC negatively regulates rRNA expression;Chromatin organization;Negative epigenetic regulation of rRNA expression;Interleukin-7 signaling;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;Estrogen-dependent gene expression;Pre-NOTCH Expression and Processing;Pre-NOTCH Transcription and Translation;Senescence-Associated Secretory Phenotype (SASP);RMTs methylate histone arginines;HDMs demethylate histones;PKMTs methylate histone lysines;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;HATs acetylate histones;RHO GTPases activate PKNs;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;RNA Polymerase I Promoter Escape;RNA Polymerase I Promoter Clearance;RNA Polymerase I Transcription;Meiotic recombination;SIRT1 negatively regulates rRNA expression;PRC2 methylates histones and DNA;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;Condensation of Prophase Chromosomes;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;DNA methylation;RNA Polymerase I Promoter Opening;Transcriptional regulation of granulopoiesis
COQ5	negative	ST3GAL1	ENSG00000008513	COQ5	1	COQ5	1	0.00604574314165884					GO:0016020;GO:0016021;GO:0016740;GO:0008373;GO:0016757;GO:0006486;GO:0097503;GO:0005794;GO:0005576;GO:0003836;GO:0006468;GO:0032580;GO:0070062;GO:0006487;GO:0006464;GO:0000139;GO:0016266;GO:0018146;GO:0006054	protein glycosylation;sialyltransferase activity;membrane;integral component of membrane;transferase activity;transferase activity, transferring glycosyl groups;sialylation;Golgi apparatus;extracellular region;beta-galactoside (CMP) alpha-2,3-sialyltransferase activity;protein phosphorylation;Golgi cisterna membrane;extracellular exosome;protein N-linked glycosylation;cellular protein modification process;Golgi membrane;O-glycan processing;keratan sulfate biosynthetic process;N-acetylneuraminate metabolic process	Disulfide bond;Glycoprotein;Glycosyltransferase;Golgi apparatus;Membrane;Polymorphism;Reference proteome;Secreted;Signal-anchor;Transferase;Transmembrane;Transmembrane helix	R-HSA-392499;R-HSA-597592;R-HSA-1430728;R-HSA-446193;R-HSA-446203;R-HSA-446219;R-HSA-5173105;R-HSA-71387;R-HSA-1630316;R-HSA-4085001;R-HSA-1638074;R-HSA-2022854;R-HSA-913709;R-HSA-977068	Metabolism of proteins;Post-translational protein modification;Metabolism;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;O-linked glycosylation;Metabolism of carbohydrates;Glycosaminoglycan metabolism;Sialic acid metabolism;Keratan sulfate/keratin metabolism;Keratan sulfate biosynthesis;O-linked glycosylation of mucins;Termination of O-glycan biosynthesis
COQ5	negative	TAB2	ENSG00000055208	COQ5	1	COQ5	1	0.00604574314165884				Polyvalvular heart disease syndrome;CONGENITAL HEART DISEASE NONSYNDROMIC 2;CONGENITAL HEART DEFECTS MULTIPLE TYPES 2	GO:0046872;GO:0005829;GO:0032496;GO:0005737;GO:0016020;GO:0005515;GO:0038095;GO:0005886;GO:0050852;GO:0005654;GO:0007507;GO:0010008;GO:0002223;GO:0070498;GO:0010507;GO:0043123;GO:0002755;GO:0007249;GO:0007254;GO:0051092;GO:0045860;GO:0000187;GO:0070423;GO:0070530	metal ion binding;protein binding;response to lipopolysaccharide;cytoplasm;membrane;cytosol;Fc-epsilon receptor signaling pathway;plasma membrane;T cell receptor signaling pathway;nucleoplasm;heart development;endosome membrane;stimulatory C-type lectin receptor signaling pathway;interleukin-1-mediated signaling pathway;negative regulation of autophagy;positive regulation of I-kappaB kinase/NF-kappaB signaling;MyD88-dependent toll-like receptor signaling pathway;I-kappaB kinase/NF-kappaB signaling;JNK cascade;positive regulation of NF-kappaB transcription factor activity;positive regulation of protein kinase activity;activation of MAPK activity;nucleotide-binding oligomerization domain containing signaling pathway;K63-linked polyubiquitin modification-dependent protein binding	3D-structure;Alternative splicing;Chromosomal rearrangement;Coiled coil;Cytoplasm;Disease mutation;Membrane;Metal-binding;Methylation;Phosphoprotein;Reference proteome;Ubl conjugation;Zinc;Zinc-finger	R-HSA-1280218;R-HSA-168249;R-HSA-168256;R-HSA-2454202;R-HSA-2871837;R-HSA-202403;R-HSA-202424;R-HSA-162582;R-HSA-73887;R-HSA-1280215;R-HSA-446652;R-HSA-449147;R-HSA-5607764;R-HSA-5621481;R-HSA-9020702;R-HSA-9006934;R-HSA-166016;R-HSA-166058;R-HSA-166166;R-HSA-168138;R-HSA-168179;R-HSA-168181;R-HSA-168188;R-HSA-168898;R-HSA-181438;R-HSA-937061;R-HSA-937072;R-HSA-975138;R-HSA-975155;R-HSA-975163;R-HSA-1236394;R-HSA-1251985;R-HSA-168142;R-HSA-168164;R-HSA-168176;R-HSA-448424;R-HSA-450294;R-HSA-450321;R-HSA-975871;R-HSA-168643;R-HSA-168638;R-HSA-445989;R-HSA-5357956;R-HSA-75893;R-HSA-9014325;R-HSA-450302;R-HSA-937042	Adaptive Immune System;Innate Immune System;Immune System;Fc epsilon receptor (FCERI) signaling;FCERI mediated NF-kB activation;TCR signaling;Downstream TCR signaling;Signal Transduction;Death Receptor Signalling;Cytokine Signaling in Immune system;Interleukin-1 family signaling;Signaling by Interleukins;CLEC7A (Dectin-1) signaling;C-type lectin receptors (CLRs);Interleukin-1 signaling;Signaling by Receptor Tyrosine Kinases;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6-mediated induction of TAK1 complex within TLR4 complex;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation;Signaling by ERBB4;Nuclear signaling by ERBB4;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Interleukin-17 signaling;MAP kinase activation;JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1;MyD88 cascade initiated on plasma membrane;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;NOD1/2 Signaling Pathway;TAK1 activates NFkB by phosphorylation and activation of IKKs complex;TNFR1-induced NFkappaB signaling pathway;TNF signaling;TICAM1,TRAF6-dependent induction of TAK1 complex;activated TAK1 mediates p38 MAPK activation;IRAK2 mediated activation of TAK1 complex
COQ5	negative	RNF126	ENSG00000070423	COQ5	1	COQ5	1	0.00604574314165884	WBGene00021842				GO:0016567;GO:0061630;GO:0005634;GO:0005737;GO:0046872;GO:0016740;GO:0005829;GO:0005654;GO:0005515;GO:0005154;GO:0070534;GO:0070936;GO:0006511;GO:0042147;GO:0042127;GO:0043161;GO:0006513;GO:0043162;GO:0042059;GO:0071629	protein ubiquitination;ubiquitin protein ligase activity;nucleus;cytoplasm;metal ion binding;transferase activity;nucleoplasm;cytosol;protein binding;epidermal growth factor receptor binding;protein K63-linked ubiquitination;protein K48-linked ubiquitination;ubiquitin-dependent protein catabolic process;retrograde transport, endosome to Golgi;regulation of cell population proliferation;proteasome-mediated ubiquitin-dependent protein catabolic process;protein monoubiquitination;ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway;negative regulation of epidermal growth factor receptor signaling pathway;cytoplasm protein quality control by the ubiquitin-proteasome system	3D-structure;Acetylation;Cytoplasm;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Transferase;Ubl conjugation;Ubl conjugation pathway;Zinc;Zinc-finger	R-HSA-1280218;R-HSA-168256;R-HSA-983168;R-HSA-983169	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
COQ5	negative	NCK2	ENSG00000071051	COQ5	1	COQ5	1	0.00604574314165884	WBGene00006410	WBGene00006410(0)			GO:0005737;GO:0005783;GO:0005515;GO:0005070;GO:0044877;GO:0097110;GO:0001771;GO:0007015;GO:0016477;GO:0030032;GO:0036493;GO:0048013;GO:0060996;GO:1902237;GO:1903898;GO:1903912;GO:1990441;GO:0012506;GO:0014069;GO:0045202;GO:0045944;GO:0005829;GO:0006417;GO:0042102;GO:0007165;GO:0042110;GO:0001784;GO:0048010;GO:0008093;GO:0008285;GO:0030838;GO:0030159;GO:0007172;GO:0007173;GO:0007176;GO:0033137	protein binding;SH3/SH2 adaptor activity;cytoplasm;endoplasmic reticulum;protein-containing complex binding;scaffold protein binding;immunological synapse formation;actin filament organization;cell migration;lamellipodium assembly;positive regulation of translation in response to endoplasmic reticulum stress;ephrin receptor signaling pathway;dendritic spine development;positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway;negative regulation of PERK-mediated unfolded protein response;negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation;negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress;vesicle membrane;postsynaptic density;synapse;positive regulation of transcription by RNA polymerase II;cytosol;regulation of translation;positive regulation of T cell proliferation;signal transduction;T cell activation;phosphotyrosine residue binding;vascular endothelial growth factor receptor signaling pathway;cytoskeletal adaptor activity;negative regulation of cell population proliferation;positive regulation of actin filament polymerization;receptor signaling complex adaptor activity;signal complex assembly;epidermal growth factor receptor signaling pathway;regulation of epidermal growth factor-activated receptor activity;negative regulation of peptidyl-serine phosphorylation	3D-structure;Acetylation;Cytoplasm;Endoplasmic reticulum;Phosphoprotein;Reference proteome;Repeat;SH2 domain;SH3 domain;Translation regulation	R-HSA-1266738;R-HSA-422475;R-HSA-162582;R-HSA-376176;R-HSA-186797;R-HSA-9006934;R-HSA-1500931;R-HSA-2682334;R-HSA-373753;R-HSA-186763;R-HSA-194138;R-HSA-4420097;R-HSA-3928664;R-HSA-428540;R-HSA-8985801	Developmental Biology;Axon guidance;Signal Transduction;Signaling by ROBO receptors;Signaling by PDGF;Signaling by Receptor Tyrosine Kinases;Cell-Cell communication;EPH-Ephrin signaling;Nephrin family interactions;Downstream signal transduction;Signaling by VEGF;VEGFA-VEGFR2 Pathway;Ephrin signaling;Activation of RAC1;Regulation of cortical dendrite branching
COQ5	negative	ACTN1	ENSG00000072110	COQ5	1	COQ5	1	0.00604574314165884	WBGene00000228			Autosomal dominant macrothrombocytopenia;BLEEDING DISORDER PLATELET-TYPE 15	GO:0005737;GO:0016020;GO:0046872;GO:0005509;GO:0003779;GO:0051015;GO:1903508;GO:0005615;GO:0042803;GO:0005886;GO:0005856;GO:0042995;GO:0005515;GO:0030054;GO:0051017;GO:0051764;GO:0030374;GO:0005925;GO:0005576;GO:0005829;GO:0070062;GO:0007015;GO:0001725;GO:0044325;GO:0042981;GO:0030018;GO:0001726;GO:0002576;GO:0048041;GO:0005178;GO:0031093;GO:0005911;GO:0005884;GO:0098978;GO:0017166;GO:0003725;GO:0031143;GO:0030220;GO:0051271;GO:0099186;GO:0036344;GO:0051639;GO:0099173;GO:0005903;GO:0005916;GO:0030017	protein binding;calcium ion binding;actin filament binding;actin filament bundle assembly;actin crosslink formation;cytoplasm;membrane;metal ion binding;actin binding;cytoskeleton;focal adhesion;positive regulation of nucleic acid-templated transcription;extracellular space;protein homodimerization activity;plasma membrane;cell projection;cell junction;nuclear receptor transcription coactivator activity;extracellular region;cytosol;extracellular exosome;actin filament organization;stress fiber;ion channel binding;regulation of apoptotic process;Z disc;ruffle;platelet degranulation;focal adhesion assembly;integrin binding;platelet alpha granule lumen;cell-cell junction;actin filament;glutamatergic synapse;vinculin binding;double-stranded RNA binding;pseudopodium;platelet formation;negative regulation of cellular component movement;structural constituent of postsynapse;platelet morphogenesis;actin filament network formation;postsynapse organization;brush border;fascia adherens;sarcomere	3D-structure;Acetylation;Actin-binding;Alternative splicing;Calcium;Cell junction;Cell membrane;Cell projection;Cytoplasm;Cytoskeleton;Direct protein sequencing;Disease mutation;Membrane;Metal-binding;Phosphoprotein;Polymorphism;Reference proteome;Repeat	R-HSA-109582;R-HSA-1474244;R-HSA-76002;R-HSA-76005;R-HSA-114608;R-HSA-1500931;R-HSA-373753;R-HSA-3000171;R-HSA-446728;R-HSA-3000170;R-HSA-446353;R-HSA-446388	Hemostasis;Extracellular matrix organization;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Platelet degranulation ;Cell-Cell communication;Nephrin family interactions;Non-integrin membrane-ECM interactions;Cell junction organization;Syndecan interactions;Cell-extracellular matrix interactions;Regulation of cytoskeletal remodeling and cell spreading by IPP complex components
COQ5	negative	ARAF	ENSG00000078061	COQ5	1	COQ5	1	0.00604574314165884	WBGene00003030				GO:0046872;GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0043066;GO:0035556;GO:0007165;GO:0005515;GO:0005739;GO:0005829;GO:0005575;GO:0033138;GO:0000165;GO:0006464;GO:0032006;GO:0032434;GO:0000186;GO:0004709;GO:0020021	ATP binding;signal transduction;protein phosphorylation;intracellular signal transduction;protein kinase activity;metal ion binding;nucleotide binding;protein serine/threonine kinase activity;kinase activity;transferase activity;phosphorylation;negative regulation of apoptotic process;protein binding;cytosol;mitochondrion;cellular_component;positive regulation of peptidyl-serine phosphorylation;MAPK cascade;cellular protein modification process;regulation of proteasomal ubiquitin-dependent protein catabolic process;regulation of TOR signaling;activation of MAPKK activity;MAP kinase kinase kinase activity	3D-structure;ATP-binding;Alternative splicing;Kinase;Metal-binding;Nucleotide-binding;Phosphoprotein;Polymorphism;Proto-oncogene;Reference proteome;Serine/threonine-protein kinase;Transferase;Zinc;Zinc-finger	R-HSA-168256;R-HSA-162582;R-HSA-1643685;R-HSA-1280215;R-HSA-449147;R-HSA-449836;R-HSA-5663202;R-HSA-5673001;R-HSA-5683057;R-HSA-5684996;R-HSA-9607240;R-HSA-6802952;R-HSA-6802957;R-HSA-6802949;R-HSA-5673000;R-HSA-6802946;R-HSA-6802955;R-HSA-5674135;R-HSA-5675221;R-HSA-6802948	Immune System;Signal Transduction;Disease;Cytokine Signaling in Immune system;Signaling by Interleukins;Other interleukin signaling;Diseases of signal transduction;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;FLT3 Signaling;Signaling by BRAF and RAF fusions;Oncogenic MAPK signaling;Signaling by RAS mutants;RAF activation;Signaling by moderate kinase activity BRAF mutants;Paradoxical activation of RAF signaling by kinase inactive BRAF;MAP2K and MAPK activation;Negative regulation of MAPK pathway;Signaling by high-kinase activity BRAF mutants
COQ5	negative	REXO1	ENSG00000079313	COQ5	1	COQ5	1	0.00604574314165884	WBGene00013244;WBGene00004095				GO:0003676;GO:0005634;GO:0005654;GO:0016787;GO:0090305;GO:0016604;GO:0004527;GO:0004518	nucleic acid binding;nucleus;nucleoplasm;hydrolase activity;nucleic acid phosphodiester bond hydrolysis;nuclear body;exonuclease activity;nuclease activity	Coiled coil;Exonuclease;Hydrolase;Methylation;Nuclease;Nucleus;Phosphoprotein;Polymorphism;Reference proteome		
COQ5	negative	ITGB5	ENSG00000082781	COQ5	1	COQ5	1	0.00604574314165884	WBGene00003930				GO:0016020;GO:0016021;GO:0007155;GO:0005515;GO:0007229;GO:0009986;GO:0008305;GO:0046718;GO:0005925;GO:0005886;GO:0038023;GO:0070062;GO:0016477;GO:0002479;GO:0016032;GO:0005178;GO:0007160;GO:0033627;GO:0030198;GO:0007179;GO:0006936;GO:0001618;GO:0043235;GO:0035987;GO:0034684;GO:0045335;GO:0043149;GO:0090136	integrin complex;signaling receptor activity;integrin-mediated signaling pathway;membrane;integral component of membrane;cell adhesion;focal adhesion;protein binding;cell surface;viral entry into host cell;plasma membrane;extracellular exosome;cell migration;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;viral process;integrin binding;cell-matrix adhesion;cell adhesion mediated by integrin;stress fiber assembly;extracellular matrix organization;transforming growth factor beta receptor signaling pathway;muscle contraction;virus receptor activity;receptor complex;endodermal cell differentiation;integrin alphav-beta5 complex;phagocytic vesicle;epithelial cell-cell adhesion	Cell adhesion;Disulfide bond;Glycoprotein;Host cell receptor for virus entry;Host-virus interaction;Integrin;Membrane;Phosphoprotein;Polymorphism;Receptor;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix	R-HSA-1280218;R-HSA-168256;R-HSA-983169;R-HSA-1236975;R-HSA-1474244;R-HSA-216083;R-HSA-3000178;R-HSA-397014;R-HSA-3000171;R-HSA-3000170;R-HSA-445355;R-HSA-1566948;R-HSA-2129379;R-HSA-1236973	Adaptive Immune System;Immune System;Class I MHC mediated antigen processing & presentation;Antigen processing-Cross presentation;Extracellular matrix organization;Integrin cell surface interactions;ECM proteoglycans;Muscle contraction;Non-integrin membrane-ECM interactions;Syndecan interactions;Smooth Muscle Contraction;Elastic fibre formation;Molecules associated with elastic fibres;Cross-presentation of particulate exogenous antigens (phagosomes)
COQ5	negative	PITPNM2	ENSG00000090975	COQ5	1	COQ5	1	0.00604574314165884	WBGene00010813				GO:0016020;GO:0046872;GO:0005548;GO:0015914;GO:0048015;GO:0005509;GO:0008289;GO:0005737;GO:0005829;GO:0031210;GO:0035091;GO:0012505;GO:0006661;GO:0030971;GO:0008525;GO:0008526;GO:0005622;GO:0044297	metal ion binding;phospholipid transporter activity;phospholipid transport;membrane;lipid binding;phosphatidylinositol-mediated signaling;calcium ion binding;cytoplasm;cytosol;phosphatidylcholine binding;phosphatidylinositol binding;endomembrane system;phosphatidylinositol biosynthetic process;receptor tyrosine kinase binding;phosphatidylcholine transporter activity;phosphatidylinositol transfer activity;cell body	Alternative splicing;Calcium;Lipid-binding;Membrane;Metal-binding;Methylation;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-1430728;R-HSA-556833;R-HSA-1483257;R-HSA-1483206;R-HSA-1483226	Metabolism;Metabolism of lipids;Phospholipid metabolism;Glycerophospholipid biosynthesis;Synthesis of PI
COQ5	negative	IKZF5	ENSG00000095574	COQ5	1	COQ5	1	0.00604574314165884					GO:0003676;GO:0005634;GO:0046872;GO:0003677;GO:0005515;GO:0003700;GO:0045944;GO:0001227;GO:0000122;GO:0005654;GO:0044212;GO:0032991;GO:0019904;GO:0008270;GO:0000977;GO:0051291	nucleic acid binding;nucleus;metal ion binding;DNA binding;protein binding;DNA-binding transcription factor activity;nucleoplasm;positive regulation of transcription by RNA polymerase II;DNA-binding transcription repressor activity, RNA polymerase II-specific;negative regulation of transcription by RNA polymerase II;transcription regulatory region DNA binding;protein-containing complex;protein domain specific binding;zinc ion binding;RNA polymerase II regulatory region sequence-specific DNA binding	DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger		
COQ5	negative	JOSD1	ENSG00000100221	COQ5	1	COQ5	1	0.00604574314165884	WBGene00022190	WBGene00022190(1)			GO:0005737;GO:0016020;GO:0004843;GO:0016579;GO:0016787;GO:0005886;GO:0005515;GO:0008233;GO:0006508;GO:0036459;GO:0005829	protein deubiquitination;thiol-dependent ubiquitin-specific protease activity;cytoplasm;membrane;hydrolase activity;plasma membrane;protein binding;peptidase activity;proteolysis;thiol-dependent ubiquitinyl hydrolase activity;cytosol	Cell membrane;Cytoplasm;Hydrolase;Membrane;Phosphoprotein;Polymorphism;Protease;Reference proteome;Ubl conjugation;Ubl conjugation pathway	R-HSA-392499;R-HSA-597592;R-HSA-5688426;R-HSA-5689877	Metabolism of proteins;Post-translational protein modification;Deubiquitination;Josephin domain DUBs
COQ5	negative	SGSM3	ENSG00000100359	COQ5	1	COQ5	1	0.00604574314165884	WBGene00018281	WBGene00018281(1)			GO:0005737;GO:0005829;GO:0007049;GO:0005096;GO:0017137;GO:0006886;GO:0090630;GO:0005515;GO:0043547;GO:0007050;GO:0045732;GO:0005921;GO:0032486;GO:0048227;GO:0032483	protein binding;cytoplasm;cytosol;cell cycle;GTPase activator activity;Rab GTPase binding;intracellular protein transport;activation of GTPase activity;positive regulation of GTPase activity;cell cycle arrest;positive regulation of protein catabolic process;gap junction;Rap protein signal transduction;plasma membrane to endosome transport;regulation of Rab protein signal transduction	Alternative splicing;Cell cycle;Coiled coil;Cytoplasm;Growth arrest;Phosphoprotein;Polymorphism;Reference proteome;SH3 domain		
COQ5	negative	CGRRF1	ENSG00000100532	COQ5	1	COQ5	1	0.00604574314165884	WBGene00019649				GO:0016020;GO:0016021;GO:0005634;GO:0043231;GO:0046872;GO:0005654;GO:0005783;GO:0007049;GO:0007050;GO:0008285	membrane;integral component of membrane;nucleus;intracellular membrane-bounded organelle;metal ion binding;nucleoplasm;endoplasmic reticulum;cell cycle;cell cycle arrest;negative regulation of cell population proliferation	3D-structure;Cell cycle;Endoplasmic reticulum;Growth arrest;Metal-binding;Nucleus;Polymorphism;Reference proteome;Zinc;Zinc-finger		
COQ5	negative	TPD52L2	ENSG00000101150	COQ5	1	COQ5	1	0.00604574314165884	WBGene00008745	WBGene00008745(0)			GO:0003723;GO:0003824;GO:0005515	RNA binding;catalytic activity;protein binding	Acetylation;Alternative splicing;Coiled coil;Phosphoprotein;Reference proteome		
COQ5	negative	TUBB1	ENSG00000101162	COQ5	1	COQ5	1	0.00604574314165884	WBGene00000248;WBGene00003171;WBGene00006536;WBGene00006537;WBGene00006538	WBGene00006539(0);WBGene00000248(0);WBGene00006536(0);WBGene00006537(0);WBGene00006532(0)		Autosomal dominant macrothrombocytopenia;MACROTHROMBOCYTOPENIA AUTOSOMAL DOMINANT TUBB1-RELATED	GO:0005737;GO:0000166;GO:0003924;GO:0005525;GO:0005856;GO:0005200;GO:0005874;GO:0007017;GO:0000226;GO:0000278;GO:0070062;GO:0051225	GTP binding;microtubule-based process;microtubule;GTPase activity;structural constituent of cytoskeleton;cytoplasm;nucleotide binding;cytoskeleton;microtubule cytoskeleton organization;mitotic cell cycle;extracellular exosome;spindle assembly	Cytoplasm;Cytoskeleton;Direct protein sequencing;Disease mutation;GTP-binding;Isopeptide bond;Microtubule;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-109582;R-HSA-1280218;R-HSA-168256;R-HSA-5653656;R-HSA-1266738;R-HSA-1852241;R-HSA-5617833;R-HSA-5620924;R-HSA-392499;R-HSA-597592;R-HSA-373760;R-HSA-422475;R-HSA-437239;R-HSA-162582;R-HSA-194315;R-HSA-1640170;R-HSA-199991;R-HSA-6811434;R-HSA-6811442;R-HSA-8856688;R-HSA-446203;R-HSA-2262752;R-HSA-2467813;R-HSA-2555396;R-HSA-453274;R-HSA-5358351;R-HSA-5610787;R-HSA-68882;R-HSA-68886;R-HSA-69275;R-HSA-69278;R-HSA-8852276;R-HSA-8953897;R-HSA-112314;R-HSA-112315;R-HSA-112316;R-HSA-195258;R-HSA-1445148;R-HSA-157858;R-HSA-190828;R-HSA-190840;R-HSA-190861;R-HSA-190872;R-HSA-199977;R-HSA-2132295;R-HSA-2500257;R-HSA-3371497;R-HSA-380320;R-HSA-389958;R-HSA-389960;R-HSA-389977;R-HSA-390466;R-HSA-391251;R-HSA-438064;R-HSA-442755;R-HSA-5626467;R-HSA-5663220;R-HSA-6807878;R-HSA-6811436;R-HSA-68877;R-HSA-8955332;R-HSA-948021;R-HSA-9609736;R-HSA-9619483;R-HSA-983189;R-HSA-983231;R-HSA-389957	Hemostasis;Adaptive Immune System;Immune System;Vesicle-mediated transport;Developmental Biology;Organelle biogenesis and maintenance;Cilium Assembly;Intraflagellar transport;Metabolism of proteins;Post-translational protein modification;L1CAM interactions;Axon guidance;Recycling pathway of L1;Signal Transduction;Signaling by Rho GTPases;Cell Cycle;Membrane Trafficking;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Asparagine N-linked glycosylation;Cellular responses to stress;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Mitotic G2-G2/M phases;Signaling by Hedgehog;Hedgehog 'off' state;Mitotic Anaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;The role of GTSE1 in G2/M progression after G2 checkpoint;Cellular responses to external stimuli;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;RHO GTPase Effectors;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Gap junction trafficking and regulation;Gap junction trafficking;Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane;Gap junction assembly;Transport of connexons to the plasma membrane;ER to Golgi Anterograde Transport;MHC class II antigen presentation;Resolution of Sister Chromatid Cohesion;HSP90 chaperone cycle for steroid hormone receptors (SHR);Recruitment of NuMA to mitotic centrosomes;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding;Formation of tubulin folding intermediates by CCT/TriC;Post-chaperonin tubulin folding pathway;Chaperonin-mediated protein folding;Protein folding;Post NMDA receptor activation events;Activation of NMDA receptors and postsynaptic events;RHO GTPases activate IQGAPs;RHO GTPases Activate Formins;COPI-mediated anterograde transport;COPI-independent Golgi-to-ER retrograde traffic;Mitotic Prometaphase;Carboxyterminal post-translational modifications of tubulin;Transport to the Golgi and subsequent modification;Assembly and cell surface presentation of NMDA receptors;Activation of AMPK downstream of NMDARs;Kinesins;Factors involved in megakaryocyte development and platelet production;Prefoldin mediated transfer of substrate  to CCT/TriC
COQ5	negative	SNPH	ENSG00000101298	COQ5	1	COQ5	1	0.00604574314165884					GO:0017075;GO:0005737;GO:0016020;GO:0016021;GO:0030054;GO:0045202;GO:0043005;GO:0007269;GO:0016081;GO:0005881;GO:0007420;GO:0030182;GO:0005886;GO:0031966;GO:0042734;GO:0043025	syntaxin-1 binding;cytoplasm;membrane;integral component of membrane;cell junction;synapse;neuron projection;neurotransmitter secretion;synaptic vesicle docking;cytoplasmic microtubule;brain development;neuron differentiation;plasma membrane;mitochondrial membrane;presynaptic membrane;neuronal cell body	Alternative splicing;Cell junction;Coiled coil;Membrane;Phosphoprotein;Reference proteome;Synapse;Synaptosome;Transmembrane;Transmembrane helix		
COQ5	negative	RIOK3	ENSG00000101782	COQ5	1	COQ5	1	0.00604574314165884	WBGene00014012	WBGene00014012(1)			GO:0005737;GO:0046872;GO:0000166;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0005515;GO:0002376;GO:0045087;GO:0042254;GO:0030688;GO:0051607;GO:0005829;GO:0098586;GO:0032728;GO:0089720;GO:0007059;GO:0030490;GO:0032463;GO:0039534;GO:0043124;GO:0045089;GO:0071359;GO:1990786	ATP binding;protein phosphorylation;protein serine/threonine kinase activity;cytoplasm;metal ion binding;nucleotide binding;kinase activity;transferase activity;phosphorylation;protein binding;immune system process;innate immune response;ribosome biogenesis;cytosol;preribosome, small subunit precursor;defense response to virus;cellular response to virus;negative regulation of protein-containing complex assembly;positive regulation of interferon-beta production;caspase binding;chromosome segregation;maturation of SSU-rRNA;negative regulation of MDA-5 signaling pathway;negative regulation of I-kappaB kinase/NF-kappaB signaling;positive regulation of innate immune response;cellular response to dsRNA;cellular response to dsDNA	ATP-binding;Alternative splicing;Antiviral defense;Cytoplasm;Immunity;Innate immunity;Kinase;Magnesium;Metal-binding;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Ribosome biogenesis;Serine/threonine-protein kinase;Transferase	R-HSA-8953854;R-HSA-6791226;R-HSA-72312;R-HSA-8868773	Metabolism of RNA;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol
COQ5	negative	NFAT5	ENSG00000102908	COQ5	1	COQ5	1	0.00604574314165884				Inflammatory bowel disease-recurrent sinopulmonary infections syndrome	GO:1901224;GO:0071345;GO:0005634;GO:0005737;GO:0005829;GO:0005654;GO:0006355;GO:0003677;GO:0003700;GO:0006366;GO:0005515;GO:0000978;GO:0044798;GO:0045944;GO:0000981;GO:0000790;GO:0008134;GO:0005667;GO:0001228;GO:0003682;GO:0007165;GO:0007588;GO:0001816;GO:0033173;GO:1904996;GO:0006970;GO:0010628;GO:0070884;GO:0016020;GO:0016021	positive regulation of NIK/NF-kappaB signaling;cellular response to cytokine stimulus;nucleus;cytoplasm;nucleoplasm;cytosol;regulation of transcription, DNA-templated;DNA binding;DNA-binding transcription factor activity;transcription by RNA polymerase II;protein binding;RNA polymerase II cis-regulatory region sequence-specific DNA binding;nuclear transcription factor complex;positive regulation of transcription by RNA polymerase II;DNA-binding transcription factor activity, RNA polymerase II-specific;nuclear chromatin;transcription factor binding;transcription factor complex;DNA-binding transcription activator activity, RNA polymerase II-specific;chromatin binding;signal transduction;excretion;cytokine production;calcineurin-NFAT signaling cascade;positive regulation of leukocyte adhesion to vascular endothelial cell;response to osmotic stress;positive regulation of gene expression;regulation of calcineurin-NFAT signaling cascade;membrane;integral component of membrane	3D-structure;Acetylation;Activator;Alternative splicing;Cytoplasm;DNA-binding;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation		
COQ5	negative	TRIM35	ENSG00000104228	COQ5	1	COQ5	1	0.00604574314165884	WBGene00015114;WBGene00016190;WBGene00016191;WBGene00018384;WBGene00022868;WBGene00022870;WBGene00022871;WBGene00022872;WBGene00022873				GO:0005634;GO:0005737;GO:0008270;GO:0046872;GO:0006915;GO:0045087;GO:0003674;GO:0043065;GO:0045930;GO:1902187;GO:0005515	zinc ion binding;protein binding;nucleus;cytoplasm;metal ion binding;apoptotic process;innate immune response;molecular_function;positive regulation of apoptotic process;negative regulation of mitotic cell cycle;negative regulation of viral release from host cell	Acetylation;Alternative splicing;Apoptosis;Coiled coil;Cytoplasm;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Zinc;Zinc-finger	R-HSA-168256;R-HSA-1280215;R-HSA-913531;R-HSA-877300	Immune System;Cytokine Signaling in Immune system;Interferon Signaling;Interferon gamma signaling
COQ5	negative	TLE5	ENSG00000104964	COQ5	1	COQ5	1	0.00604574314165884	WBGene00006773				GO:0005634;GO:0006355;GO:0005515;GO:0016055;GO:0003714;GO:0070491;GO:0090090;GO:0005667;GO:0010629;GO:0007275;GO:0000122;GO:0045892;GO:0009887;GO:0032091;GO:0070555;GO:0060761;GO:0001501;GO:0006357;GO:0031668;GO:0040008;GO:2000210	regulation of transcription, DNA-templated;nucleus;protein binding;Wnt signaling pathway;transcription corepressor activity;repressing transcription factor binding;negative regulation of canonical Wnt signaling pathway;transcription factor complex;negative regulation of gene expression;multicellular organism development;negative regulation of transcription by RNA polymerase II;negative regulation of transcription, DNA-templated;animal organ morphogenesis;negative regulation of protein binding;response to interleukin-1;negative regulation of response to cytokine stimulus;skeletal system development;regulation of transcription by RNA polymerase II;cellular response to extracellular stimulus;regulation of growth;positive regulation of anoikis	Alternative splicing;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation;Wnt signaling pathway	R-HSA-162582;R-HSA-195253;R-HSA-195721;R-HSA-4641265	Signal Transduction;Degradation of beta-catenin by the destruction complex;Signaling by WNT;Repression of WNT target genes
COQ5	negative	TGFB1	ENSG00000105329	COQ5	1	COQ5	1	0.00604574314165884	WBGene00021594			CAMURATI-ENGELMANN DISEASE;Cystic Fibrosis;CAMURATI-ENGELMANN DISEASE;CAMURATI-ENGELMANN DISEASE;Cystic Fibrosis;INFLAMMATORY BOWEL DISEASE IMMUNODEFICIENCY AND ENCEPHALOPATHY	GO:0008083;GO:0007165;GO:0005576;GO:0005615;GO:0010629;GO:0043539;GO:0031012;GO:0009986;GO:0045944;GO:0060325;GO:0008283;GO:0021915;GO:0001843;GO:0007507;GO:0006468;GO:0055010;GO:0060389;GO:0010468;GO:0045893;GO:0030308;GO:0000122;GO:0003180;GO:0030316;GO:0070168;GO:0001657;GO:0008284;GO:0010628;GO:0032967;GO:0090190;GO:0030217;GO:0001775;GO:0042110;GO:0042306;GO:0045591;GO:0001570;GO:0032740;GO:0071549;GO:0010718;GO:0032700;GO:1903911;GO:0003179;GO:0048146;GO:0050868;GO:0006874;GO:0042127;GO:0002028;GO:0002513;GO:0006954;GO:0007179;GO:0007219;GO:0007492;GO:0008354;GO:0010763;GO:0016202;GO:0030279;GO:0030879;GO:0031065;GO:0032943;GO:0035066;GO:0042130;GO:0042482;GO:0043011;GO:0043029;GO:0045066;GO:0045589;GO:0046716;GO:0048535;GO:0051098;GO:0051101;GO:0060744;GO:0060751;GO:0060762;GO:0061035;GO:0061448;GO:0070306;GO:0071158;GO:0071363;GO:0071560;GO:1900182;GO:2000249;GO:0005160;GO:0042803;GO:0046982;GO:0047485;GO:0001666;GO:0001763;GO:0001837;GO:0002460;GO:0007406;GO:0007565;GO:0007568;GO:0009314;GO:0009749;GO:0009817;GO:0010033;GO:0014003;GO:0014008;GO:0014070;GO:0031100;GO:0031536;GO:0032355;GO:0032667;GO:0033280;GO:0034616;GO:0035902;GO:0042060;GO:0042493;GO:0042552;GO:0043065;GO:0048565;GO:0048839;GO:0050679;GO:0050680;GO:0050765;GO:0050777;GO:0051092;GO:0051152;GO:0051280;GO:0060364;GO:0071260;GO:0071479;GO:0071677;GO:0085029;GO:0097421;GO:1902074;GO:1905313;GO:1990314;GO:1990402;GO:0005737;GO:0030141;GO:0030424;GO:0043025;GO:0062023;GO:0016049	growth factor activity;signal transduction;extracellular region;extracellular space;transforming growth factor beta receptor binding;cell;positive regulation of protein serine/threonine kinase activity;identical protein binding;protein serine/threonine kinase activator activity;protein-containing complex binding;protein N-terminus binding;negative regulation of transcription by RNA polymerase II;vasculogenesis;ureteric bud development;response to hypoxia;morphogenesis of a branching structure;cell activation;epithelial to mesenchymal transition;neural tube closure;regulation of sodium ion transport;adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains;tolerance induction to self antigen;heart valve morphogenesis;aortic valve morphogenesis;protein phosphorylation;cellular calcium ion homeostasis;inflammatory response;transforming growth factor beta receptor signaling pathway;Notch signaling pathway;negative regulation of neuroblast proliferation;endoderm development;heart development;female pregnancy;aging;cell population proliferation;positive regulation of cell population proliferation;germ cell migration;response to radiation;response to glucose;defense response to fungus, incompatible interaction;response to organic substance;regulation of gene expression;positive regulation of gene expression;negative regulation of gene expression;positive regulation of epithelial to mesenchymal transition;positive regulation of fibroblast migration;oligodendrocyte development;positive regulation of microglia differentiation;response to organic cyclic compound;regulation of striated muscle tissue development;neural tube development;T cell differentiation;negative regulation of ossification;negative regulation of cell growth;osteoclast differentiation;mammary gland development;positive regulation of histone deacetylation;animal organ regeneration;positive regulation of exit from mitosis;response to estradiol;regulation of interleukin-23 production;negative regulation of interleukin-17 production;positive regulation of interleukin-17 production;mononuclear cell proliferation;positive regulation of collagen biosynthetic process;response to vitamin D;response to laminar fluid shear stress;positive regulation of histone acetylation;response to immobilization stress;wound healing;T cell activation;regulation of cell population proliferation;negative regulation of T cell proliferation;regulation of protein import into nucleus;positive regulation of odontogenesis;response to drug;myelination;myeloid dendritic cell differentiation;T cell homeostasis;positive regulation of apoptotic process;regulatory T cell differentiation;regulation of regulatory T cell differentiation;positive regulation of regulatory T cell differentiation;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;muscle cell cellular homeostasis;positive regulation of fibroblast proliferation;lymph node development;digestive tract development;inner ear development;positive regulation of epithelial cell proliferation;negative regulation of epithelial cell proliferation;negative regulation of phagocytosis;negative regulation of immune response;negative regulation of T cell activation;positive regulation of NF-kappaB transcription factor activity;regulation of binding;regulation of DNA binding;positive regulation of smooth muscle cell differentiation;negative regulation of release of sequestered calcium ion into cytosol;positive regulation of cell division;ventricular cardiac muscle tissue morphogenesis;face morphogenesis;frontal suture morphogenesis;pathway-restricted SMAD protein phosphorylation;mammary gland branching involved in thelarche;branch elongation involved in mammary gland duct branching;regulation of branching involved in mammary gland duct morphogenesis;regulation of cartilage development;connective tissue development;negative regulation of biomineral tissue development;lens fiber cell differentiation;positive regulation of cell cycle arrest;cellular response to mechanical stimulus;cellular response to growth factor stimulus;cellular response to ionizing radiation;cellular response to dexamethasone stimulus;cellular response to transforming growth factor beta stimulus;positive regulation of mononuclear cell migration;extracellular matrix assembly;positive regulation of branching involved in ureteric bud morphogenesis;liver regeneration;positive regulation of protein localization to nucleus;response to salt;positive regulation of receptor clustering;transforming growth factor beta receptor signaling pathway involved in heart development;cellular response to insulin-like growth factor stimulus;embryonic liver development;regulation of actin cytoskeleton reorganization;cytoplasm;cell surface;secretory granule;axon;extracellular matrix;neuronal cell body;collagen-containing extracellular matrix			
COQ5	negative	NAPA	ENSG00000105402	COQ5	1	COQ5	1	0.00604574314165884	WBGene00017016	WBGene00017016(1)			GO:0016020;GO:0006886;GO:0015031;GO:0005886;GO:0000149;GO:0019905;GO:0044877;GO:0007420;GO:0010807;GO:0016082;GO:0030182;GO:0032781;GO:0032984;GO:0035249;GO:0035494;GO:0045176;GO:0070044;GO:0098793;GO:0098794;GO:0098978;GO:0005515;GO:0016192;GO:0000139;GO:0005829;GO:0070062;GO:0006890;GO:0031201;GO:0005774;GO:0061025;GO:0006888;GO:0048208;GO:0006891;GO:0005483;GO:0005623	protein binding;intracellular protein transport;membrane;protein transport;plasma membrane;SNARE binding;syntaxin binding;protein-containing complex binding;brain development;regulation of synaptic vesicle priming;synaptic vesicle priming;neuron differentiation;positive regulation of ATPase activity;protein-containing complex disassembly;synaptic transmission, glutamatergic;SNARE complex disassembly;apical protein localization;synaptobrevin 2-SNAP-25-syntaxin-1a complex;presynapse;postsynapse;glutamatergic synapse;vesicle-mediated transport;Golgi membrane;cytosol;extracellular exosome;retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;SNARE complex;vacuolar membrane;membrane fusion;endoplasmic reticulum to Golgi vesicle-mediated transport;COPII vesicle coating;intra-Golgi vesicle-mediated transport;soluble NSF attachment protein activity	Acetylation;Cell membrane;ER-Golgi transport;Membrane;Phosphoprotein;Protein transport;Reference proteome;Transport	R-HSA-5653656;R-HSA-392499;R-HSA-597592;R-HSA-199991;R-HSA-6811434;R-HSA-6811442;R-HSA-8856688;R-HSA-446203;R-HSA-199977;R-HSA-6807878;R-HSA-948021;R-HSA-199992;R-HSA-432722;R-HSA-6811438;R-HSA-204005;R-HSA-6811440	Vesicle-mediated transport;Metabolism of proteins;Post-translational protein modification;Membrane Trafficking;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Asparagine N-linked glycosylation;ER to Golgi Anterograde Transport;COPI-mediated anterograde transport;Transport to the Golgi and subsequent modification;trans-Golgi Network Vesicle Budding;Golgi Associated Vesicle Biogenesis;Intra-Golgi traffic;COPII-mediated vesicle transport;Retrograde transport at the Trans-Golgi-Network
COQ5	negative	DNAJB6	ENSG00000105993	COQ5	1	COQ5	1	0.00604574314165884	WBGene00001042	WBGene00001019(0);WBGene00001044(0)		Autosomal dominant limb-girdle muscular dystrophy type 1D;MUSCULAR DYSTROPHY LIMB-GIRDLE AUTOSOMAL DOMINANT 1	GO:0005634;GO:0005737;GO:0016020;GO:0005654;GO:0005829;GO:0005515;GO:0048471;GO:0032781;GO:1900034;GO:0006457;GO:0030018;GO:0043154;GO:0051082;GO:0051087;GO:0001671;GO:0031072;GO:0032880;GO:0045109;GO:0090084;GO:0003677;GO:0030036;GO:0030198;GO:0034504;GO:0045892;GO:0060710;GO:0060715;GO:0060717	nucleus;cytoplasm;membrane;nucleoplasm;cytosol;protein binding;perinuclear region of cytoplasm;positive regulation of ATPase activity;regulation of cellular response to heat;protein folding;Z disc;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;unfolded protein binding;chaperone binding;ATPase activator activity;heat shock protein binding;regulation of protein localization;intermediate filament organization;negative regulation of inclusion body assembly;DNA binding;actin cytoskeleton organization;extracellular matrix organization;protein localization to nucleus;negative regulation of transcription, DNA-templated;chorio-allantoic fusion;syncytiotrophoblast cell differentiation involved in labyrinthine layer development;chorion development	3D-structure;Alternative splicing;Chaperone;Cytoplasm;Direct protein sequencing;Disease mutation;Limb-girdle muscular dystrophy;Methylation;Nucleus;Phosphoprotein;Reference proteome	R-HSA-2262752;R-HSA-8953897;R-HSA-3371453;R-HSA-3371556	Cellular responses to stress;Cellular responses to external stimuli;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress
COQ5	negative	SUSD1	ENSG00000106868	COQ5	1	COQ5	1	0.00604574314165884					GO:0005509;GO:0016020;GO:0016021	calcium ion binding;membrane;integral component of membrane	Alternative splicing;Calcium;Disulfide bond;EGF-like domain;Glycoprotein;Membrane;Polymorphism;Reference proteome;Repeat;Signal;Sushi;Transmembrane;Transmembrane helix		
COQ5	negative	FGFR1OP2	ENSG00000111790	COQ5	1	COQ5	1	0.00604574314165884		WBGene00007579(0)			GO:0005737;GO:0005515;GO:0005829;GO:0042803;GO:0009611;GO:0042060	cytoplasm;protein binding;cytosol;identical protein binding;response to wounding;wound healing	Alternative splicing;Chromosomal rearrangement;Coiled coil;Cytoplasm;Phosphoprotein;Reference proteome	R-HSA-1643685;R-HSA-5663202;R-HSA-1226099;R-HSA-1839117;R-HSA-1839124;R-HSA-5655302	Disease;Diseases of signal transduction;Signaling by FGFR in disease;Signaling by cytosolic FGFR1 fusion mutants;FGFR1 mutant receptor activation;Signaling by FGFR1 in disease
COQ5	negative	SOD2	ENSG00000112096	COQ5	1	COQ5	1	0.00604574314165884	WBGene00004931;WBGene00004932	WBGene00004932(1);WBGene00004931(1)		MICROVASCULAR COMPLICATIONS OF DIABETES SUSCEPTIBILITY TO 6	GO:1904706;GO:0008285;GO:0030335;GO:1905461;GO:1905932;GO:0046872;GO:0016491;GO:0055114;GO:0005739;GO:0005759;GO:0030145;GO:0042802;GO:0004784;GO:0006801;GO:0019430;GO:0070062;GO:0006357;GO:0035722;GO:0051289;GO:0034599;GO:0043524;GO:0008217;GO:1902176;GO:0000303;GO:0001315;GO:0001836;GO:0003069;GO:0032364	metal ion binding;oxidation-reduction process;superoxide dismutase activity;superoxide metabolic process;negative regulation of vascular smooth muscle cell proliferation;negative regulation of cell population proliferation;positive regulation of cell migration;positive regulation of vascular associated smooth muscle cell apoptotic process;positive regulation of vascular smooth muscle cell differentiation involved in phenotypic switching;oxidoreductase activity;mitochondrion;mitochondrial matrix;manganese ion binding;identical protein binding;removal of superoxide radicals;extracellular exosome;regulation of transcription by RNA polymerase II;interleukin-12-mediated signaling pathway;protein homotetramerization;cellular response to oxidative stress;negative regulation of neuron apoptotic process;regulation of blood pressure;negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway;response to superoxide;age-dependent response to reactive oxygen species;release of cytochrome c from mitochondria;acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure;oxygen homeostasis	3D-structure;Acetylation;Alternative splicing;Direct protein sequencing;Manganese;Metal-binding;Mitochondrion;Nitration;Oxidoreductase;Polymorphism;Reference proteome;Transit peptide;Ubl conjugation	R-HSA-168256;R-HSA-1852241;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-1280215;R-HSA-2262752;R-HSA-449147;R-HSA-8953897;R-HSA-9614085;R-HSA-9615017;R-HSA-447115;R-HSA-8950505;R-HSA-9020591;R-HSA-3299685;R-HSA-1592230;R-HSA-2151201;R-HSA-8862803;R-HSA-8863678	Immune System;Organelle biogenesis and maintenance;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;Cytokine Signaling in Immune system;Cellular responses to stress;Signaling by Interleukins;Cellular responses to external stimuli;FOXO-mediated transcription;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes;Interleukin-12 family signaling;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Interleukin-12 signaling;Detoxification of Reactive Oxygen Species;Mitochondrial biogenesis;Transcriptional activation of mitochondrial biogenesis;Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models;Neurodegenerative Diseases
COQ5	negative	PHF1	ENSG00000112511	COQ5	1	COQ5	1	0.00604574314165884					GO:0046872;GO:0006974;GO:0035064;GO:0031060;GO:0005634;GO:0005737;GO:0005654;GO:0006325;GO:0005856;GO:0005515;GO:0005813;GO:0005815;GO:0003700;GO:0043565;GO:0045893;GO:0035098;GO:0035861;GO:0061087;GO:0031491;GO:0045814;GO:0061086;GO:0003682	cellular response to DNA damage stimulus;methylated histone binding;regulation of histone methylation;metal ion binding;nucleus;cytoplasm;nucleoplasm;cytoskeleton;chromatin organization;protein binding;centrosome;microtubule organizing center;regulation of transcription, DNA-templated;DNA binding;ESC/E(Z) complex;site of double-strand break;chromatin binding;DNA-binding transcription factor activity;positive regulation of histone H3-K27 methylation;negative regulation of gene expression, epigenetic;negative regulation of histone H3-K27 methylation	3D-structure;Alternative splicing;Chromatin regulator;Chromosomal rearrangement;Cytoplasm;Cytoskeleton;DNA damage;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Zinc;Zinc-finger	R-HSA-74160;R-HSA-212165;R-HSA-212300	Gene expression (Transcription);Epigenetic regulation of gene expression;PRC2 methylates histones and DNA
COQ5	negative	LOX	ENSG00000113083	COQ5	1	COQ5	1	0.00604574314165884				Familial thoracic aortic aneurysm and aortic dissection;AORTIC ANEURYSM FAMILIAL THORACIC 10	GO:0046872;GO:0016491;GO:0055114;GO:0005615;GO:0005515;GO:0005576;GO:0005507;GO:0016641;GO:0004720;GO:0001568;GO:0001649;GO:0001932;GO:0007507;GO:0009725;GO:0010468;GO:0016202;GO:0017015;GO:0018158;GO:0030199;GO:0030282;GO:0030324;GO:0035791;GO:0035904;GO:0035905;GO:0035906;GO:0042060;GO:0042493;GO:0042981;GO:0043491;GO:0045652;GO:0046716;GO:0048251;GO:0048514;GO:0048545;GO:0048747;GO:0060326;GO:0061448;GO:0071310;GO:0071897;GO:1900120;GO:1903010;GO:1990869;GO:2000586;GO:0005581;GO:0005634;GO:0031012;GO:0006464;GO:0030198;GO:0005518;GO:0018057	oxidation-reduction process;copper ion binding;oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor;cell;metal ion binding;oxidoreductase activity;extracellular space;protein binding;extracellular region;protein-lysine 6-oxidase activity;blood vessel development;osteoblast differentiation;regulation of protein phosphorylation;heart development;response to hormone;regulation of gene expression;regulation of striated muscle tissue development;regulation of transforming growth factor beta receptor signaling pathway;protein oxidation;collagen fibril organization;bone mineralization;lung development;platelet-derived growth factor receptor-beta signaling pathway;aorta development;ascending aorta development;descending aorta development;wound healing;response to drug;regulation of apoptotic process;protein kinase B signaling;regulation of megakaryocyte differentiation;muscle cell cellular homeostasis;elastic fiber assembly;blood vessel morphogenesis;response to steroid hormone;muscle fiber development;cell chemotaxis;connective tissue development;cellular response to organic substance;DNA biosynthetic process;regulation of receptor binding;regulation of bone development;cellular response to chemokine;regulation of platelet-derived growth factor receptor-beta signaling pathway;collagen trimer;nucleus;extracellular matrix;cellular protein modification process;extracellular matrix organization;collagen binding;peptidyl-lysine oxidation	Aortic aneurysm;Copper;Disease mutation;Disulfide bond;Glycoprotein;LTQ;Metal-binding;Oxidoreductase;Polymorphism;Reference proteome;Secreted;Signal;Sulfation;TPQ	R-HSA-1474244;R-HSA-1474290;R-HSA-2022090;R-HSA-2243919;R-HSA-1566948	Extracellular matrix organization;Collagen formation;Assembly of collagen fibrils and other multimeric structures;Crosslinking of collagen fibrils;Elastic fibre formation
COQ5	negative	MOB4	ENSG00000115540	COQ5	1	COQ5	1	0.00604574314165884	WBGene00016238	WBGene00016238(1)			GO:0005737;GO:0016020;GO:0046872;GO:0005794;GO:0005515;GO:0048471;GO:0032580	cytoplasm;membrane;metal ion binding;Golgi apparatus;protein binding;perinuclear region of cytoplasm;Golgi cisterna membrane	3D-structure;Alternative splicing;Cytoplasm;Direct protein sequencing;Golgi apparatus;Membrane;Metal-binding;Phosphoprotein;Reference proteome;Transport;Zinc		
COQ5	negative	BLZF1	ENSG00000117475	COQ5	1	COQ5	1	0.00604574314165884	WBGene00020018	WBGene00020018(0)			GO:0005634;GO:0005737;GO:0016020;GO:0015031;GO:0005794;GO:0003677;GO:0003700;GO:0005515;GO:0000139;GO:0006355;GO:0007030;GO:0043001;GO:0016192;GO:0031625;GO:0001558;GO:0019899	Golgi organization;Golgi to plasma membrane protein transport;nucleus;cytoplasm;membrane;protein transport;Golgi apparatus;nucleoplasm;DNA binding;DNA-binding transcription factor activity;protein binding;regulation of transcription, DNA-templated;Golgi membrane;vesicle-mediated transport;ubiquitin protein ligase binding;regulation of cell growth;enzyme binding	ADP-ribosylation;Alternative splicing;Coiled coil;Cytoplasm;ER-Golgi transport;Golgi apparatus;Membrane;Nucleus;Phosphoprotein;Polymorphism;Protein transport;Reference proteome;Transport;Ubl conjugation	R-HSA-1640170;R-HSA-68886;R-HSA-69278;R-HSA-68875;R-HSA-162658	Cell Cycle;M Phase;Cell Cycle, Mitotic;Mitotic Prophase;Golgi Cisternae Pericentriolar Stack Reorganization
COQ5	negative	UBE2B	ENSG00000119048	COQ5	1	COQ5	1	0.00604574314165884	WBGene00006701				GO:0005634;GO:0005737;GO:0016020;GO:0000166;GO:0005524;GO:0016740;GO:0016567;GO:0005886;GO:0005515;GO:0004842;GO:0006281;GO:0006974;GO:0051865;GO:0006511;GO:0007283;GO:0000790;GO:0061631;GO:0070936;GO:0005654;GO:0050821;GO:0043161;GO:0031625;GO:0090263;GO:0009411;GO:0000785;GO:0000209;GO:0070534;GO:0043951;GO:0070979;GO:0005657;GO:0006513;GO:0033503;GO:0033522;GO:0042493;GO:0042769;GO:0006301;GO:0001701;GO:0006344;GO:0007288;GO:0010845;GO:0031056;GO:0033128;GO:0043066;GO:0045141;GO:0051026;GO:0070076;GO:0070193;GO:0001741	cell;nucleus;cytoplasm;membrane;nucleotide binding;ATP binding;transferase activity;protein ubiquitination;plasma membrane;protein binding;ubiquitin-protein transferase activity;DNA repair;cellular response to DNA damage stimulus;protein autoubiquitination;ubiquitin-dependent protein catabolic process;spermatogenesis;nuclear chromatin;ubiquitin conjugating enzyme activity;protein K48-linked ubiquitination;nucleoplasm;protein stabilization;proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin protein ligase binding;protein polyubiquitination;positive regulation of canonical Wnt signaling pathway;response to UV;chromatin;protein K63-linked ubiquitination;negative regulation of cAMP-mediated signaling;protein K11-linked ubiquitination;replication fork;protein monoubiquitination;HULC complex;histone H2A ubiquitination;response to drug;DNA damage response, detection of DNA damage;postreplication repair;histone ubiquitination;in utero embryonic development;maintenance of chromatin silencing;sperm axoneme assembly;positive regulation of reciprocal meiotic recombination;regulation of histone modification;negative regulation of histone phosphorylation;negative regulation of apoptotic process;meiotic telomere clustering;chiasma assembly;histone lysine demethylation;synaptonemal complex organization;XY body	3D-structure;ATP-binding;Cell membrane;DNA damage;DNA repair;Direct protein sequencing;Membrane;Nucleotide-binding;Nucleus;Reference proteome;Transferase;Ubl conjugation pathway	R-HSA-1280218;R-HSA-168256;R-HSA-392499;R-HSA-597592;R-HSA-8852135;R-HSA-8866654;R-HSA-8866652;R-HSA-983168;R-HSA-983169;R-HSA-73894;R-HSA-73893;R-HSA-110314	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins;Synthesis of active ubiquitin: roles of E1 and E2 enzymes;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;DNA Repair;DNA Damage Bypass;Recognition of DNA damage by PCNA-containing replication complex
COQ5	negative	SENP5	ENSG00000119231	COQ5	1	COQ5	1	0.00604574314165884	WBGene00006736				GO:0005634;GO:0016787;GO:0051301;GO:0005515;GO:0008233;GO:0008234;GO:0006508;GO:0007049;GO:0005730;GO:0016926;GO:0005654;GO:0016925;GO:0019783	proteolysis;cysteine-type peptidase activity;nucleolus;ubiquitin-like protein-specific protease activity;protein desumoylation;nucleus;plasma membrane;hydrolase activity;cell division;protein binding;peptidase activity;cell cycle;nucleoplasm;protein sumoylation	Alternative splicing;Cell cycle;Cell division;Hydrolase;Nucleus;Polymorphism;Protease;Reference proteome;Thiol protease;Ubl conjugation pathway	R-HSA-392499;R-HSA-597592;R-HSA-2990846;R-HSA-3065679;R-HSA-3215018	Metabolism of proteins;Post-translational protein modification;SUMOylation;SUMO is proteolytically processed;Processing and activation of SUMO
COQ5	negative	ELF1	ENSG00000120690	COQ5	1	COQ5	1	0.00604574314165884	WBGene00016029		CD68;FLI1;MEIS1;TEK		GO:0005634;GO:0006355;GO:0003677;GO:0003700;GO:0043565;GO:0005515;GO:0045893;GO:0000978;GO:0001228;GO:0001817;GO:0045944;GO:0050860;GO:0000981;GO:0030154;GO:0006357;GO:0000790;GO:0005654;GO:0001959;GO:0050855	regulation of transcription, DNA-templated;DNA-binding transcription factor activity;sequence-specific DNA binding;nucleus;DNA binding;protein binding;positive regulation of transcription, DNA-templated;RNA polymerase II cis-regulatory region sequence-specific DNA binding;DNA-binding transcription activator activity, RNA polymerase II-specific;regulation of cytokine production;positive regulation of transcription by RNA polymerase II;negative regulation of T cell receptor signaling pathway;DNA-binding transcription factor activity, RNA polymerase II-specific;cell differentiation;regulation of transcription by RNA polymerase II;nuclear chromatin;nucleoplasm;regulation of cytokine-mediated signaling pathway;regulation of B cell receptor signaling pathway	Activator;Alternative splicing;DNA-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Transcription;Transcription regulation	R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-8878171;R-HSA-8939247;R-HSA-8939245	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in interleukin signaling;RUNX1 regulates transcription of genes involved in BCR signaling
COQ5	negative	CYREN	ENSG00000122783	COQ5	1	COQ5	1	0.00604574314165884					GO:0005634;GO:0005737;GO:0005515;GO:0006281;GO:0006974;GO:2001033;GO:0006303	negative regulation of double-strand break repair via nonhomologous end joining;nucleus;cytoplasm;protein binding;DNA repair;cellular response to DNA damage stimulus;double-strand break repair via nonhomologous end joining	3D-structure;Acetylation;Alternative splicing;Cytoplasm;DNA damage;DNA repair;Direct protein sequencing;Nucleus;Polymorphism;Reference proteome		
COQ5	negative	AMD1	ENSG00000123505	COQ5	1	COQ5	1	0.00604574314165884	WBGene00004875	WBGene00004875(0)			GO:0004014;GO:0006597;GO:0008295;GO:0016829;GO:0016831;GO:0005829;GO:0006596;GO:0006595;GO:0019810;GO:0006557;GO:0046500	adenosylmethionine decarboxylase activity;spermine biosynthetic process;spermidine biosynthetic process;lyase activity;carboxy-lyase activity;cytosol;polyamine biosynthetic process;polyamine metabolic process;putrescine binding;S-adenosylmethioninamine biosynthetic process;S-adenosylmethionine metabolic process	3D-structure;Alternative splicing;Autocatalytic cleavage;Decarboxylase;Direct protein sequencing;Lyase;Phosphoprotein;Polyamine biosynthesis;Pyruvate;Reference proteome;S-adenosyl-L-methionine;Schiff base;Spermidine biosynthesis;Zymogen	R-HSA-1430728;R-HSA-71291;R-HSA-351202	Metabolism;Metabolism of amino acids and derivatives;Metabolism of polyamines
COQ5	negative	PPP1R12C	ENSG00000125503	COQ5	1	COQ5	1	0.00604574314165884	WBGene00003196				GO:0005737;GO:0007165;GO:0050790;GO:0005856;GO:0005515;GO:0043086;GO:0019901;GO:0019208;GO:0004857	protein binding;signal transduction;protein kinase binding;phosphatase regulator activity;cytoplasm;cytoskeleton;regulation of catalytic activity;negative regulation of catalytic activity;enzyme inhibitor activity	ANK repeat;Acetylation;Alternative splicing;Coiled coil;Cytoplasm;Cytoskeleton;Phosphoprotein;Polymorphism;Reference proteome;Repeat		
COQ5	negative	PHF20L1	ENSG00000129292	COQ5	1	COQ5	1	0.00604574314165884					GO:0005634;GO:0006355;GO:0046872;GO:0005515	regulation of transcription, DNA-templated;nucleus;metal ion binding;protein binding	3D-structure;Acetylation;Alternative splicing;Isopeptide bond;Metal-binding;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation;Zinc;Zinc-finger		
COQ5	negative	ABHD17A	ENSG00000129968	COQ5	1	COQ5	1	0.00604574314165884	WBGene00045192	WBGene00045192(1)			GO:0016020;GO:0016787;GO:0005886;GO:0042995;GO:0005515;GO:0030054;GO:0045202;GO:0045211;GO:0005768;GO:0072657;GO:0010008;GO:0014069;GO:0043197;GO:0008474;GO:0018345;GO:0002084;GO:0099175;GO:1902817;GO:1905668;GO:0055038;GO:0098978;GO:0099031;GO:0099033	membrane;hydrolase activity;endosome;plasma membrane;cell projection;protein binding;cell junction;synapse;postsynaptic membrane;protein localization to membrane;endosome membrane;postsynaptic density membrane;dendritic spine;palmitoyl-(protein) hydrolase activity;protein palmitoylation;protein depalmitoylation;regulation of postsynapse organization;negative regulation of protein localization to microtubule;positive regulation of protein localization to endosome;postsynaptic density;recycling endosome membrane;glutamatergic synapse;anchored component of postsynaptic density membrane;anchored component of postsynaptic recycling endosome membrane	Alternative splicing;Cell junction;Cell membrane;Cell projection;Endosome;Hydrolase;Lipoprotein;Membrane;Palmitate;Phosphoprotein;Postsynaptic cell membrane;Reference proteome;Synapse		
COQ5	negative	CMPK2	ENSG00000134326	COQ5	1	COQ5	1	0.00604574314165884		WBGene00011272(0)			GO:0000166;GO:0005524;GO:0016301;GO:0016740;GO:0016310;GO:0005739;GO:0004550;GO:0006221;GO:0005737;GO:0046940;GO:0006165;GO:0009142;GO:0004798;GO:0009041;GO:0006227;GO:0006233;GO:0006235;GO:0004127;GO:0033862;GO:0050145;GO:0071222	nucleoside monophosphate kinase activity;nucleotide binding;ATP binding;kinase activity;transferase activity;phosphorylation;mitochondrion;nucleoside diphosphate kinase activity;pyrimidine nucleotide biosynthetic process;cytoplasm;nucleoside monophosphate phosphorylation;nucleoside diphosphate phosphorylation;nucleoside triphosphate biosynthetic process;thymidylate kinase activity;uridylate kinase activity;dUDP biosynthetic process;dTDP biosynthetic process;dTTP biosynthetic process;cytidylate kinase activity;UMP kinase activity;cellular response to lipopolysaccharide	ATP-binding;Alternative splicing;Coiled coil;Kinase;Mitochondrion;Nucleotide-binding;Polymorphism;Pyrimidine biosynthesis;Reference proteome;Transferase;Transit peptide		
COQ5	negative	ABI1	ENSG00000136754	COQ5	1	COQ5	1	0.00604574314165884	WBGene00015146				GO:0005634;GO:0005737;GO:0016020;GO:0005886;GO:0008154;GO:0005856;GO:0042995;GO:0005515;GO:0030054;GO:0045202;GO:0045211;GO:0038096;GO:0030296;GO:0061098;GO:0005829;GO:0045296;GO:0030027;GO:0030175;GO:0030426;GO:0070062;GO:0014069;GO:0016032;GO:0017124;GO:0005783;GO:0007169;GO:0048010;GO:0008285;GO:0032433;GO:0018108;GO:0031209;GO:0008092;GO:0001756;GO:0035855;GO:0048813;GO:0072673;GO:0031252;GO:0043005	protein binding;actin polymerization or depolymerization;protein tyrosine kinase activator activity;nucleus;cytoplasm;cytosol;plasma membrane;cytoskeleton;cell junction;cell projection;aggresome;synapse;Fc-gamma receptor signaling pathway involved in phagocytosis;positive regulation of protein tyrosine kinase activity;cadherin binding;lamellipodium;filopodium;growth cone;extracellular exosome;postsynaptic density;viral process;SH3 domain binding;endoplasmic reticulum;transmembrane receptor protein tyrosine kinase signaling pathway;vascular endothelial growth factor receptor signaling pathway;negative regulation of cell population proliferation;filopodium tip;peptidyl-tyrosine phosphorylation;SCAR complex;cytoskeletal protein binding;somitogenesis;megakaryocyte development;dendrite morphogenesis;lamellipodium morphogenesis;cell leading edge;neuron projection	Acetylation;Alternative splicing;Cell junction;Cell projection;Chromosomal rearrangement;Coiled coil;Cytoplasm;Cytoskeleton;Direct protein sequencing;Host-virus interaction;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;SH3 domain;Synapse	R-HSA-168249;R-HSA-168256;R-HSA-2029480;R-HSA-2029482;R-HSA-162582;R-HSA-194315;R-HSA-195258;R-HSA-5663213;R-HSA-9006934;R-HSA-194138;R-HSA-4420097	Innate Immune System;Immune System;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;Signal Transduction;Signaling by Rho GTPases;RHO GTPase Effectors;RHO GTPases Activate WASPs and WAVEs;Signaling by Receptor Tyrosine Kinases;Signaling by VEGF;VEGFA-VEGFR2 Pathway
COQ5	negative	TUBB2A	ENSG00000137267	COQ5	1	COQ5	1	0.00604574314165884	WBGene00006538;WBGene00003171;WBGene00000248;WBGene00006536;WBGene00006537	WBGene00006539(0);WBGene00000248(0);WBGene00006536(0);WBGene00006537(0)		Cortical dysplasia complex with other brain malformations 5;Cortical dysplasia complex with other brain malformations 5	GO:0005634;GO:0005737;GO:0000166;GO:0003924;GO:0005525;GO:0005856;GO:0005515;GO:0005200;GO:0005874;GO:0007017;GO:0000226;GO:0000278;GO:0070062;GO:1903561;GO:0001764	GTP binding;microtubule-based process;microtubule;GTPase activity;structural constituent of cytoskeleton;nucleus;cytoplasm;nucleotide binding;cytoskeleton;protein binding;microtubule cytoskeleton organization;mitotic cell cycle;extracellular exosome;extracellular vesicle;neuron migration	Acetylation;Cytoplasm;Cytoskeleton;Direct protein sequencing;Disease mutation;GTP-binding;Isopeptide bond;Methylation;Microtubule;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation	R-HSA-109582;R-HSA-1280218;R-HSA-168256;R-HSA-5653656;R-HSA-1266738;R-HSA-1852241;R-HSA-5617833;R-HSA-5620924;R-HSA-392499;R-HSA-597592;R-HSA-373760;R-HSA-422475;R-HSA-437239;R-HSA-162582;R-HSA-194315;R-HSA-1640170;R-HSA-199991;R-HSA-6811434;R-HSA-6811442;R-HSA-8856688;R-HSA-446203;R-HSA-2262752;R-HSA-2467813;R-HSA-2555396;R-HSA-453274;R-HSA-5358351;R-HSA-5610787;R-HSA-68882;R-HSA-68886;R-HSA-69275;R-HSA-69278;R-HSA-8852276;R-HSA-8953897;R-HSA-112314;R-HSA-112315;R-HSA-112316;R-HSA-195258;R-HSA-1445148;R-HSA-157858;R-HSA-190828;R-HSA-190840;R-HSA-190861;R-HSA-190872;R-HSA-199977;R-HSA-2132295;R-HSA-2500257;R-HSA-3371497;R-HSA-380320;R-HSA-389958;R-HSA-389960;R-HSA-389977;R-HSA-390466;R-HSA-391251;R-HSA-438064;R-HSA-442755;R-HSA-5626467;R-HSA-5663220;R-HSA-6807878;R-HSA-6811436;R-HSA-68877;R-HSA-8955332;R-HSA-948021;R-HSA-9609736;R-HSA-9619483;R-HSA-983189;R-HSA-983231;R-HSA-389957	Hemostasis;Adaptive Immune System;Immune System;Vesicle-mediated transport;Developmental Biology;Organelle biogenesis and maintenance;Cilium Assembly;Intraflagellar transport;Metabolism of proteins;Post-translational protein modification;L1CAM interactions;Axon guidance;Recycling pathway of L1;Signal Transduction;Signaling by Rho GTPases;Cell Cycle;Membrane Trafficking;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Asparagine N-linked glycosylation;Cellular responses to stress;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Mitotic G2-G2/M phases;Signaling by Hedgehog;Hedgehog 'off' state;Mitotic Anaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;The role of GTSE1 in G2/M progression after G2 checkpoint;Cellular responses to external stimuli;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;RHO GTPase Effectors;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Gap junction trafficking and regulation;Gap junction trafficking;Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane;Gap junction assembly;Transport of connexons to the plasma membrane;ER to Golgi Anterograde Transport;MHC class II antigen presentation;Resolution of Sister Chromatid Cohesion;HSP90 chaperone cycle for steroid hormone receptors (SHR);Recruitment of NuMA to mitotic centrosomes;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding;Formation of tubulin folding intermediates by CCT/TriC;Post-chaperonin tubulin folding pathway;Chaperonin-mediated protein folding;Protein folding;Post NMDA receptor activation events;Activation of NMDA receptors and postsynaptic events;RHO GTPases activate IQGAPs;RHO GTPases Activate Formins;COPI-mediated anterograde transport;COPI-independent Golgi-to-ER retrograde traffic;Mitotic Prometaphase;Carboxyterminal post-translational modifications of tubulin;Transport to the Golgi and subsequent modification;Assembly and cell surface presentation of NMDA receptors;Activation of AMPK downstream of NMDARs;Kinesins;Factors involved in megakaryocyte development and platelet production;Prefoldin mediated transfer of substrate  to CCT/TriC
COQ5	negative	MTCH1	ENSG00000137409	COQ5	1	COQ5	1	0.00604574314165884	WBGene00018395	WBGene00018395(0);WBGene00018397(0)			GO:0016020;GO:0016021;GO:0005743;GO:0005739;GO:0006915;GO:0005515;GO:0043065;GO:0009966;GO:0006919;GO:0045161	membrane;integral component of membrane;mitochondrial inner membrane;mitochondrion;apoptotic process;protein binding;positive regulation of apoptotic process;regulation of signal transduction;activation of cysteine-type endopeptidase activity involved in apoptotic process;neuronal ion channel clustering	Alternative splicing;Apoptosis;Membrane;Methylation;Mitochondrion;Mitochondrion inner membrane;Reference proteome;Repeat;Transmembrane;Transmembrane helix;Transport		
COQ5	negative	IFI44	ENSG00000137965	COQ5	1	COQ5	1	0.00604574314165884					GO:0005737;GO:0006955;GO:0009615;GO:0009617	cytoplasm;immune response;response to virus;response to bacterium	Alternative splicing;Cytoplasm;Polymorphism;Reference proteome		
COQ5	negative	RHOF	ENSG00000139725	COQ5	1	COQ5	1	0.00604574314165884					GO:0005737;GO:0016020;GO:0000166;GO:0003924;GO:0005525;GO:0007264;GO:0005886;GO:0005856;GO:0043231;GO:0030334;GO:0005829;GO:0070062;GO:0051056;GO:0016477;GO:0007015;GO:0019901;GO:0005938;GO:0007266;GO:0008360;GO:0051017;GO:0043312;GO:0030950;GO:0032956;GO:0032153;GO:0030667;GO:0005622	GTP binding;GTPase activity;small GTPase mediated signal transduction;cytoplasm;membrane;nucleotide binding;cytoskeleton;plasma membrane;intracellular membrane-bounded organelle;regulation of cell migration;cytosol;extracellular exosome;regulation of small GTPase mediated signal transduction;cell migration;actin filament organization;regulation of cell shape;protein kinase binding;cell cortex;Rho protein signal transduction;actin filament bundle assembly;neutrophil degranulation;cell division site;cytoplasmic vesicle;establishment or maintenance of cell polarity;establishment or maintenance of actin cytoskeleton polarity;regulation of actin cytoskeleton organization;secretory granule membrane	Acetylation;Alternative splicing;Cell membrane;Cytoplasm;Cytoskeleton;GTP-binding;Lipoprotein;Membrane;Methylation;Nucleotide-binding;Prenylation;Reference proteome	R-HSA-168249;R-HSA-168256;R-HSA-162582;R-HSA-194315;R-HSA-194840;R-HSA-6798695	Innate Immune System;Immune System;Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle;Neutrophil degranulation
COQ5	negative	KIFC3	ENSG00000140859	COQ5	1	COQ5	1	0.00604574314165884	WBGene00002216;WBGene00002227;WBGene00002225;WBGene00002226	WBGene00002216(0)			GO:0005737;GO:0016020;GO:0000166;GO:0005524;GO:0003777;GO:0005856;GO:0005515;GO:0008017;GO:0030054;GO:0031410;GO:0005874;GO:0030659;GO:0007018;GO:0005813;GO:0005815;GO:0008569;GO:0016887;GO:0070062;GO:0005912;GO:0007601;GO:0005871;GO:0090136;GO:0045218;GO:0005915;GO:0007017;GO:0007030;GO:0005794;GO:0003774	ATP binding;microtubule binding;microtubule motor activity;microtubule-based movement;ATP-dependent microtubule motor activity, minus-end-directed;cytoplasm;membrane;nucleotide binding;cytoskeleton;protein binding;cell junction;cytoplasmic vesicle;microtubule;cytoplasmic vesicle membrane;centrosome;microtubule organizing center;ATPase activity;extracellular exosome;adherens junction;visual perception;kinesin complex;epithelial cell-cell adhesion;zonula adherens maintenance;zonula adherens;microtubule-based process;Golgi organization;Golgi apparatus;motor activity	3D-structure;ATP-binding;Alternative splicing;Cell junction;Coiled coil;Cytoplasm;Cytoplasmic vesicle;Cytoskeleton;Membrane;Microtubule;Motor protein;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome		
COQ5	negative	SH3GL1	ENSG00000141985	COQ5	1	COQ5	1	0.00604574314165884	WBGene00006791	WBGene00015128(0)		LEUKEMIA ACUTE MYELOID	GO:0005737;GO:0016020;GO:0005829;GO:0098793;GO:0042995;GO:0005515;GO:0030054;GO:0008289;GO:0042802;GO:0005768;GO:0045296;GO:0006897;GO:0002102;GO:0031901;GO:0007165;GO:0007417;GO:0098978;GO:0008022;GO:0017124;GO:0019902;GO:0031697;GO:0044325;GO:0051020;GO:0016191;GO:0098815;GO:1900242;GO:1900244;GO:0045202;GO:0098685;GO:0098686;GO:0099092	protein binding;cytoplasm;membrane;cytosol;endosome;cell projection;cell junction;lipid binding;presynapse;identical protein binding;endocytosis;cadherin binding;podosome;early endosome membrane;signal transduction;central nervous system development;glutamatergic synapse;protein C-terminus binding;SH3 domain binding;phosphatase binding;beta-1 adrenergic receptor binding;ion channel binding;GTPase binding;synaptic vesicle uncoating;modulation of excitatory postsynaptic potential;regulation of synaptic vesicle endocytosis;positive regulation of synaptic vesicle endocytosis;synapse;Schaffer collateral - CA1 synapse;hippocampal mossy fiber to CA3 synapse;postsynaptic density, intracellular component	Alternative splicing;Cell junction;Cell projection;Chromosomal rearrangement;Coiled coil;Cytoplasm;Endocytosis;Endosome;Lipid-binding;Membrane;Phosphoprotein;Proto-oncogene;Reference proteome;SH3 domain	R-HSA-5653656;R-HSA-162582;R-HSA-199991;R-HSA-1643685;R-HSA-5663205;R-HSA-9006934;R-HSA-8856828;R-HSA-8856825;R-HSA-177929;R-HSA-182971;R-HSA-6806834;R-HSA-6807004;R-HSA-8875360;R-HSA-8876384	Vesicle-mediated transport;Signal Transduction;Membrane Trafficking;Disease;Infectious disease;Signaling by Receptor Tyrosine Kinases;Clathrin-mediated endocytosis;Cargo recognition for clathrin-mediated endocytosis;Signaling by EGFR;EGFR downregulation;Signaling by MET;Negative regulation of MET activity;InlB-mediated entry of Listeria monocytogenes into host cell;Listeria monocytogenes entry into host cells
COQ5	negative	ASAP1	ENSG00000153317	COQ5	1	COQ5	1	0.00604574314165884					GO:0005096;GO:0043547;GO:0005515;GO:0005737;GO:0016020;GO:0046872;GO:0060271;GO:0005829;GO:0045296;GO:0030030;GO:0031253;GO:1903527;GO:0002102;GO:0001786;GO:0005546;GO:0005547;GO:0061000;GO:0071803;GO:0043197	protein binding;GTPase activator activity;positive regulation of GTPase activity;cytoplasm;membrane;metal ion binding;cilium assembly;cytosol;cadherin binding;cell projection organization;cell projection membrane;positive regulation of membrane tubulation;podosome;phosphatidylserine binding;phosphatidylinositol-4,5-bisphosphate binding;phosphatidylinositol-3,4,5-trisphosphate binding;negative regulation of dendritic spine development;positive regulation of podosome assembly;dendritic spine	3D-structure;ANK repeat;Alternative splicing;Cilium biogenesis/degradation;Cytoplasm;GTPase activation;Membrane;Metal-binding;Phosphoprotein;Polymorphism;Reference proteome;Repeat;SH3 domain;Zinc;Zinc-finger	R-HSA-1852241;R-HSA-5617833;R-HSA-5620920;R-HSA-5620916	Organelle biogenesis and maintenance;Cilium Assembly;Cargo trafficking to the periciliary membrane;VxPx cargo-targeting to cilium
COQ5	negative	PSD3	ENSG00000156011	COQ5	1	COQ5	1	0.00604574314165884	WBGene00013223	WBGene00007703(0);WBGene00012386(0);WBGene00008685(0)			GO:0016020;GO:0005886;GO:0042995;GO:0030054;GO:0045202;GO:0045211;GO:0005086;GO:0032012;GO:0005085;GO:0032587;GO:0014069;GO:0005515;GO:0005543	ARF guanyl-nucleotide exchange factor activity;regulation of ARF protein signal transduction;membrane;plasma membrane;cell projection;cell junction;synapse;guanyl-nucleotide exchange factor activity;ruffle membrane;postsynaptic density;protein binding;phospholipid binding	Alternative splicing;Cell junction;Cell membrane;Cell projection;Coiled coil;Guanine-nucleotide releasing factor;Membrane;Phosphoprotein;Polymorphism;Reference proteome;Synapse		
COQ5	negative	FBRS	ENSG00000156860	COQ5	1	COQ5	1	0.00604574314165884							Alternative splicing;Isopeptide bond;Methylation;Phosphoprotein;Reference proteome;Ubl conjugation		
COQ5	negative	MFSD14A	ENSG00000156875	COQ5	1	COQ5	1	0.00604574314165884	WBGene00020798	WBGene00017861(0);WBGene00021814(0);WBGene00020798(0);WBGene00010182(0);WBGene00010282(0);WBGene00016095(0);WBGene00016094(0);WBGene00016093(0);WBGene00012222(0);WBGene00021870(0)			GO:0016020;GO:0016021;GO:0022857;GO:0055085;GO:0005887;GO:0005215	integral component of membrane;transmembrane transporter activity;transmembrane transport;membrane;acrosome assembly;spermatogenesis;spermatid development;spermatid nucleus differentiation;sperm mitochondrion organization	Acetylation;Glycoprotein;Membrane;Reference proteome;Transmembrane;Transmembrane helix;Transport		
COQ5	negative	ZFAND2B	ENSG00000158552	COQ5	1	COQ5	1	0.00604574314165884	WBGene00000097	WBGene00000097(0)			GO:0008270;GO:0046872;GO:0016020;GO:0005783;GO:0005789;GO:0005515;GO:0000502;GO:0031225;GO:0045047;GO:0043161;GO:0043567;GO:0036435;GO:0006616;GO:0031593;GO:0043130	zinc ion binding;metal ion binding;membrane;endoplasmic reticulum;endoplasmic reticulum membrane;protein binding;proteasome complex;anchored component of membrane;protein targeting to ER;proteasome-mediated ubiquitin-dependent protein catabolic process;regulation of insulin-like growth factor receptor signaling pathway;K48-linked polyubiquitin modification-dependent protein binding;SRP-dependent cotranslational protein targeting to membrane, translocation;polyubiquitin modification-dependent protein binding;ubiquitin binding	3D-structure;Alternative splicing;Endoplasmic reticulum;Lipoprotein;Membrane;Metal-binding;Methylation;Phosphoprotein;Prenylation;Reference proteome;Repeat;Zinc;Zinc-finger		
COQ5	negative	TRAPPC10	ENSG00000160218	COQ5	1	COQ5	1	0.00604574314165884	WBGene00022138	WBGene00022138(0)			GO:0005794;GO:0005515;GO:0016192;GO:0006891;GO:0034498;GO:1990071;GO:0000139;GO:0005829;GO:0051259;GO:0048208;GO:0030008	Golgi apparatus;protein binding;vesicle-mediated transport;intra-Golgi vesicle-mediated transport;early endosome to Golgi transport;TRAPPII protein complex;Golgi membrane;cytosol;TRAPP complex;COPII vesicle coating	Alternative splicing;ER-Golgi transport;Golgi apparatus;Phosphoprotein;Polymorphism;Reference proteome;Transport	R-HSA-5653656;R-HSA-392499;R-HSA-597592;R-HSA-199991;R-HSA-8876198;R-HSA-9007101;R-HSA-446203;R-HSA-199977;R-HSA-948021;R-HSA-204005	Vesicle-mediated transport;Metabolism of proteins;Post-translational protein modification;Membrane Trafficking;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking;Asparagine N-linked glycosylation;ER to Golgi Anterograde Transport;Transport to the Golgi and subsequent modification;COPII-mediated vesicle transport
COQ5	negative	SRSF2	ENSG00000161547	COQ5	1	COQ5	1	0.00604574314165884	WBGene00004701	WBGene00004701(0)			GO:0003676;GO:0003723;GO:0006397;GO:0008380;GO:0005634;GO:0016607;GO:0005829;GO:0005515;GO:0000381;GO:1903507;GO:0005654;GO:0003714;GO:0006406;GO:0006405;GO:0031124;GO:0000398;GO:0045292;GO:0043484	RNA binding;nucleic acid binding;regulation of alternative mRNA splicing, via spliceosome;mRNA processing;RNA splicing;nucleus;nuclear speck;nucleoplasm;cytosol;protein binding;negative regulation of nucleic acid-templated transcription;cytoplasm;transcription corepressor activity;mRNA export from nucleus;RNA export from nucleus;mRNA 3'-end processing;mRNA splicing, via spliceosome;mRNA cis splicing, via spliceosome;protein kinase C binding;pre-mRNA binding;mitotic cell cycle;response to vitamin E;spliceosomal complex;interchromatin granule	3D-structure;Acetylation;Alternative splicing;Direct protein sequencing;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;mRNA processing;mRNA splicing	R-HSA-73857;R-HSA-74160;R-HSA-8953854;R-HSA-159236;R-HSA-72202;R-HSA-72203;R-HSA-72187;R-HSA-73856;R-HSA-72163;R-HSA-72172;R-HSA-72165	RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA;Transport of Mature mRNA derived from an Intron-Containing Transcript;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;mRNA 3'-end processing;RNA Polymerase II Transcription Termination;mRNA Splicing - Major Pathway;mRNA Splicing;mRNA Splicing - Minor Pathway
COQ5	negative	ANTXR2	ENSG00000163297	COQ5	1	COQ5	1	0.00604574314165884				INFANTILE SYSTEMIC HYALINOSIS;JUVENILE HYALINE FIBROMATOSIS;HYALINE FIBROMATOSIS SYNDROME	GO:0016020;GO:0016021;GO:0046872;GO:0005783;GO:0005789;GO:0005886;GO:0005515;GO:0005576;GO:0038023;GO:0009986;GO:0010008;GO:0004888;GO:1901998;GO:0022414;GO:0009897	integral component of membrane;signaling receptor activity;membrane;metal ion binding;endoplasmic reticulum;endoplasmic reticulum membrane;plasma membrane;protein binding;extracellular region;cell surface;transmembrane signaling receptor activity;endosome membrane;toxin transport;reproductive process;external side of plasma membrane	3D-structure;Alternative splicing;Cell membrane;Disease mutation;Disulfide bond;Endoplasmic reticulum;Glycoprotein;Membrane;Metal-binding;Phosphoprotein;Polymorphism;Receptor;Reference proteome;Secreted;Signal;Transmembrane;Transmembrane helix		
COQ5	negative	MICALL2	ENSG00000164877	COQ5	1	COQ5	1	0.00604574314165884					GO:0005737;GO:0016020;GO:0046872;GO:0005829;GO:0005886;GO:0032456;GO:0005856;GO:0042995;GO:0005515;GO:0030054;GO:0017137;GO:0005768;GO:0005923;GO:0051015;GO:0005815;GO:0001725;GO:0055037;GO:0030036;GO:0031941;GO:0030041;GO:0043005;GO:0005911;GO:0031175;GO:1903955;GO:0031532;GO:0070830;GO:0034446;GO:0031005;GO:0032432;GO:0042805	cytoplasm;membrane;metal ion binding;endosome;cytoskeleton;cytosol;plasma membrane;endocytic recycling;cell projection;protein binding;cell junction;Rab GTPase binding;bicellular tight junction;neuron projection;actin filament binding;microtubule organizing center;stress fiber;recycling endosome;actin cytoskeleton organization;filamentous actin;actin filament polymerization;cell-cell junction;neuron projection development;positive regulation of protein targeting to mitochondrion;actin cytoskeleton reorganization;bicellular tight junction assembly;substrate adhesion-dependent cell spreading;filamin binding;actin filament bundle	Alternative splicing;Cell junction;Cell membrane;Cell projection;Coiled coil;Cytoplasm;Cytoskeleton;Endosome;LIM domain;Membrane;Metal-binding;Phosphoprotein;Polymorphism;Reference proteome;Tight junction;Zinc		
COQ5	negative	ANKRD11	ENSG00000167522	COQ5	1	COQ5	1	0.00604574314165884				16q24.3 microdeletion syndrome;KBG syndrome;KBG syndrome;KBG syndrome	GO:0005634;GO:0005829;GO:0005654;GO:0005886;GO:0001701;GO:0001894;GO:0035264;GO:0042475;GO:0048705;GO:0060323;GO:0060325;GO:0060348;GO:0005515	protein binding;nucleus;nucleoplasm;cytosol;plasma membrane;anatomical structure morphogenesis;in utero embryonic development;tissue homeostasis;multicellular organism growth;odontogenesis of dentin-containing tooth;skeletal system morphogenesis;head morphogenesis;face morphogenesis;bone development	ANK repeat;Disease mutation;Dwarfism;Mental retardation;Nucleus;Phosphoprotein;Reference proteome;Repeat		
COQ5	negative	ZEB2	ENSG00000169554	COQ5	1	COQ5	1	0.00604574314165884	WBGene00006970		ITGA5;POU5F1;VIM	Mowat-Wilson syndrome due to a ZEB2 point mutation;Mowat-Wilson syndrome due to monosomy 2q22;MOWAT-WILSON SYNDROME;MOWAT-WILSON SYNDROME	GO:0003676;GO:0005634;GO:0005730;GO:0005829;GO:0003677;GO:0045944;GO:0046872;GO:0005515;GO:0007399;GO:0000981;GO:0000790;GO:0000122;GO:0001227;GO:0019208;GO:0043565;GO:0001228;GO:0070412;GO:0001755;GO:0001756;GO:0001843;GO:0007417;GO:0021540;GO:0021766;GO:0021846;GO:0021957;GO:0030177;GO:0043507;GO:0045636;GO:0048023;GO:0048066;GO:0048598;GO:0048668;GO:0050772;GO:0061373;GO:0097324;GO:1902748;GO:1903056	DNA binding;nucleic acid binding;positive regulation of transcription by RNA polymerase II;nucleus;metal ion binding;nucleoplasm;nucleolus;cytosol;protein binding;nervous system development;DNA-binding transcription factor activity, RNA polymerase II-specific;nuclear chromatin;negative regulation of transcription by RNA polymerase II;DNA-binding transcription repressor activity, RNA polymerase II-specific;phosphatase regulator activity;sequence-specific DNA binding;DNA-binding transcription activator activity, RNA polymerase II-specific;R-SMAD binding;neural crest cell migration;somitogenesis;neural tube closure;central nervous system development;corpus callosum morphogenesis;hippocampus development;cell proliferation in forebrain;corticospinal tract morphogenesis;positive regulation of Wnt signaling pathway;positive regulation of JUN kinase activity;positive regulation of melanocyte differentiation;positive regulation of melanin biosynthetic process;developmental pigmentation;embryonic morphogenesis;collateral sprouting;positive regulation of axonogenesis;mammillary axonal complex development;melanocyte migration;positive regulation of lens fiber cell differentiation;regulation of melanosome organization	3D-structure;Acetylation;Alternative splicing;DNA-binding;Disease mutation;Epilepsy;Hirschsprung disease;Homeobox;Isopeptide bond;Mental retardation;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger		
COQ5	negative	NPPA	ENSG00000175206	COQ5	1	COQ5	1	0.00604574314165884				Atrial standstill;Familial atrial fibrillation;ATRIAL FIBRILLATION FAMILIAL 6;ATRIAL STANDSTILL 2	GO:0010460;GO:0060452;GO:1902514;GO:1903766;GO:0005576;GO:0005515;GO:0005179;GO:0005615;GO:0005634;GO:0005737;GO:0044267;GO:0062023;GO:0008217;GO:0005102;GO:1903779;GO:0007565;GO:0006367;GO:0032991;GO:0019934;GO:0035994;GO:0007218;GO:1902261;GO:1901841;GO:0006182;GO:0005184;GO:0051427;GO:0071855;GO:0001666;GO:0003085;GO:0006457;GO:0007168;GO:0010753;GO:0014898;GO:0030308;GO:0032868;GO:0060372;GO:0061049;GO:0071260;GO:1903595;GO:1903815;GO:0042629;GO:0048471;GO:0007165	extracellular region;hormone activity;positive regulation of heart rate;positive regulation of cardiac muscle contraction;regulation of calcium ion transmembrane transport via high voltage-gated calcium channel;positive regulation of potassium ion export across plasma membrane;protein binding;extracellular space;nucleus;cytoplasm;cellular protein metabolic process;collagen-containing extracellular matrix;regulation of blood pressure;signaling receptor binding;regulation of cardiac conduction;female pregnancy;transcription initiation from RNA polymerase II promoter;protein-containing complex;cGMP-mediated signaling;response to muscle stretch;neuropeptide signaling pathway;positive regulation of delayed rectifier potassium channel activity;regulation of high voltage-gated calcium channel activity;cGMP biosynthetic process;neuropeptide hormone activity;hormone receptor binding;neuropeptide receptor binding;response to hypoxia;negative regulation of systemic arterial blood pressure;protein folding;receptor guanylyl cyclase signaling pathway;positive regulation of cGMP-mediated signaling;cardiac muscle hypertrophy in response to stress;negative regulation of cell growth;response to insulin;negative regulation of JUN kinase activity;regulation of atrial cardiac muscle cell membrane repolarization;cell growth involved in cardiac muscle cell development;cellular response to mechanical stimulus;positive regulation of histamine secretion by mast cell;negative regulation of collecting lymphatic vessel constriction;brush border;mast cell granule;perinuclear region of cytoplasm;signal transduction	3D-structure;Atrial fibrillation;Cardiomyopathy;Cell projection;Direct protein sequencing;Disease mutation;Disulfide bond;Hormone;Phosphoprotein;Polymorphism;Reference proteome;Secreted;Signal;Vasoactive;Vasodilator	R-HSA-392499;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-977225;R-HSA-397014;R-HSA-5576891;R-HSA-2032785;R-HSA-5578768	Metabolism of proteins;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Amyloid fiber formation;Muscle contraction;Cardiac conduction;YAP1- and WWTR1 (TAZ)-stimulated gene expression;Physiological factors
COQ5	negative	MCTP1	ENSG00000175471	COQ5	1	COQ5	1	0.00604574314165884	WBGene00017063	WBGene00017063(0)			GO:0016020;GO:0016021;GO:0005783;GO:0005789;GO:0030054;GO:0031410;GO:0045202;GO:0005768;GO:0005509;GO:0055037;GO:0030672;GO:0046928;GO:0030336;GO:0019722;GO:0048168;GO:0045806;GO:1902883	membrane;integral component of membrane;endoplasmic reticulum;endoplasmic reticulum membrane;endosome;cell junction;cytoplasmic vesicle;synapse;calcium ion binding;recycling endosome;synaptic vesicle membrane;regulation of neurotransmitter secretion;negative regulation of cell migration;calcium-mediated signaling;regulation of neuronal synaptic plasticity;negative regulation of endocytosis;negative regulation of response to oxidative stress	Alternative splicing;Calcium;Cell junction;Cytoplasmic vesicle;Endoplasmic reticulum;Endosome;Membrane;Metal-binding;Polymorphism;Reference proteome;Repeat;Synapse;Transmembrane;Transmembrane helix		
COQ5	negative	MLXIP	ENSG00000175727	COQ5	1	COQ5	1	0.00604574314165884	WBGene00003378;WBGene00003510	WBGene00003378(0)			GO:0005634;GO:0005737;GO:0016020;GO:0046983;GO:0006355;GO:0003677;GO:0005739;GO:0000981;GO:0005741;GO:0003700;GO:1900402;GO:0006357;GO:0000790;GO:0001228;GO:0045944;GO:0000977	regulation of transcription, DNA-templated;protein dimerization activity;DNA-binding transcription factor activity, RNA polymerase II-specific;obsolete regulation of carbohydrate metabolic process by regulation of transcription from RNA polymerase II promoter;nucleus;cytoplasm;membrane;DNA binding;mitochondrion;mitochondrial outer membrane;DNA-binding transcription factor activity;regulation of transcription by RNA polymerase II;positive regulation of transcription by RNA polymerase II;nuclear chromatin;DNA-binding transcription activator activity, RNA polymerase II-specific;RNA polymerase II regulatory region sequence-specific DNA binding	Acetylation;Activator;Alternative splicing;Cytoplasm;DNA-binding;Membrane;Mitochondrion;Mitochondrion outer membrane;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Transcription;Transcription regulation		
COQ5	negative	LYSMD3	ENSG00000176018	COQ5	1	COQ5	1	0.00604574314165884	WBGene00009665	WBGene00009665(0)			GO:0016020;GO:0016021	membrane;integral component of membrane;Golgi apparatus;plasma membrane;Golgi organization	Alternative splicing;Cell membrane;Glycoprotein;Golgi apparatus;Membrane;Phosphoprotein;Reference proteome;Transmembrane;Transmembrane helix		
COQ5	negative	USF3	ENSG00000176542	COQ5	1	COQ5	1	0.00604574314165884					GO:0046983;GO:0005634;GO:0003677;GO:0006357;GO:0000981;GO:0010719	protein dimerization activity;nucleus;DNA binding;regulation of transcription by RNA polymerase II;DNA-binding transcription factor activity, RNA polymerase II-specific;negative regulation of epithelial to mesenchymal transition	Coiled coil;DNA-binding;Nucleus;Polymorphism;Reference proteome		
COQ5	negative	PNMA1	ENSG00000176903	COQ5	1	COQ5	1	0.00604574314165884					GO:0005634;GO:0005737;GO:0005515;GO:0005730;GO:0043065;GO:0002437	nucleus;cytoplasm;protein binding;nucleolus;positive regulation of apoptotic process;inflammatory response to antigenic stimulus	Nucleus;Polymorphism;Reference proteome;Tumor antigen		
COQ5	negative	ARID3B	ENSG00000179361	COQ5	1	COQ5	1	0.00604574314165884	WBGene00000476	WBGene00000476(0)			GO:0005634;GO:0005654;GO:0003677;GO:0005515;GO:0000977;GO:0001228;GO:0008150;GO:0000978;GO:0000980;GO:0045944	DNA binding;nucleus;nucleoplasm;protein binding;RNA polymerase II regulatory region sequence-specific DNA binding;biological_process;DNA-binding transcription activator activity, RNA polymerase II-specific;RNA polymerase II cis-regulatory region sequence-specific DNA binding;positive regulation of transcription by RNA polymerase II	Acetylation;Alternative splicing;DNA-binding;Methylation;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Tumor suppressor		
COQ5	negative	ZNRF2	ENSG00000180233	COQ5	1	COQ5	1	0.00604574314165884	WBGene00022115	WBGene00022115(1)			GO:0016020;GO:0046872;GO:0016740;GO:0016567;GO:0005765;GO:0005886;GO:0030054;GO:0045202;GO:0005764;GO:0005768;GO:0005829;GO:0000209;GO:0010008;GO:0032991;GO:0005737;GO:0042734;GO:0061630;GO:0030659	membrane;metal ion binding;transferase activity;protein ubiquitination;endosome;lysosomal membrane;plasma membrane;cell projection;cell junction;synapse;lysosome;cytosol;protein polyubiquitination;endosome membrane;protein-containing complex;cytoplasm;presynaptic membrane;ubiquitin protein ligase activity;cytoplasmic vesicle membrane	Cell junction;Cell membrane;Cell projection;Endosome;Lipoprotein;Lysosome;Membrane;Metal-binding;Myristate;Phosphoprotein;Reference proteome;Synapse;Transferase;Ubl conjugation pathway;Zinc;Zinc-finger	R-HSA-1280218;R-HSA-168256;R-HSA-983168;R-HSA-983169	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
COQ5	negative	MTURN	ENSG00000180354	COQ5	1	COQ5	1	0.00604574314165884					GO:0007275	cytoplasm;multicellular organism development;negative regulation of NF-kappaB transcription factor activity;positive regulation of ERK1 and ERK2 cascade;positive regulation of JNK cascade;positive regulation of megakaryocyte differentiation	Alternative splicing;Cytoplasm;Developmental protein;Phosphoprotein;Reference proteome		
COQ5	negative	OXTR	ENSG00000180914	COQ5	1	COQ5	1	0.00604574314165884	WBGene00008808;WBGene00011582				GO:0016020;GO:0016021;GO:0004930;GO:0007186;GO:0005886;GO:0007165;GO:0005000;GO:0005887;GO:0045907;GO:0004990;GO:0017046;GO:0001967;GO:0001975;GO:0007204;GO:0007507;GO:0007565;GO:0007613;GO:0010701;GO:0014070;GO:0021537;GO:0030431;GO:0032230;GO:0032355;GO:0032570;GO:0034059;GO:0034097;GO:0035176;GO:0042220;GO:0042493;GO:0042711;GO:0042713;GO:0042755;GO:0043434;GO:0044058;GO:0044849;GO:0045777;GO:0048545;GO:0048565;GO:0051965;GO:0051968;GO:0060137;GO:0060406;GO:0060455;GO:0070371;GO:0070474;GO:0120162;GO:0005902;GO:0005913;GO:0016324;GO:0006936;GO:0007166;GO:0032870;GO:0007595;GO:0001992	G protein-coupled receptor signaling pathway;integral component of membrane;G protein-coupled receptor activity;vasopressin receptor activity;oxytocin receptor activity;cell;membrane;plasma membrane;signal transduction;integral component of plasma membrane;positive regulation of vasoconstriction;peptide hormone binding;suckling behavior;response to amphetamine;positive regulation of cytosolic calcium ion concentration;heart development;female pregnancy;memory;positive regulation of norepinephrine secretion;response to organic cyclic compound;telencephalon development;sleep;positive regulation of synaptic transmission, GABAergic;response to estradiol;response to progesterone;response to anoxia;response to cytokine;social behavior;response to cocaine;response to drug;maternal behavior;sperm ejaculation;eating behavior;response to peptide hormone;regulation of digestive system process;estrous cycle;positive regulation of blood pressure;response to steroid hormone;digestive tract development;positive regulation of synapse assembly;positive regulation of synaptic transmission, glutamatergic;maternal process involved in parturition;positive regulation of penile erection;negative regulation of gastric acid secretion;ERK1 and ERK2 cascade;positive regulation of uterine smooth muscle contraction;positive regulation of cold-induced thermogenesis;microvillus;apical plasma membrane;muscle contraction;cell surface receptor signaling pathway;peptide binding;cellular response to hormone stimulus;lactation;regulation of systemic arterial blood pressure by vasopressin	Cell membrane;Disulfide bond;G-protein coupled receptor;Glycoprotein;Membrane;Phosphoprotein;Polymorphism;Receptor;Reference proteome;Transducer;Transmembrane;Transmembrane helix	R-HSA-162582;R-HSA-372790;R-HSA-388396;R-HSA-416476;R-HSA-500792;R-HSA-373076;R-HSA-375276;R-HSA-388479	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (q) signalling events;GPCR ligand binding;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Vasopressin-like receptors
COQ5	negative	MOB2	ENSG00000182208	COQ5	1	COQ5	1	0.00604574314165884	WBGene00008601	WBGene00008601(0)			GO:0005634;GO:0005737;GO:0046872;GO:0005730;GO:0005829;GO:0005515;GO:0048471;GO:0001934;GO:0010976;GO:0030036;GO:0044306	nucleus;cytoplasm;metal ion binding;nucleoplasm;nucleolus;cytosol;protein binding;perinuclear region of cytoplasm;positive regulation of protein phosphorylation;positive regulation of neuron projection development;actin cytoskeleton organization;neuron projection terminus	Alternative splicing;Cytoplasm;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Zinc		
COQ5	negative	HGS	ENSG00000185359	COQ5	1	COQ5	1	0.00604574314165884	WBGene00004101	WBGene00004101(1)			GO:0005623;GO:0006886;GO:0016525;GO:0005737;GO:0016020;GO:0015031;GO:0043231;GO:0046872;GO:0016301;GO:0016310;GO:0005829;GO:0005515;GO:0005768;GO:0005764;GO:0070062;GO:0010628;GO:0072657;GO:0031901;GO:0016197;GO:0016236;GO:0036258;GO:0016579;GO:0007165;GO:0019904;GO:0006622;GO:0032585;GO:0061024;GO:1903543;GO:0044389;GO:0008285;GO:0042059;GO:0010324;GO:0010642;GO:0030948;GO:0042176;GO:0043405;GO:0046426;GO:0005769;GO:0033565	intracellular protein transport;metal ion binding;negative regulation of angiogenesis;negative regulation of vascular endothelial growth factor receptor signaling pathway;cytoplasm;membrane;protein transport;intracellular membrane-bounded organelle;kinase activity;phosphorylation;cytosol;endosome;protein binding;lysosome;extracellular exosome;positive regulation of gene expression;protein localization to membrane;early endosome membrane;endosomal transport;macroautophagy;multivesicular body assembly;protein deubiquitination;signal transduction;protein domain specific binding;protein targeting to lysosome;multivesicular body membrane;membrane organization;positive regulation of exosomal secretion;ubiquitin-like protein ligase binding;negative regulation of cell population proliferation;negative regulation of epidermal growth factor receptor signaling pathway;membrane invagination;negative regulation of platelet-derived growth factor receptor signaling pathway;regulation of protein catabolic process;regulation of MAP kinase activity;negative regulation of receptor signaling pathway via JAK-STAT;early endosome;ESCRT-0 complex	3D-structure;Acetylation;Alternative splicing;Cytoplasm;Endosome;Membrane;Metal-binding;Phosphoprotein;Polymorphism;Protein transport;Reference proteome;Transport;Ubl conjugation;Zinc;Zinc-finger	R-HSA-5653656;R-HSA-392499;R-HSA-597592;R-HSA-162582;R-HSA-199991;R-HSA-1643685;R-HSA-5663205;R-HSA-917729;R-HSA-5688426;R-HSA-5689880;R-HSA-9006934;R-HSA-199992;R-HSA-432720;R-HSA-8856828;R-HSA-8856825;R-HSA-177929;R-HSA-182971;R-HSA-6806834;R-HSA-6807004;R-HSA-8875360;R-HSA-8876384	Vesicle-mediated transport;Metabolism of proteins;Post-translational protein modification;Signal Transduction;Membrane Trafficking;Disease;Infectious disease;Endosomal Sorting Complex Required For Transport (ESCRT);Deubiquitination;Ub-specific processing proteases;Signaling by Receptor Tyrosine Kinases;trans-Golgi Network Vesicle Budding;Lysosome Vesicle Biogenesis;Clathrin-mediated endocytosis;Cargo recognition for clathrin-mediated endocytosis;Signaling by EGFR;EGFR downregulation;Signaling by MET;Negative regulation of MET activity;InlB-mediated entry of Listeria monocytogenes into host cell;Listeria monocytogenes entry into host cells
COQ5	negative	DUSP28	ENSG00000188542	COQ5	1	COQ5	1	0.00604574314165884					GO:0016787;GO:0004721;GO:0006470;GO:0016311;GO:0035335;GO:0016791;GO:0008138;GO:0004725	phosphatase activity;protein dephosphorylation;protein tyrosine/serine/threonine phosphatase activity;dephosphorylation;hydrolase activity;phosphoprotein phosphatase activity;peptidyl-tyrosine dephosphorylation;protein tyrosine phosphatase activity	3D-structure;Hydrolase;Protein phosphatase;Reference proteome		
COQ5	negative	MMP1	ENSG00000196611	COQ5	1	COQ5	1	0.00604574314165884	WBGene00016283;WBGene00006987;WBGene00010423	WBGene00010524(0);WBGene00016283(0);WBGene00012364(0);WBGene00012185(0);WBGene00194737(0)		Severe generalized recessive dystrophic epidermolysis bullosa;EPIDERMOLYSIS BULLOSA DYSTROPHICA AUTOSOMAL RECESSIVE;PULMONARY DISEASE CHRONIC OBSTRUCTIVE	GO:0008270;GO:0046872;GO:0016787;GO:0008233;GO:0006508;GO:0005576;GO:0004222;GO:0008237;GO:0031012;GO:0050900;GO:0030198;GO:0044267;GO:0031334;GO:0016032;GO:0019221;GO:0022617;GO:0030574;GO:0004252;GO:0004175	zinc ion binding;proteolysis;metalloendopeptidase activity;metallopeptidase activity;extracellular matrix;metal ion binding;hydrolase activity;peptidase activity;extracellular region;leukocyte migration;extracellular matrix organization;cellular protein metabolic process;positive regulation of protein-containing complex assembly;viral process;cytokine-mediated signaling pathway;extracellular matrix disassembly;collagen catabolic process;serine-type endopeptidase activity;endopeptidase activity	3D-structure;Autocatalytic cleavage;Calcium;Collagen degradation;Direct protein sequencing;Disulfide bond;Extracellular matrix;Glycoprotein;Host-virus interaction;Hydrolase;Metal-binding;Metalloprotease;Phosphoprotein;Polymorphism;Protease;Reference proteome;Repeat;Secreted;Signal;Zinc;Zymogen	R-HSA-109582;R-HSA-168256;R-HSA-202733;R-HSA-392499;R-HSA-1280215;R-HSA-449147;R-HSA-1474228;R-HSA-1474244;R-HSA-1442490;R-HSA-381426;R-HSA-6785807;R-HSA-210991;R-HSA-1592389	Hemostasis;Immune System;Cell surface interactions at the vascular wall;Metabolism of proteins;Cytokine Signaling in Immune system;Signaling by Interleukins;Degradation of the extracellular matrix;Extracellular matrix organization;Collagen degradation;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Interleukin-4 and Interleukin-13 signaling;Basigin interactions;Activation of Matrix Metalloproteinases
COQ5	negative	CD47	ENSG00000196776	COQ5	1	COQ5	1	0.00604574314165884					GO:0071347;GO:0016020;GO:0016021;GO:0007155;GO:0005886;GO:0005515;GO:0050900;GO:0005887;GO:0050870;GO:0043312;GO:0035579;GO:0070821;GO:0008284;GO:0098609;GO:0022409;GO:0050766;GO:0009986;GO:0030198;GO:0045428;GO:0007229;GO:0034113;GO:0050729;GO:0070053;GO:0035696;GO:0086080;GO:0016477;GO:0051496;GO:0098632;GO:0032649;GO:0032675;GO:0032680;GO:0071346;GO:0071349;GO:0032653;GO:0032655;GO:1905450;GO:0070062;GO:0008228;GO:0009617	cellular response to interleukin-1;protein binding;membrane;integral component of membrane;cell adhesion;plasma membrane;leukocyte migration;integral component of plasma membrane;positive regulation of T cell activation;neutrophil degranulation;specific granule membrane;tertiary granule membrane;positive regulation of cell population proliferation;positive regulation of cell-cell adhesion;positive regulation of phagocytosis;cell surface;extracellular matrix organization;regulation of nitric oxide biosynthetic process;integrin-mediated signaling pathway;heterotypic cell-cell adhesion;positive regulation of inflammatory response;thrombospondin receptor activity;monocyte extravasation;protein binding involved in heterotypic cell-cell adhesion;cell migration;positive regulation of stress fiber assembly;cell-cell adhesion mediator activity;regulation of interferon-gamma production;regulation of interleukin-6 production;regulation of tumor necrosis factor production;cellular response to interferon-gamma;cellular response to interleukin-12;regulation of interleukin-10 production;regulation of interleukin-12 production;negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis;extracellular exosome;inflammatory response;opsonization;response to bacterium;monocyte aggregation	3D-structure;Alternative splicing;Cell adhesion;Cell membrane;Direct protein sequencing;Disulfide bond;Glycoprotein;Immunoglobulin domain;Membrane;Phosphoprotein;Pyrrolidone carboxylic acid;Reference proteome;Signal;Transmembrane;Transmembrane helix	R-HSA-109582;R-HSA-168249;R-HSA-168256;R-HSA-202733;R-HSA-1474244;R-HSA-216083;R-HSA-6798695;R-HSA-1500931;R-HSA-391160	Hemostasis;Innate Immune System;Immune System;Cell surface interactions at the vascular wall;Extracellular matrix organization;Integrin cell surface interactions;Neutrophil degranulation;Cell-Cell communication;Signal regulatory protein family interactions
COQ5	negative	CASP4	ENSG00000196954	COQ5	1	COQ5	1	0.00604574314165884	WBGene00000819;WBGene00000417;WBGene00000820;WBGene00000821	WBGene00000819(0);WBGene00000821(0);WBGene00000820(0);WBGene00000417(0)			GO:0005737;GO:0016020;GO:0005829;GO:0005783;GO:0005789;GO:0016787;GO:0042981;GO:0005739;GO:0005886;GO:0008233;GO:0008234;GO:0006508;GO:0005576;GO:0004197;GO:0006954;GO:0002376;GO:0045087;GO:0005515;GO:0050700;GO:0032991;GO:0006919;GO:0012501;GO:0006915;GO:0070059;GO:0097169;GO:0097199;GO:0050727;GO:1903265;GO:0072557;GO:0072559;GO:0097193;GO:1904646;GO:0061702	regulation of apoptotic process;proteolysis;cysteine-type peptidase activity;cysteine-type endopeptidase activity;cytoplasm;membrane;cytosol;plasma membrane;endoplasmic reticulum;endoplasmic reticulum membrane;hydrolase activity;mitochondrion;peptidase activity;extracellular region;inflammatory response;immune system process;innate immune response;protein binding;CARD domain binding;protein-containing complex;activation of cysteine-type endopeptidase activity involved in apoptotic process;programmed cell death;inflammasome complex;apoptotic process;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;AIM2 inflammasome complex;cysteine-type endopeptidase activity involved in apoptotic signaling pathway;regulation of inflammatory response;positive regulation of tumor necrosis factor-mediated signaling pathway;IPAF inflammasome complex;NLRP3 inflammasome complex;intrinsic apoptotic signaling pathway;cellular response to amyloid-beta	Acetylation;Alternative splicing;Cytoplasm;Endoplasmic reticulum;Hydrolase;Immunity;Inflammasome;Inflammatory response;Innate immunity;Membrane;Mitochondrion;Necrosis;Phosphoprotein;Polymorphism;Protease;Reference proteome;Secreted;Thiol protease;Zymogen	R-HSA-168249;R-HSA-168256;R-HSA-168643;R-HSA-168638	Innate Immune System;Immune System;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;NOD1/2 Signaling Pathway
COQ5	negative	DNM3	ENSG00000197959	COQ5	1	COQ5	1	0.00604574314165884	WBGene00001130;WBGene00001093				GO:0003924;GO:0005525;GO:0000166;GO:0005737;GO:0016787;GO:0005856;GO:0048471;GO:0005874;GO:0005886;GO:0016020;GO:0005515;GO:0045202;GO:0006897;GO:0070062;GO:0008017;GO:0014069;GO:0045211;GO:0043197;GO:0046847;GO:0030424;GO:0031410;GO:0000266;GO:0007416;GO:0016185;GO:0031623;GO:0099173;GO:0050803;GO:0098884;GO:0044327;GO:0098844;GO:0031798;GO:0031802;GO:0050998;GO:0099186;GO:0048488;GO:0051491;GO:0061001;GO:0061002;GO:1903423;GO:0001917;GO:0005794;GO:0043083;GO:0061828;GO:0061829;GO:0098793;GO:0098978	GTP binding;GTPase activity;cytoplasm;nucleotide binding;hydrolase activity;cytoskeleton;perinuclear region of cytoplasm;microtubule;plasma membrane;protein binding;endocytosis;membrane;synapse;membrane fusion;extracellular exosome;microtubule binding;postsynaptic density;postsynaptic membrane;dendritic spine;filopodium assembly;mitochondrial membrane;microtubule cytoskeleton;axon;cytoplasmic vesicle;organelle fission;mitochondrial fission;synapse assembly;synaptic vesicle budding from presynaptic endocytic zone membrane;receptor internalization;postsynapse organization;regulation of synapse structure or activity;postsynaptic neurotransmitter receptor internalization;dendritic spine head;postsynaptic endocytic zone membrane;type 1 metabotropic glutamate receptor binding;type 5 metabotropic glutamate receptor binding;nitric-oxide synthase binding;structural constituent of postsynapse;synaptic vesicle endocytosis;positive regulation of filopodium assembly;regulation of dendritic spine morphogenesis;negative regulation of dendritic spine morphogenesis;positive regulation of synaptic vesicle recycling;photoreceptor inner segment;Golgi apparatus;synaptic cleft;apical tubulobulbar complex;basal tubulobulbar complex;presynapse;glutamatergic synapse	3D-structure;Acetylation;Alternative splicing;Cytoplasm;Cytoskeleton;Endocytosis;GTP-binding;Hydrolase;Microtubule;Motor protein;Nucleotide-binding;Phosphoprotein;Reference proteome	R-HSA-1280218;R-HSA-168249;R-HSA-168256;R-HSA-5653656;R-HSA-1266738;R-HSA-373760;R-HSA-422475;R-HSA-437239;R-HSA-162582;R-HSA-199991;R-HSA-2132295;R-HSA-9006934;R-HSA-166016;R-HSA-168898;R-HSA-8856828;R-HSA-166520;R-HSA-187037;R-HSA-177504	Adaptive Immune System;Innate Immune System;Immune System;Vesicle-mediated transport;Developmental Biology;L1CAM interactions;Axon guidance;Recycling pathway of L1;Signal Transduction;Membrane Trafficking;MHC class II antigen presentation;Signaling by Receptor Tyrosine Kinases;Toll Like Receptor 4 (TLR4) Cascade;Toll-like Receptor Cascades;Clathrin-mediated endocytosis;Signaling by NTRKs;Signaling by NTRK1 (TRKA);Retrograde neurotrophin signalling
COQ5	negative	MIER1	ENSG00000198160	COQ5	1	COQ5	1	0.00604574314165884	WBGene00017352;WBGene00020320	WBGene00020320(0);WBGene00017352(0)			GO:0005634;GO:0005737;GO:0005654;GO:0006355;GO:0003677;GO:0005515;GO:0017053;GO:0042826;GO:0000122;GO:0000981;GO:0003714;GO:0004407;GO:0032991;GO:0043123;GO:0016575;GO:0001103;GO:0031937	DNA binding;regulation of transcription, DNA-templated;transcriptional repressor complex;histone deacetylase binding;nucleus;cytoplasm;nucleoplasm;protein binding;negative regulation of transcription by RNA polymerase II;DNA-binding transcription factor activity, RNA polymerase II-specific;transcription corepressor activity;histone deacetylase activity;protein-containing complex;positive regulation of I-kappaB kinase/NF-kappaB signaling;histone deacetylation;RNA polymerase II repressing transcription factor binding;positive regulation of chromatin silencing	Alternative splicing;Cytoplasm;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation		
COQ5	negative	R3HDM4	ENSG00000198858	COQ5	1	COQ5	1	0.00604574314165884	WBGene00012908	WBGene00012908(0)			GO:0003676;GO:0005634	nucleic acid binding;nucleus	Nucleus;Reference proteome		
COQ5	negative	PPP1CB	ENSG00000213639	COQ5	1	COQ5	1	0.00604574314165884	WBGene00001747;WBGene00001748	WBGene00001747(1)		NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR;Rasopathy with developmental delay short stature and sparse slow-growing hair;NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2	GO:0046872;GO:0016787;GO:0004721;GO:0006470;GO:0005634;GO:0005737;GO:0005829;GO:0005886;GO:0051301;GO:0005515;GO:0007049;GO:0048511;GO:0005975;GO:0032922;GO:0005654;GO:0005730;GO:0005925;GO:0070062;GO:0019901;GO:0004722;GO:0000784;GO:0005977;GO:0030155;GO:0000086;GO:0042752;GO:0072357;GO:0043153;GO:0016791;GO:0017018;GO:0050115;GO:0005979;GO:0005981;GO:0000164;GO:0042587	hydrolase activity;metal ion binding;phosphoprotein phosphatase activity;protein dephosphorylation;nucleus;cytoplasm;nucleoplasm;cytosol;plasma membrane;focal adhesion;cell division;protein binding;cell cycle;rhythmic process;circadian regulation of gene expression;carbohydrate metabolic process;nucleolus;extracellular exosome;protein kinase binding;protein serine/threonine phosphatase activity;nuclear chromosome, telomeric region;glycogen metabolic process;regulation of cell adhesion;G2/M transition of mitotic cell cycle;regulation of circadian rhythm;PTW/PP1 phosphatase complex;entrainment of circadian clock by photoperiod;phosphatase activity;myosin phosphatase activity;myosin-light-chain-phosphatase activity;regulation of glycogen biosynthetic process;regulation of glycogen catabolic process;protein phosphatase type 1 complex;glycogen granule	Acetylation;Biological rhythms;Carbohydrate metabolism;Cell cycle;Cell division;Cytoplasm;Direct protein sequencing;Disease mutation;Glycogen metabolism;Hydrolase;Manganese;Metal-binding;Nucleus;Phosphoprotein;Protein phosphatase;Reference proteome	R-HSA-1430728;R-HSA-556833;R-HSA-162582;R-HSA-194315;R-HSA-1640170;R-HSA-453274;R-HSA-69275;R-HSA-69278;R-HSA-163560;R-HSA-8979227;R-HSA-195258;R-HSA-2565942;R-HSA-9006936;R-HSA-170834;R-HSA-400253;R-HSA-5625900;R-HSA-5625740;R-HSA-5627117;R-HSA-5627123;R-HSA-2173788;R-HSA-2173789	Metabolism;Metabolism of lipids;Signal Transduction;Signaling by Rho GTPases;Cell Cycle;Mitotic G2-G2/M phases;G2/M Transition;Cell Cycle, Mitotic;Triglyceride catabolism;Triglyceride metabolism;RHO GTPase Effectors;Regulation of PLK1 Activity at G2/M Transition;Signaling by TGF-beta family members;Signaling by TGF-beta Receptor Complex;Circadian Clock;RHO GTPases activate CIT;RHO GTPases activate PKNs;RHO GTPases Activate ROCKs;RHO GTPases activate PAKs;Downregulation of TGF-beta receptor signaling;TGF-beta receptor signaling activates SMADs
COQ5	negative	SMIM27	ENSG00000235453	COQ5	1	COQ5	1	0.00604574314165884					GO:0016020;GO:0016021	membrane;integral component of membrane	Membrane;Reference proteome;Transmembrane;Transmembrane helix		
COQ5	negative	RNF103	ENSG00000239305	COQ5	1	COQ5	1	0.00604574314165884					GO:0016020;GO:0016021;GO:0046872;GO:0016740;GO:0005783;GO:0005789;GO:0016567;GO:0004842;GO:0044322;GO:0005515;GO:0061630;GO:0030433;GO:0007417;GO:1904380	ubiquitin-protein transferase activity;protein ubiquitination;membrane;integral component of membrane;metal ion binding;transferase activity;endoplasmic reticulum;endoplasmic reticulum membrane;endoplasmic reticulum quality control compartment;protein binding;ubiquitin protein ligase activity;ubiquitin-dependent ERAD pathway;central nervous system development;endoplasmic reticulum mannose trimming	Endoplasmic reticulum;Membrane;Metal-binding;Reference proteome;Transferase;Transmembrane;Transmembrane helix;Ubl conjugation pathway;Zinc;Zinc-finger	R-HSA-392499;R-HSA-597592;R-HSA-446203;R-HSA-532668;R-HSA-901032;R-HSA-901042	Metabolism of proteins;Post-translational protein modification;Asparagine N-linked glycosylation;N-glycan trimming in the ER and Calnexin/Calreticulin cycle;ER Quality Control Compartment (ERQC);Calnexin/calreticulin cycle
COQ5	negative	TMEM189	ENSG00000240849	COQ5	1	COQ5	1	0.00604574314165884	WBGene00013136				GO:0016020;GO:0016021;GO:0005783;GO:0005789	membrane;integral component of membrane;endoplasmic reticulum;oxidoreductase activity;oxidation-reduction process;endoplasmic reticulum membrane;lipid metabolic process;fatty acid metabolic process;ether lipid biosynthetic process;plasmanylethanolamine desaturase activity	Alternative splicing;Endoplasmic reticulum;Fatty acid metabolism;Lipid metabolism;Membrane;Oxidoreductase;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix		
COQ5	negative	TMEM158	ENSG00000249992	COQ5	1	COQ5	1	0.00604574314165884					GO:0016020;GO:0016021;GO:0042277	membrane;integral component of membrane;peptide binding	Alternative splicing;Glycoprotein;Membrane;Reference proteome;Signal;Transmembrane;Transmembrane helix		
